mirror of
https://github.com/end-of-term/eot2024
synced 2025-01-18 21:13:45 +01:00
14609 lines
1.2 MiB
Plaintext
14609 lines
1.2 MiB
Plaintext
|
https://www.cancer.gov/
|
||
|
|
https://www.cancer.gov/2012-aacr-hand-out.pdf
|
||
|
|
https://www.cancer.gov/about-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/care-choices
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/care-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/palliative-care-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/bereavement-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/bereavement-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/last-days-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/planning/last-days-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/caregivers/self-care
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/feelings
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/finding-purpose-meaning
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/planning
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/planning/end-of-life-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/planning/end-of-life-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/planning/hospice-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/questions
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/research
|
||
|
|
https://www.cancer.gov/about-cancer/advanced-cancer/talking
|
||
|
|
https://www.cancer.gov/about-cancer/build-your-own-quit-plan-video
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention-0
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/genetics
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-exchange-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-changes-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-testing-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/hp-prevention-overview-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/patient-prevention-overview-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/research
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/research/aspirin-cancer-risk
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/age
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/alcohol
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/alcohol/alcohol-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/alcohol/alcohol-related-cancers-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/chronic-inflammation
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/did-you-know-risk-factors-video
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/acrylamide-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/antioxidants-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/artificial-sweeteners-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/cooked-meats-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/cruciferous-vegetables-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/down-home-healthy-cooking.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/diet/vitamin-d-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/des-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/mht-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/oral-contraceptives-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/reproductive-history-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/immunosuppression
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/h-pylori-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hiv-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-uptake-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/myths
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/myths/antiperspirants-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/myths/fluoridated-water-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/overweight-cancers-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/physical-activity-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/cell-phones-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/electromagnetic-fields-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/fallout-pdf
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/i-131
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/i131-report-and-appendix
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/interventional-fluoroscopy.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/na-flip-chart-v-7-0
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/nuclear-accidents-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/pediatric-ct-scans
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/radiation/tsda.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/aflatoxins
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/aristolochic-acids
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/arsenic
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/asbestos/asbestos-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/benzene
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/benzidine
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/beryllium
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/butadiene
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/cadmium
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/cancer-clusters-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/carcinogens
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/chromium
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/coal-tar
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/coke-oven
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/crystalline-silica
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/erionite
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/ethylene-oxide
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/formaldehyde
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/formaldehyde/formaldehyde-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/hair-dyes-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/indoor-coal
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/inorganic-acid
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/mineral-oils
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/nickel
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/radon
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/radon/radon-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/secondhand-smoke
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/soot
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/thorium
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/trichloroethylene
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/vinyl-chloride
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/substances/wood-dust
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/sunlight
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/cessation-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/cigars-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/help-quitting-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/light-cigarettes-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/quit-smoking-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/quit-smoking-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/second-hand-smoke-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/smokeless-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/withdrawal-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/coping
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/changes-for-family
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/communication-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/communication-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/spouse-or-partner
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/support-groups
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/talk-to-children
|
||
|
|
https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/talk-with-doctors
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/caregiving-after-treatment
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/parents
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/parents/child-cancer-diagnosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/parents/family-support-video
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/parents/managing-cancer-information-video
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/parents/supporting-child-with-cancer-video
|
||
|
|
https://www.cancer.gov/about-cancer/coping/caregiver-support/teens
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/back-to-work
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/benefits-of-exercise-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/daily-routine
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/faith-and-spirituality
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/faith-and-spirituality/spirituality-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/day-to-day/faith-and-spirituality/spirituality-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/family-friends/family-caregivers-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/family-friends/family-caregivers-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/anxiety-distress-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/anxiety-distress-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/depression-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/depression-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/relaxation
|
||
|
|
https://www.cancer.gov/about-cancer/coping/feelings/stress-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/coping/nci-asco-wallet-card.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/coping/questions
|
||
|
|
https://www.cancer.gov/about-cancer/coping/research
|
||
|
|
https://www.cancer.gov/about-cancer/coping/self-image
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/advanced-cancer-long-term
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/cancer-survivorship-did-you-know
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/child-care
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/did-you-know-cancer-survival-update-video
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/family-issues
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/follow-up-care
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/late-effects
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/new-normal
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/new-normal/ptsd-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/new-normal/ptsd-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/questions
|
||
|
|
https://www.cancer.gov/about-cancer/coping/survivorship/survivorship-facebook-live
|
||
|
|
https://www.cancer.gov/about-cancer/coronavirus
|
||
|
|
https://www.cancer.gov/about-cancer/coronavirus/coronavirus-cancer-patient-information
|
||
|
|
https://www.cancer.gov/about-cancer/coronavirus/covid-19-vaccines-people-with-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/ct-scans-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/pathology-reports-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-grade
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-markers-list
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/creative-response-prognosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/diving-out-of-the-dark-prognosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/for-doctors-prognosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/from-anger-to-acceptance-prognosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/patient-viewer-guide.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/provider-viewer-guide.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/understanding-prognosis-video
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/questions
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/research
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/staging
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/staging/sentinel-node-biopsy-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/diagnosis-staging/symptoms
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/advance-directives
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/finding-cancer-care
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/finding-cancer-care/providers
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/finding-cancer-care/support
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/track-care-costs
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-conversation-log.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/track-care-costs/medical-care-record.pdf
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/using-trusted-resources
|
||
|
|
https://www.cancer.gov/about-cancer/managing-care/using-trusted-resources/health-info-online
|
||
|
|
https://www.cancer.gov/about-cancer/screening
|
||
|
|
https://www.cancer.gov/about-cancer/screening/hp-screening-overview-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/screening/patient-screening-overview-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/screening/research
|
||
|
|
https://www.cancer.gov/about-cancer/screening/research/what-screening-statistics-mean
|
||
|
|
https://www.cancer.gov/about-cancer/screening/screening-tests
|
||
|
|
https://www.cancer.gov/about-cancer/treatment
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/cam-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/diets-supplements
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/714-x-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/acupuncture-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/antineoplastons-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/aromatherapy-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/black-cohosh-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/cancell-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/cartilage-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/coenzyme-q10-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/curcumin-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/dietary-interactions-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/essiac-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/gerson-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/gonzalez-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/hydrazine-sulfate-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/laetrile-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/milk-thistle-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/mistletoe-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/mushrooms-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/ndv-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/pc-spes-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/prostate-supplements-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/suns-soup-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/hp/vitamin-c-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/714-x-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/acupuncture-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/antineoplastons-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/aromatherapy-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/black-cohosh-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/cancell-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/cartilage-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/coenzyme-q10-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/curcumin-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/dietary-interactions-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/essiac-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/gerson-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/gonzalez-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/hydrazine-sulfate-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/laetrile-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/milk-thistle-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/mistletoe-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/mushrooms-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/ndv-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/pc-spes-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/prostate-supplements-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/suns-soup-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/cam/patient/vitamin-c-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/clinical-center
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/abemaciclib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/abirateroneacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/abvd
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/abve
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/abve-pc
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ac
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ac-t
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/acalabrutinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/access-experimental
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/adagrasib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ade
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ado-trastuzumab-emtansine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/afamitresgene-autoleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/afatinibdimaleate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/aldesleukin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/alectinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/alemtuzumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/alpelisib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/amifostine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/aminolevulinicacid
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/amivantamab-vmjw
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/anal
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/anastrozole
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/apalutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/aprepitant
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/arsenictrioxide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/asciminib-hydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/asparaginase-erwinia-chrysanthemi
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/asparaginase-erwinia-chrysanthemi-recombinant
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/atezolizumab-and-hyaluronidase-tqjs
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/avapritinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/avelumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/axicabtageneciloleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/axitinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/azacitidine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/beacopp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/belinostat
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/belzutifan
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bendamustinehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bep
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bexarotene
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bicalutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/binimetinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bladder
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bleomycin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/blinatumomab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bone
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bosutinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/brain
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/breast
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/brentuximabvedotin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/brexucabtageneautoleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/brigatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/bumel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/busulfan
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cabazitaxel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cabozantinib-s-malate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/caf
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/calaspargasepegol-mknl
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cancer-type
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/capecitabine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/capivasertib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/caplacizumab-yhdp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/capmatinibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/capox
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin-taxol
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/carfilzomib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/carmustine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/carmustineimplant
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cem
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cemiplimab-rwlc
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ceritinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cervical
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cetuximab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cev
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/childhood-cancer-fda-approved-drugs
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/chlorambucil
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/chlorambucil-prednisone
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/chop
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ciltacabtagene-autoleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cisplatin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cladribine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/clofarabine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cmf
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cobimetinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/colorectal
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/copdac
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/copp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/copp-abv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/crizotinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cvp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cyclophosphamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/cytarabine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dabrafenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dacarbazine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dacomitinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dactinomycin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/daratumumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/daratumumabandhyaluronidase-fihj
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/darbepoetinalfa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/darolutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dasatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/daunorubicinhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/daunorubicinhydrochlorideandcytarabineliposome
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/decitabine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/decitabineandcedazuridine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/defibrotide-sodium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/degarelix
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/denileukindiftitox-cxdl
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/denosumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dexamethasone
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dexrazoxanehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dinutuximab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/docetaxel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/dostarlimab-gxly
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicin-hydrochloride-liposome
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/doxorubicinhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/durvalumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/duvelisib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/eflornithine-hydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/elacestrant-dihydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/elotuzumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/elranatamab-bcmm
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/eltrombopagolamine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/emapalumab-lzsg
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/enasidenibmesylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/encorafenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/endometrial
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/enfortumabvedotin-ejfv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/entrectinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/enzalutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/epcoritamab-bysp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/epirubicinhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/epoch
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/epoetinalfa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/erdafitinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/eribulinmesylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/erlotinibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/esophageal
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/etoposide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/etoposidephosphate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/everolimus
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/exemestane
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/famtrastuzumabderuxtecan-nxki
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fec
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fedratinibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/filgrastim
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fludarabinephosphate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fluorouracil
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fluorouracil-topical
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/flutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/folfiri
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-bevacizumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/folfiri-cetuximab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/folfirinox
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/folfox
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fostamatinibdisodium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fruquintinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fu-lv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/fulvestrant
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/futibatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gefitinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabine-cisplatin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabine-oxaliplatin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gemcitabinehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gemtuzumabozogamicin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gestationaldisease
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gilteritinibfumarate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/gist
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/glasdegibmaleate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/glofitamab-gxbm
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/glucarpidase
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/goserelinacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/granisetron
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/granisetronhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/head-neck
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/hodgkin-lymphoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/hydroxyurea
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/hyper-cvad
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ice
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/idarubicinhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/idecabtagenevicleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/idelalisib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ifosfamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/imatinibmesylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/imetelstat-sodium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/imiquimod
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/inavolisib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/inotuzumabozogamicin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/iobenguanei131
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ipilimumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/irinotecan-hydrochloride-liposome
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/irinotecanhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/isatuximab-irfc
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ivosidenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ixabepilone
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ixazomibcitrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/jeb
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/kaposi-sarcoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/kidney
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lanreotideacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lapatinibditosylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/larotrectinibsulfate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lazertinib-mesylate-hydrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lenalidomide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lenvatinibmesylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/letrozole
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/leucovorincalcium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/leukemia
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/leuprolide-mesylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/leuprolideacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lifileucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lisocabtagenemaraleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/liver
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lomustine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/loncastuximabtesirine-lpyl
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lorlatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lung
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lurbinectedin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/luspatercept-aamt
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lutetium-lu-177-vipivotide-tetraxetan
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/lutetiumlu177-dotatate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/margetuximab-cmkb
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mechlorethaminehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/megestrolacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/melanoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/melphalan
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/melphalan-hydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mercaptopurine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mesna
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mesothelioma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/methotrexate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/methylnaltrexonebromide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/midostaurin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mirvetuximab-soravtansine-gynx
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mitomycin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mitoxantronehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mogamulizumabkpkc
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/momelotinib-dihydrochloride-monohydrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mopp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mosunetuzumab-axgb
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/multicentric-castleman-disease
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/multiple-myeloma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/mvac
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/myeloproliferative-neoplasms
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nadofaragene-firadenovec-vncg
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nanoparticlepaclitaxel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/naxitamab-gqgk
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/necitumumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nelarabine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/neratinibmaleate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/netupitant-palonosetronhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/neuroblastoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nilotinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nilutamide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/niraparib-tosylate-monohydrate-and-abiraterone-acetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/niraparibtosylatemonohydrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nirogacestat
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab-and-relatlimab-rmbw
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/nogapendekin-alfa-inbakicept-pmln
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/non-hodgkin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/obinutuzumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/oepa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ofatumumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/off
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/off-label
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/olaparib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/olutasidenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/omacetaxinemepesuccinate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ondansetronhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/oppa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/osimertinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ovarian
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/oxaliplatin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/paclitaxel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pacritinib-citrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pad
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/palbociclib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/palifermin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/palonosetronhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pamidronatedisodium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pancreatic
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/panitumumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pazopanibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pcv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/peb
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pegaspargase
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pegfilgrastim
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pemetrexeddisodium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pemigatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/penile
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pertuzumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pertuzumabtrastuzumabandhyaluronidase-zzxf
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pexidartinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pheochromocytoma-paraganglioma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pirtobrutinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/plerixafor
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/polatuzumabvedotin-piiq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pomalidomide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ponatinibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pralatrexate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/pralsetinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/prednisone
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/procarbazinehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/propranolol-hydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/prostate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/quizartinib-dihydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/r-chop
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/r-cvp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/r-epoch
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/r-ice
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/radium-223-dichloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/raloxifenehydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ramucirumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rasburicase
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ravulizumab-cwvz
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-bivalent-vaccine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-nonavalent-vaccine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/recombinant-interferon-alfa-2b
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/regorafenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/related-conditions
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/relugolix
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/repotrectinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/retifanlimab-dlwr
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/retinoblastoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rhabdomyosarcoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ribociclib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ribociclib-succinate-and-letrozole
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ripretinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rituximab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rituximabandhyaluronidasehuman
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rolapitanthydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/romidepsin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/romiplostim
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ropeginterferon-alfa-2b-njft
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/rucaparibcamsylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ruxolitinibphosphate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sacituzumabgovitecan-hziy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/selinexor
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/selpercatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/selumetinibsulfate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/siltuximab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sipuleucel-t
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sirolimus-protein-bound-particles
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/skin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/soft-tissue-sarcoma
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/solid-tumors
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sonidegib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sorafenibtosylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sotorasib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/stanfordv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/stomach
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/sunitinibmalate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tac
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tafasitamab-cxix
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tagraxofusp-erzs
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/talazoparibtosylate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/talc
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/talimogenelaherparepvec
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/talquetamab-tgvs
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tamoxifencitrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tarlatamab-dlle
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tazemetostathydrobromide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tebentafusp-tebn
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/teclistamab-cqyv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/temozolomide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/temsirolimus
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tepotinibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/testicular
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/thalidomide
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/thioguanine
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/thiotepa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/thyroid
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tisagenlecleucel
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tislelizumab-jsgr
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tisotumabvedotin-tftv
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tivozanibhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tocilizumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/topotecanhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/toremifene
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/toripalimab-tpzi
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tovorafenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tpf
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/trabectedin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/trametinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumab
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/trastuzumabandhyaluronidase-oysk
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tremelimumab-actl
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/trifluridine-tipiracilhydrochloride
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/triptorelin-pamoate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/tucatinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/uridinetriacetate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vac
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vaginal
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/valrubicin
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vamp
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vandetanib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/veip
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vemurafenib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/venetoclax
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vinblastinesulfate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vincristinesulfate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vinorelbinetartrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vip
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vismodegib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vorasidenib-citrate
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vorinostat
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/vulvar
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/wilms-tumor
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/xeliri
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/xelox
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/zanubrutinib
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/ziv-aflibercept
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/drugs/zoledronicacid
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/questions
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research/cachexia
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research/car-t-cell-therapy-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research/drug-combo-resistance
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/research/exceptional-responders-initiative-qa
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/anemia
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/anemia/radiationtherapy-03-fatigue.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/ways-deal-with-appetite-loss-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/ascites
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/bleeding-bruising
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/bowel-obstruction
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/cancer-cachexia
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/cancer-symptom-clusters-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/cardiopulmonary-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/cardiopulmonary-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/constipation
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/constipation/gi-complications-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/delirium
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/diarrhea
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/diarrhea/radiationtherapy-07-diarrhea.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/edema
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fatigue
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fatigue/fatigue-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-men
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-men/radiationtherapy-08-sexuality-and-fertility-in-men.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/fertility-women/radiationtherapy-09-sexuality-and-fertility-in-women.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/food-safety-tips-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/hair-loss
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/hair-loss/radiationtherapy-04-hair-loss.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/hot-flashes-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/hot-flashes-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/improving-taste-smell-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/infection
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/memory
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/memory/cognitive-impairment-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/memory/cognitive-impairment-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/mouth-throat
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/mouth-throat/oral-complications-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/mouth-throat/oral-complications-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/mouth-throat/radiationtherapy-05-mouth-or-throat-pain.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nausea-vomiting
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nausea-vomiting/radiationtherapy-06-nausea-and-vomiting.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nerve-problems
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/add-calories
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/add-protein
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/clear-liquids
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/easy-chew-swallow
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/easy-to-digest
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/full-liquid-foods
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/high-fiber-foods
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/nutrition/low-fiber-foods
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/pain
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/pain/pain-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/sexuality-men
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/sexuality-women
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes/pruritus-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes/pruritus-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes/radiationtherapy-02-skin-problems.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/sleep-disorders-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/sleep-disorders-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/sleep-problems
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/urination-changes
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/side-effects/urination-changes/radiationtherapy-10-urination-problems.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/agnostic-cancer-therapies-hp-pdq
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/hormone-therapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/hyperthermia
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/angiogenesis-inhibitors-fact-sheet
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitor-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immunotherapy-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/nonspecific-immune-stimulation-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/photodynamic-therapy/photodyamic-therapy-process-infographic
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/photoimmunotherapy-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/brachytherapy
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/external-beam
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/radiationtherapy-11-brachytherapy.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/radiationtherapy-12-external-beam-radiation-therapy.mp3
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/side-effects
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/bone-marrow-video
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/donating-blood-stem-cells
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/surgery
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/surgery/cryosurgery
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/surgery/lasers
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/approved-drug-list
|
||
|
|
https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/monoclonal-antibodies-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/disparities
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/disparities/addressing-cancer-disparities-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/disparities/american-indian-alaska-native-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/disparities/cancer-health-disparities-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/statistics
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/statistics/did-you-know-status-cancer-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/statistics/dyk-rare-cancer-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/defining-cancer-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/genetics-and-cancer-treatment-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/immune-system-and-cancer-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/oncogenes-video
|
||
|
|
https://www.cancer.gov/about-cancer/understanding/what-is-cancer/tumor-suppressor-genes-video
|
||
|
|
https://www.cancer.gov/about-nci
|
||
|
|
https://www.cancer.gov/about-nci/advisory-boards
|
||
|
|
https://www.cancer.gov/about-nci/budget
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-budget-proposal-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2001.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2002.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2003.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2004.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2005.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2006.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2007.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2008.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2009.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2010.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-plan-2016.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/about-budget-proposal/nci-research-future-at-a-glance.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/appropriations-history.jpg
|
||
|
|
https://www.cancer.gov/about-nci/budget/budget-allocation-2022.jpg
|
||
|
|
https://www.cancer.gov/about-nci/budget/cancer-moonshot-fy17-factbook
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2003-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2004-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2005-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2006-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2007-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2008-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2009-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2010-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2011-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2012-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2013-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2014-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2015-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2016-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2017-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2018-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2019-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2020-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2021-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2022-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2023-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2024-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2025-nci-congressional-justification-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/congressional-justification/fy2025-nci-congressional-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/aids-funding.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1971-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1972-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1973-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1974-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1975-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1976-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1977-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1978-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1979-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1980-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1981-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1982-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1983-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1984-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1985-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1986-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1987-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1988-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1989-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1990-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1991-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1992-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1993-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1994-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1995-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1996-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1997-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1998-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/1999-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2000-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2001-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2002-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2003-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2004-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2005-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2006-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2007-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2008-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2009-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2010-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2011-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2012-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2013-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2014-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2015-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2016-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2017-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2018-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2019-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2020-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/2021-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/archive/fy22-fact-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/budget-glance-infographic
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/bypass-appropriations.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-funding-m1-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-funding-m3-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-funding-m3-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-obligations-m3-fy20-2.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-obligations-m3-fy21-2.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-obligations-m3-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-obligations/moonshot-obligations-m3-fy23
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-funding-m2-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-funding-m2-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-research-categories-m2-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-research-categories-m2-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-research-categories-m2-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-research-categories/moonshot-research-categories-m2-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-summary-m1-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-summary-m1-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-summary-m1-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/cancer-moonshot/moonshot-summary-m1-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/extramural/extramural-funds-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/management-fund/management-fund-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/division-obligation-mechanism-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-division-obligation-by-mechanism-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-division-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-division-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-division-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-division-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-mechanism-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-mechanism-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-mechanism-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-mechanism-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/nci-obligation-by-mechanism-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/obligations/obligations-mechanism-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy18.xls
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/program-structure/program-structure-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/budget-summary-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/fiscal-year-budget-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/fiscal-year-budget-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/fiscal-year-budget-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/fiscal-year-budget-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/recent-fiscal-year/fiscal-year-budget-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy21-508.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/research-funding/research-dollars-by-cancer-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy19
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/data/special-sources/special-sources-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/cancer-centers/p30-cancer-centers-by-state.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-country-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/awards-by-state-and-institution-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/grant-contract-awards/inst-receiving-more-than-15m-fy17.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/k-awards/k-awards-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/nrsa/nrsa-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-by-activity-code-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-awards-summary-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-funding-paylines.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-awards-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-awards-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-awards-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-awards-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-awards.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-number-of-awards-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-and-awarded-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-awarded-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-awarded-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-awarded-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-awarded-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/rpg/rpg-requested-awarded-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs/spores/spores-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/fiscal-year-2018-highlights.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/grants-contracts.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-history-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/aids-funding/aids-funding-history-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/appropriations-nci-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/appropriations-nci-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/appropriations-nci-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/appropriations-nci-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/bypass-appropriations-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/bypass-appropriations-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/bypass-requests-nci-appropriations-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgement-presidents-budget-enacted-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgement-presidents-budget-enacted-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgement-presidents-budget-enacted-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgement-presidents-budget-enacted-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgement-presidents-budget-enacted-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/bypass-appropriations/professional-judgment-budget-requests-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/comparison/comparison-dollars-position-space-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/extramural-intramural-rms/extramural-vs-ir-and-rms-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/funding/funding-trends-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/nci-personnel-fy18.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/nci-personnel-fy19.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/personnel-fy20.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/personnel-fy21.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/personnel-fy22.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/historical-trends/personnel/personnel-fy23.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/html-amount.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/html-bar.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/html-extramural.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/html-nrsa.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/kawards-pie.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/management-fund.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/moonshot-obligations.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/number-rpg-awards.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/obligations-mechanism.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/program-structure.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/rms-funding.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/fact-book/rpg-funding.json
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/2019-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/2019-professional-judgment-budget.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/2020-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/2021-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/lowy-annual-plan-2017-video
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/nci-annual-plan-aag-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/budget/plan/nci-annual-plan-aag-2021.pdf
|
||
|
|
https://www.cancer.gov/about-nci/careers
|
||
|
|
https://www.cancer.gov/about-nci/careers/pmf
|
||
|
|
https://www.cancer.gov/about-nci/contracts
|
||
|
|
https://www.cancer.gov/about-nci/contracts/about-oa
|
||
|
|
https://www.cancer.gov/about-nci/contracts/acquisition-resources
|
||
|
|
https://www.cancer.gov/about-nci/contracts/acquisition-resources/transition-to-faculty-position-slides-02232022
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/acquisition-notices
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/fedbizopps-notices
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/ffrdc-pre-proposal-2015-conference-day-2-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/previous-competition-notices
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources-0
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/additional-business-proposal-instructions.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/additional-technical-proposal-instructions.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/attachment-20-proposed-estimated-costs-breakdown.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/award-fee-evaluation-plan.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/basic-translational-clinical-research
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/business-operations-procurement-closing
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/business-operations.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/closing-remarks.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/core-research-services
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/current-determinations-of-exceptional-circumstances.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/draft-ffrdc-statement-of-work.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/facilities-and-support-functions
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-background-information-7-1-2015.ppt
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-facilities-overview.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-facilities-reference-information.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-fnlcr-facilities-photo-slideshow.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-policy.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-pre-proposal-2015-conference-day-1-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/ffrdc-statement-of-work.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/75n91019d00024-ffrdc-annualrpt-dec2020-redacted
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-25-breakdown-of-proposed-estimated-costs-plus-fee-spreadsheet
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-45-acronyms-ffrdc-sow
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-46-additional-information-background-examples
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-47-buildings-to-oversee-sq-ftg-and-stats-2019-leases
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-49-lab-list
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-50-composite-metrics
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-51-website-list
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-52-ffrdc-certifications-license-permits-full-list
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/attachment-53-docs-narrative
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/cbiit.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/cc.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ccr.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/cssi.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/dcb.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/dccps.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/dceg.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/dcp.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/dctd.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/draft-request-for-proposal-n01co72400-11.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/draft-rfp-attachment-44-ffrdc-policy-101
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/drfp-comment-template.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/executive-summary-amended-28-april-2016.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ffrdc-draft-rfp-comments-template
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ffrdc-draft-rfp-executive-summary
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/hhs-subcontracting-plan-template.doc
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/niaid.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/osfm.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/overview-of-procurement-process.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/overview-of-the-ffrdc.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ppc-agenda
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ppc-list-of-vendors
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ppc-slides
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ppc-transcripts
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ras-initiative.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/redacted-contract
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/redacted-operational-task-order
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/scientific-programs-overview.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/ttc.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/files/welcome-to-the-nci-ffrdc-pre-proposal-conference.pptx
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/fnlcr-annual-report-2014-2015.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/government-furnished-property.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/industry-day-agenda
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/nci-ffrdc-contract-redacted-24sep2015.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/overview-history-national-mission-programs
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/packaging-and-delivery-of-proposal.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/proposed-advance-understandings.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/proposed-special-contract-requirements.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/sample-task-order-1-statement-of-work.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/sample-task-order-2-statement-of-work.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/section-k-representations-certification-other-statements-of-offerors.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/resources/transition-task-order-statement-of-work.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-001694.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-002059bid.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-0033110-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-007302-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-007888-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-008918-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-009113-tp
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-009600.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-009825-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-011150.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-011599-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-011643-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-013337-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-013536.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-013942-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-014196-tp
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-014212-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-014610-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-015196.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-015382-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-017644-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-018094-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-01827-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-018531-jm
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019112-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019280-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019615-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-0196960.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019735-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019891.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-019991-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-020169-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-020804-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-021643-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-021951-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-022168-jm
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-022420-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-022627-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-023192-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-023206-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-023697-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-024988-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-025232-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-025734-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-025958-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-025963-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-026162-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-026163-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-026549-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-026710-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-027313-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-028785-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-028898-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-029243-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-029413-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-029496-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-029685-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-029942-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030015-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030038-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030050-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030694-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-030991-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-031065-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-031827-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-032024-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-032323-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-032519-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-032623-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-032965-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-033138-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-033399-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-033908-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-033910-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-034046-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-034238-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-034262-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-034304-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-034322-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-035838-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-036329-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-036331-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-036607-jm
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-037474-jm
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-038194-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-038215-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-038472-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-039492-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-039607-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-040195-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-040520-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-041629-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043058-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043531-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043626-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043644-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043772-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-043775-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-044006-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-045055-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/24-045423-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000050-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000080-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000100-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000136-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000161-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000163-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000178-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000222-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000223-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000241.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000263-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000269-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000273-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000297-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000308-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000311-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000313-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000335-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000343-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000373-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000413-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000437-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000453-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000497-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000522-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-000523-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001200.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001399-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001437-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001495-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001640-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-001697-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-002546-tg
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-002892-mo
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-004123-cb
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-005270-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-005654-tr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-006005-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-006477-vr
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/25-008255-jm
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/75n91023q00143-ds.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/bbquote23000619.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-015112.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-021916.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-023410.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-024070.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-024316.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-024636.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-025513.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-038173.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-038471.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-038975.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-24-040499.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-25-000235.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/nci-25-002751.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/bidboard/ncibid75n91023q00058.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/fnlcr-procurement-forecast.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/nci-forecast-handout.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/nci-prime-meets-sub-presentation.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/sub-faq.pdf
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/subcontracting
|
||
|
|
https://www.cancer.gov/about-nci/contracts/opportunities/subcontracting-opportunities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership
|
||
|
|
https://www.cancer.gov/about-nci/leadership/amber-lowery
|
||
|
|
https://www.cancer.gov/about-nci/leadership/dinah-singer-bio
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/blog-posts
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/interviews
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/lowy-message-2017
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/lowy-social-media-clip1
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/lowy-social-media-clip2
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/lowy-social-media-clip3
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/lowy-social-media-clip4
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations-0
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/2018-pediatric-precision-oncology-conference
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/aacr-2019-remarks.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/accelerating-rural-cancer-control-meeting-transcript
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/ccdi-symposium-final-thoughts-video
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/ending-cancer-as-we-know-it
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/hem-onc-2019-remarks.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/n.sharpless-aacr-2021-pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-address-aacr-annual-meeting-2023
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-report-june-14.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-report-june-16.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-report-march-10.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-report-march-15.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/nci-directors-report-march-17.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-2018-hardesty-lecture-west-virginia-university
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-aacr-2018-transcript
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-american-society-hematology-2018-meeting
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-asco-2018-transcript
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-asco-2018-video
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-town-hall-video
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/sharpless-yale-calabresi-lecture.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/tribute-to-research-patients-remarks-powerpoint.pptx
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/tribute-to-research-patients-remarks.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/presentations/wkr-remarks-asco2024.pdf
|
||
|
|
https://www.cancer.gov/about-nci/leadership/director/publications
|
||
|
|
https://www.cancer.gov/about-nci/leadership/james-doroshow-bio
|
||
|
|
https://www.cancer.gov/about-nci/leadership/nci-deputy-director
|
||
|
|
https://www.cancer.gov/about-nci/leadership/nci-deputy-director/blog-posts
|
||
|
|
https://www.cancer.gov/about-nci/leadership/nci-deputy-director/interviews
|
||
|
|
https://www.cancer.gov/about-nci/leadership/nci-deputy-director/presentations
|
||
|
|
https://www.cancer.gov/about-nci/leadership/nci-deputy-director/publications
|
||
|
|
https://www.cancer.gov/about-nci/leadership/oliver-bogler-bio
|
||
|
|
https://www.cancer.gov/about-nci/leadership/paulette-gray-bio
|
||
|
|
https://www.cancer.gov/about-nci/leadership/previous
|
||
|
|
https://www.cancer.gov/about-nci/leadership/warren-kibbe
|
||
|
|
https://www.cancer.gov/about-nci/legislative
|
||
|
|
https://www.cancer.gov/about-nci/legislative/about
|
||
|
|
https://www.cancer.gov/about-nci/legislative/committees
|
||
|
|
https://www.cancer.gov/about-nci/legislative/contact
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress/biomedical-research
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress/budget-appropriations
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress/cancer-research
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress/federal-health
|
||
|
|
https://www.cancer.gov/about-nci/legislative/current-congress/resolutions
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1996-cancer-genetics-environment.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1997-advances-cancer-research.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1997-environmental-risk-factors-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1997-estimated-exposures-thyroid-doses-iodine-131-fallout.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1997-mammography-screening-women-40-49.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1997-progress-against-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-breast-cancer-prevention-trial-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-breast-cancer-prevention-trial.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-cam-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-cancer-treatments-21st-century.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-management-radiation-studies.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1998-state-of-cancer-research.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1999-cancer-care-united-states.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1999-complementary-alternative-medicine-womens-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1999-planning-prostate-cancer-research.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1999-prostate-cancer-nci.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/1999-unequal-burden-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2000-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2000-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2000-ethnic-minority-disparities-cancer-treatment.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2000-integrative-oncology.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-environment-genes-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-leukemia-lymphoma-multiple-myeloma-new-understanding.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-nci-cancer-clusters.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2001-new-directions-breast-cancer-research.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2002-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2002-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2002-mammography.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-cancer-survivorship.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-molecular-targets-diagnose-prevent-treat-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-nih-research-bench-to-bedside.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-potential-reduced-risk-tobacco-prodcuts.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-robert-hoover-testimony.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2003-sv-40-exposure-cancer-development.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2004-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2004-nci-hpv-cervical-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2004-new-treatments-making-cancer-more-treatable.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2005-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2005-gynecological-cancer-education-awareness-act.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2005-nci-cancer-nuclear-weapon-testing-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2005-nci-cancer-nuclear-weapon-testing-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2005-nci-gynecological-cancers.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2006-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2006-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2006-john-agwunobi-testimony.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2007-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2007-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2007-testing-light-low-tar-tobacco-products.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2008-biorepository-policies-practices-nih.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2008-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2008-cell-phone-use-tumors.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2008-nih-breast-cancer-environment.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2009-breast-cancer-screening-improvement.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2009-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2009-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2009-cell-phone-usage-health-effects.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2010-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2010-nci-progress-challenges.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2010-prostate-cancer-research.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2010-smokeless-tobacco-mlb.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2011-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2011-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2012-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2012-preventing-treating-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2013-budget-request-house.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2013-budget-request-senate.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2014-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2014-fight-against-cancer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2014-policies-spur-medical-breakthroughs.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2015-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2016-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/hearings/2017-budget-request.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/recent-public-laws
|
||
|
|
https://www.cancer.gov/about-nci/legislative/recent-public-laws-0
|
||
|
|
https://www.cancer.gov/about-nci/legislative/recent-public-laws/biobanking-childhood-cancers-meeting.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/recent-public-laws/nci-star-act-implementation.pdf
|
||
|
|
https://www.cancer.gov/about-nci/legislative/recent-public-laws/star-act
|
||
|
|
https://www.cancer.gov/about-nci/legislative/resources
|
||
|
|
https://www.cancer.gov/about-nci/legislative/resources/glossary
|
||
|
|
https://www.cancer.gov/about-nci/nci-shady-grove-metro-express-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/nci-shady-grove-shuttle-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/2015ssc-strategicpriorities-overview
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/about/ctwg-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/about/trwg-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctac
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp/access-training
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp/access-training/ctrp-strategic-subcommittee-report-2011-07.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp/accrual
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp/collaborative
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/ctrp/registration
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/biomarker-study-eval-guide.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/biomarker-study-eval-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/cea-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/cea-study-eval-guide.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/cea-study-eval-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/concept-checklists
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/contacts
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/evaluator-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/funded-studies
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-biomarker-evaluation-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-imaging-evaluation-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-integral-biomarker-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-integral-imaging-checklist-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-integrated-biomarker-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-integrated-imaging-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-statistical-evaluation-template-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-symptom-science-qol-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy20-symptomscience-qol.biqsfp
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-biqsfp-guidelines.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integral-biomarker-biqsfp-new.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integral-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integral-imaging-biqsfp-new.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integral-imaging-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integrated-biomarker-biqsfp-new.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integrated-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integrated-imaging-biqsfp-new.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-integrated-imaging-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-symptom-science-qol-biqsfp-new.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy21-symptom-science-qol-biqsfp.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/fy24-biqsfp-guidelines.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/glossary
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/imaging-study-eval-guide.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/imaging-study-eval-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/integral-biomarker-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/integral-imaging-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/integrated-biomarker-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/integrated-imaging-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/qol-pro-study-checklist.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/qol-pro-study-eval-guide.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/qol-study-eval-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/biqsfp/statistical-evaluation-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/ccitlaguidelines-fy2019.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/2009-2015-ccitla-recipients.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/award-recipients-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/ccitla-2019-guidelines.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/ecia-and-r50-comparison.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/ecia-ccitla-award-recipients-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/clinician-scientist-awards/fy2020-ccitla-guidelines.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/ctsuharmonizationsupportannouncement2013-508compliant.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/fy2020-ccitla-announcement.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/funding/navigate
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/resources/start-clauses-brochure.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/resources/start-clauses-info.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/2015-sxqolsc-strategicpriorities
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/2016-scientific-steering-committee-meeting-schedule-deadlines
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/2021sscschedule
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/ccdr-advocate-review-form-sample
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/ccdrsc-concept-guidelines-template
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/ccdrscientificreviewform-sample.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/ccdrstatisticalreviewform-sample.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/cpscconceptguidelines
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/meeting-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/concept-submission-guidelines/oewg-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/7-24-09-phase-2-design-recommendations.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/clinresearcharticle-immtf-weber.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-feb-2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-feb2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-june-2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-june2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-nov-2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-nov2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-oct2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-newsletter-sept2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-public-summary-sept2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-publication-listing-dec2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-publications-12-13-12.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-pubs-listing-42512.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-pubs-listing-51810.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-pubs-listing-62110.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idsc-sop-structure.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idscnewsletter-feb2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idscnewsletter-june2011-v2.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idscnewsletter-may2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idscpublicatons-june2014.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/idscsymposium-meetingsummary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/presentation-bennett.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/presentation-cantley.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/presentation-garraway.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/presentation-turteltaub.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/investigational-drug/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/cancer-care
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/cancer-care/ccdr-2022-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/cancer-care/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/prevention
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/prevention/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/2017-cipn-ctpm-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/cancer-related-fatigue-ctpm-executive-summary-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/cancer-related-fatigue-nov.2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/cipn-ctpm-execsum-jnci2019.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/cipn-ctpm-final-executive-summary-for-ccct-aug-2010.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/concept-template.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/jnci-j-natl-cancer-inst-2013-sxqol-publication.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-2021-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-cipnctpm-aug-2010.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-crf-nov-2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-ctpm-execsum-2010.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-ctpm-execsum-2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-jnci-2014-1.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-jnci-2014-2.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-jnci-2014-3.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-jnci-2014-4.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqol-jnci-2014-5.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqolscconceptevaluationform.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqolscconceptrequirementupdates.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqolscpatientadvocateconceptevaluationform.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/ncorp/symptom-management/sxqolscproctpmexecutive-summary-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies/bmsc-2018-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies/bmsc-2021-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies/brain-ctpm-august2014.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies/brain-ctpm-sept2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/brain-malignancies/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/bcsc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/bcsc-2022-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/bcsc-ctpm-2017-omitting-surgery-neoadjuvant-chemo-patients.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/bcsc-lifestyleinterventionctpm-exec-sum-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfcdes-access.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfgeneralcdes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfimagingcdes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfpreoperativecdes-rev.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfpreoperativecdes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfradiationcdes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/boldtfsurgicalcdes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/estrogen-receptor-ctpm-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/her2-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/lifestyleintervention-ctpm-execsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/nciboldradiationcdesrev
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/resistance-definitions-bcsc-ctpm.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/breast-cancer/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/clinical-imaging
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/clinical-imaging/cisc-2020-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/clinical-imaging/cisc-brain-tumor-neuroimaging-ctpm-2018
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/clinical-imaging/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/colon-rectalctpmexecsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gi-ctmp-consensus
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gi-ratf-retreat-consensus.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gisc-2020-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gisc-geo-io-ctpm-execsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gisc-net-prrt-ctpm-execsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/gist-ctpm-exec-summary-05-13-09.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/hcc-sots-2008-exec-summary-05-13-09.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/netctpmexecutivesummary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/neuroendocrine-ctpm-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gastrointestinal/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/gusc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/gusc-2022-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/gusc-2022-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/gusc-ctpm-advanced-renal-cell-cancer-feb2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/gusc-spore-20101104-publication-cancer-research20110515.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/non-muscle-invasive-bladder-ctpm-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/renal-ctpm-early-stage-renalcell-execsum
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/genitourinary/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/2021-gynecologic-strategic-priorities
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/cervical-cancer-2018-ctpm.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/cervical-cancer-state-of-the-science-meeting-2007-09-27-28.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/endometrial-cancer-state-of-the-science-meeting-2006-11-28-29.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/endometrialcancer-ctpmpub-intjgynecolcancer2009.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-2022-strategic-priorities-revised.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-2022-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-2024-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-ctpm-ovariancancer-may2009.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-executivesummaryovarianctpmfinal.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gcsc-otf-ctpm-feb-execsum-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gynecologic-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/gynonctrimblecsotsinpress2009.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/ovariancancerctpmpublicaton2014.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/ovarianctpmsummary-1-may2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/ovarianctpmsummary-2-may2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/public-summary-01-11-13.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/public-summary-09-10-2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/targeted-endometrial-trials-ctpm.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/gynecologic/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/11-10-head-neck-squamous-cell-cancer-and-human-papillomavirus.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-2021-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-2022-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-2023-ctpm-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-ctpm-execsum-transoralresection-2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-ctpm-tors-2012.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-ctpm-tp53-mutated-jan2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-hnsquamouscellcancerhpv-adelstein.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-humanpapillmaviruspublication.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-immunotherapy-ctpm-publication.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-naso-pharyngeal-cancer-ctpm.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-squamous-cell-cancerhpv-adelstein.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-squamouscellhumanpapillomavirus-publication200911.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnsc-thyroidctpm-nov2013.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/hnscimmunotherapyctpmexecsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/nasopharyngeal-publication-2019.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/head-neck/task-force-rosters
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/cllwgrpmeetingsummary-111710.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/lksc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/lksc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/lksc-amlwgmeeting-summary-20100410.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/lksc-ctpm-nov2011.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/leukemia/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/dblclwg-meetingsummary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-2014-lymphomasubtypes.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-diefenbach.et.al-jncij.2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-maddocks.et.al-jncij-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-nowakowski.et.al.2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-rimsza.et.al-jncij-2016.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm-spurgeon.et.al.jncij2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/lysc-ctpm.casulo.et.al-jncij-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/lymphoma/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma/mysc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma/mysc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma/mysc-f2f-minutes-0302111.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/myeloma/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-adolescent-solid-tumor
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-adolescent-solid-tumor/pastsc-2015-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-adolescent-solid-tumor/pastsc-neuroblastomactpmexecutivesummary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-adolescent-solid-tumor/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-leukemia-lymphoma
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-leukemia-lymphoma/pllsc-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/pediatric-leukemia-lymphoma/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/tmsc-2023-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/tmsc-ctpm-executive-summary-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/tmsc-fda-workshop-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/tmsc-mesothelioma-ctpm-execsum.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn/thoracic-malignancy/tmsc-strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nihodsassessmentdietarysupplements.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/patient-advocate
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/patient-advocate/pasc-acronym-list.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/patient-advocate/roster
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/sc-2022-meetings-schedule-rev.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/sc-2022-meetings-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/sc-2023-meetings-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/sc-2024-meetings-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/sc-2025-meeting-schedule.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/standing-meeting-schedule
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccct/steering-committees/strategic-priorities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/about/ccg-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/about/videos/biden-asco-2016
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/cancer-genomics-overview/louis-staudt-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/funding/gdac-pre-app-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/funding/gdac-pre-application-qa-2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/funding/gdan-funding-application-questions.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/funding/gdan-pre-application-webinar.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/funding/trueseq-sequencing-datasheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/computational-genomics/gdc/data-commons-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/computational-genomics/gdc/gdc-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/computational-genomics/gdc/gdc-infographic
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/computational-genomics/gdc/gdc-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/genomic-pipeline/genome-characterization-pipeline-infographic
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/biological-data-sharing-principles.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/ccle-open-release-justification.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/suggested-prospective-informed-consent.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/tcga-data-use-certification-agreement.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/tcga-human-subjects-data-policies.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/tcga-legacy-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/tcga-by-the-numbers-infographic
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/abi-3730-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/abi-solid3plus-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetric-u133-plus2-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetric-u133-plus2-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetric-u133a-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-exon-1.0st-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-exon-1.0st-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-exon-1st-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-snp6-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-snp6-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-snp6.0-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-u133-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/affymetrix-u133a-tsv
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-244a-hms-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-244a-hms-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-244a-mskcc-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-244a-mskcc-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g3-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4124a-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4124a-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4447a-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4447a-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-1-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-1-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-2-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-2-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-3-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-g4502a-07-3-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-microrna-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-microrna-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-microrna-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-microrna-r12-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/agilent-microrna-r12-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-1m-duo-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-1m-duo-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-beadchip-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-gaiix-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-goldengate-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-hd-beadchip-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-hiseq2000-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanhap550-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanhap550-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanmethylation27-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanmethylation27-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanmethylation450-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-humanmethylation450-data-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-oma002-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-oma002-fasta
|
||
|
|
https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/using-tcga/technology/illumina-oma003-adf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/definitions
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/administrative-supplements-disparity-research-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/becoming-a-cancer-research-investigator-extramural-intramural-05242021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/becoming-a-cancer-research-investigator-extramural-intramural-bartolome-slides-05242021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/becoming-a-cancer-research-investigator-extramural-intramural-seewaldt-slides-05242021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/benefits-and-pathways-to-serving-on-editorial-boards-04232024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/benefits-and-pathways-to-serving-on-editorial-boards-slides-04232024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/best-practices-for-an-effective-nih-biosketch-flyer-03302022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/best-practices-for-an-effective-nih-biosketch-slides-03302022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/best-practices-to-success-after-receiving-your-r01-11292023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/best-practices-to-success-after-receiving-your-r01-slides-11292023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/beyond-data-publishing-advancing-clinician-scientist-flyer-oct-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/beyond-data-publishing-advancing-clinician-scientist-slides-oct-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/biotechnology-and-bioentrepreneurship-flyer-august-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/biotechnology-and-bioentrepreneurship-slides-august-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/building-strong-mentoring-relationships-flyer-01302023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/building-strong-mentoring-relationships-slides-01302023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cancer-and-mental-health-considerations-for-every-cancer-researcher-slides-oct-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cancer-disparities-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cancer-moonshot-scholars-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cancer-systems-biology-flyer-11302021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cancer-systems-biology-jackson-slides-11302021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cche-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/choosing-between-a-career-in-academia-and-industry-perspectives-and-advice-04302021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/choosing-between-a-career-in-academia-and-industry-perspectives-and-advice-flyer-04302021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cnpc
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cnpc-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/crchd-factsheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/crchd-opps-factsheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/crchd-training-opportunities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/crchdfactsheet-trainingfunding
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cure
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cure-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cure-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/cusp2ct-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/developing-a-strong-nih-grant-application-flyer-03292023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/developing-a-strong-nih-grant-application-slides-03292023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/diversity-focused-cancer-research-training-opportunities-09292021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/diversity-focused-cancer-research-training-opportunities-slids-09292021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/division-priorities-funding-opportunities-strategies-applying-10262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/division-priorities-funding-opportunities-strategies-applying-slides-10262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/eiap-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/establishing-your-research-group-10252021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/establishing-your-research-group-slides-10252021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/excess-cervical-cancer-mortality.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/gmap
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/how-to-build-your-online-presence-as-a-scientist-04252023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/how-to-build-your-online-presence-as-a-scientist-slids-04252023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/how-to-identify-and-apply-for-the-right-r01
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/how-to-identify-and-apply-for-the-right-r01-flyer-06282023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/informatics-technology-for-cancer-research-program-02222023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/interviewing-in-a-virtual-world-12032020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/interviewing-in-a-virtual-world-flyer-12032020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/life-of-a-grant-ecr-program-csr-initiatives-to-address-bias-peer-reiew-04272022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/life-of-a-grant-ecr-program-csr-initiatives-to-address-bias-peer-reiew-kotliarova-04272022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/life-of-a-grant-the-ecr-program-and-csr-initiatives-to-address-bias-in-peer-review-04272022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/mentoring-action-plan-worksheet-01302023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/navigate-the-grant-application-process-the-nuts-and-bolts-of-peer-review-at-nih-02252020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/navigate-the-grant-application-process-the-nuts-and-bolts-of-peer-review-at-nih-slides-02252020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/navigating-nih-nci-research-funding-a-journey-of-exploration-understanding-datta-slides-06222022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/navigating-nih-nci-research-funding-a-journey-of-exploration-understanding-flyer-06222022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/navigating-nih-nci-research-funding-a-journey-of-exploration-understanding-woodward-slides-06222022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/non
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/nuts-and-bolts-of-research-applications-peer-review-at-the-nih-flyer-07262023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/nuts-and-bolts-of-research-applications-peer-review-at-the-nih-slides-07262023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/pache
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/pache-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/paves
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/paves-19-flyer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/planning-your-next-step-nci-funding-and-training-opportunities-flyer-01212021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/planning-your-next-step-nci-funding-and-training-opportunities-slides-01212021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/putting-the-i-in-science-leveraging-your-story-to-chart-your-career-12142021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/r21-r01-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-career-advancement-in-cancer-disparities-06012021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-career-advancement-in-cancer-disparities-slides-06012021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-life-at-nci-center-for-cancer-research-clark-slides-01262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-life-at-nci-center-for-cancer-research-flyer-01262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-life-at-nci-center-for-cancer-research-lurain-slides-01262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/research-and-life-at-nci-center-for-cancer-research-mceachron-slides-01262022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/s2s-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/s2s-fact-sheet-spanish
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/team-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/team-schematic-slide-01302023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/the-all-of-us-research-hub-and-workbench-11152022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/the-all-of-us-research-hub-and-workbench-slides-11152022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/thriving-as-a-biomedical-researcher-self-care-assessment-08312022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/thriving-as-a-biomedical-researcher-self-care-plan-08312022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/thriving-as-a-biomedical-researcher-slides-08312022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/training-navigation-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/trainingfunding
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about-health-disparities/resources/transition-to-faculty-position-flyer-02232022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/director
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/director/springfield-interview
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/meetings-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/meetings-events/crchd-pdw-2015
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/mission-vision
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/organization
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/about/what-we-do
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/barajas-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/bhm-2024-akintoye-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/bhm-2024-bargonetti-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/bhm-capsule-transcripts
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/cusp2ct
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/cusp2ct-faqs.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/gmap
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/inb-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/inb-pd-2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/inb-pd-sbsa.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/non
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/screen-to-save
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/screen-to-save/connect
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/screen-to-save/connect/intent-to-support.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/screen-to-save/connect/screen-to-save-infographic
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/screen-to-save/connect/social-media-toolkit.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/team
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/team-faqs.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/community-outreach/team-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/crchd
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/crchd-annual-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/crchd-cure-infographic.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/crchd-cure-paradigm.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/admin-supp-collaborative-faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/basic-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/basic-research/pre-application-webinar-ppt
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/cancer-disparity-collaborative-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/collaborative-web-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/dep-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/disparities-research/dep-pd-sbsa
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cancer-moonshot-scholars-diversity-program
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cdss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/csss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-diversity-supplements-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-f31-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-infographic.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-k01-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-k08-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure-k22-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/cure21
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/ds-guidelines.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/f31-pre-app-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/re-entry-re-integration-re-tooling-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/reentry-supplements-guidelines
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/reentry-supplements-guidelines-20
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/workforce-diversity-r21-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/yes-fact-sheet
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/cure/yes-webinar-09132021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/dtb-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/dtb-pd-2019
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/dtb-pd-sbsa
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/eiap
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/eiap/eiap-faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/eiap/eiap-faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/eiap/eiap-preapp-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/diversity-training/eiap/eiap-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/funding-training-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/funding-training-opportunities/adminsupplement-gmap-fy15
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/funding-training-opportunities/adminsupplement-non-fy15
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/funding-training-opportunities/cpache-u54-faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/funding-training-opportunities/tips-tools
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/hermioni-amonoo-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/hhm-capsule-transcripts
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/icure-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/icure-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/icure-pd-sbsa.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/icure-pi-projects.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/icure-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/icure/respondent-burden
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/innovative-programs/pache
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/jones-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/nahm-transcripts
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/nmm-2024-transcripts
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/pinheiro-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cche/rauh-hain-transcript
|
||
|
|
https://www.cancer.gov/about-nci/organization/cea
|
||
|
|
https://www.cancer.gov/about-nci/organization/cea/peter-garrett-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/amina-chtourou
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/ann-chao
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/dalana-c-johnson
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/doug-perin
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/elise-garton
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/fatou-jallow
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/hyo-sook-bae
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/james-randiak-alaro
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/julia-gage
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/kalina-duncan
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/leshia-hansen
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/lilly-matthews
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/linsey-eldridge
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/margarita-correa-mendez
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/mark-parascandola
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/mishka-kohli-cira
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/nina-ghanem
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/ophira-ginsburg
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/patti-gravitt-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/paul-pearlman
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/sana-haider
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/satish-gopal-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/sudha-sivaram
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/tosca-le
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/contact/yelena-shnayder
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/evaluation-framework
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/fellowship-opportunity
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/strategic-plan
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/about/strategic-plan/cgh-strategic-plan.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/blog/gopal-cv.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/2023-covid-19-global-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/2023-dissemination-and-implementation-conference
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/25thawsp-survivorship
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aacr-2022-equity-implementation-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aacr-2022-equity-implementation-science
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aacr-2023-underrepresentation-of-lmic-authors-nci-supported-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aacr-conference-science-cancer-health-disparities-2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aacr-world-cancer-research-day-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-briercheck-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-gopal-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-painschab-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-tapela-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/academic-global-oncology-van-loon-2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/advance-global-cancer-research-international-collaboration
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/advancing-global-health-through-cross-cutting-approaches-stigma-reduction
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/alleviating-ebv-kshv-mediated-suffering-in-africa
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/annual-symposium-global-cancer-research-2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aortic-2021-virtual-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aortic-2023-conference
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/aortic-preconference-flyer.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/asco-women-power-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/asgcr-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/asgcr-2025
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/asgcr2020-registration.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/asgcr2020-save-the-date.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/ca-pri-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cancer-control-plwh-lmics
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cancer-discovery-virtual-symposium
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cancer-epidemiology-sub-saharan-africa
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cancer-knows-no-borders-symposium-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cancer-symposium
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/coronavirus-biobanking-collective-global-experiences
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cugh-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/cugh2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/equity-and-representation-in-global-oncology-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/evolving-global-tobacco-epidemic
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/first-lady-biden-and-letizia-queen-of-spain-world-cancer-research-day
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/fred-hutch-global-oncology-lecture
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/frequent-questions-nosi-administrative-supplements-for-global-integrative-oncology-research-not-ca-2
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/gastric-cancer-think-tank
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/ghcs2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/breast-cancer-survival-sub-saharan-africa-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/cervical-cancer-research-gcss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/cgh-gcrcss-cart-india
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/cgh-gcrcss-lajous-mexico
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/collaborative-design-in-rawanda
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/colorectal-cancer-rwanda
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/development-of-systemic-therapy-in-india-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/early-cancer-detection-gcrscss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/every-child-everywhere-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/financial-toxicity-following-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/genetics-of-breast-cancer-in-women-of-latin-american-heritage-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/implementation-science-to-improve-childhood-cancer-survival-in-lmics
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/improving-diagnosis-of-burkitts-lymphoma-in-east-africa
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/introduction-of-hpv-testing-and-self-collection
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/models-of-care-and-implementation-gcss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/national-cancer-grid-india
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/pallative-care-research-india
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/the-challenge-of-early-detection-of-breast-cancer-in-mexico
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/tobacco-control-research-in-the-middle-east-north-africa-region-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/towards-cervical-cancer-elimination
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/transforming-global-access-gcss
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-seminar-series/trust-cohort-anal-hpv-and-cancer-control-in-nigeria-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-cancer-stigma-research-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-health-catalyst-summit
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-health-catalyst-summit-university-of-penn
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-health-disparities-aacr
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-health-equity-panel-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-integrative-oncology-research-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-launch-women-power-cancer-lancet-commission
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-oncology-mentored-research-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-oncology-survey-at-aacr-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-oncology-survey-nci-designated-cancer-centers
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/global-oncology-webinar-african-cancer-institute
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/globalhealthequitypanel
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/globtrec-community-of-practice-july
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/gopal-carbone-grand-rounds
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/hepatopancreatobiliary-cancer-consortium-conference
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/hopkins-world-cancer-day-2023-seminar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/hpv-testing-self-collection-argentina
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/icap-webinar-addressing-cancer-lmics
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/icapgrandrounds-women-power-cancer-devide
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/icsn-2025
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/icsn-international-cancer-screening-network-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/impact-covid19-cervical-cancer-screening-lmics
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/integrative-medicine-cancer-prevention-cancer-patient-management
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/international-cancer-education-conference-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/international-cancer-screening-network-colorectal-cancer-screening-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/international-conference-on-malignancies-hiv-aids
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/international-perspectives-on-aging
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/ipvc-2023-international-conference
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/ipvs-hpv-latency
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/ireland-northern-ireland-nci-cancer-consortium-mou
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/lancet-global-cancer-surgery-2
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/lgcw-2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/lgcw-2024-every-woman-study
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/london-global-cancer-week-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/london-global-cancer-week-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/london-global-cancer-week-2023-lancet-commission-women-power-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/london-global-cancer-week-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/londonglobalcancerweek
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/mentorship-and-career-development-roundtable-asco2022-annual-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/milan-world-cancer-research-day-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/national-cancer-grid-india
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/nci-cancer-health-disparities-virtual-ideation-minilabs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/nci-cancer-health-disparities-virtual-visioning-workshops
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/nci-translational-technologies-symposium
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/nibib-point-care-technologies-conference-and-technology-showcase
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/nosi-global-cancer-health-disparities-research-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/not-ca-21-058-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/administrativesupplementsforglobaloncologymentoredresearchinformationalwebinar-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/global-cancer-health-disparities-research-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/global-cancer-stigma-research-workshop-day-1
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/global-cancer-stigma-research-workshop-day-2
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/global-integrative-oncology-research-webinar-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/past-events/pre-application-webinar-implementation-science-equitable-cancer-control
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/perspectives-from-the-us-nci-palliative-care-and-end-of-life-symposium
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/poster-session-exploring-country-priorities-and-contextual-considerations-for-nccp-asco2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/poster-session-mapping-global-oncology-priorities-nci-designated-cancer-centers-asco2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/pre-application-webinar-cancer-prevention-detection-diagnosis-treatment-technologies
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/pre-application-webinar-implementation-science-equitable-cancer-control
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/pre-application-webinar-implementation-science-for-cancer-control-in-people-living-with-hiv
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/project-echo-covid-19-global-conversations
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/rfa-ca-20-031-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/rfa-ca-21-030-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/sex-and-gender-in-cancer-biology-genomics-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/sex-and-gender-in-cancer-clinical-sciences-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/sex-and-gender-in-cancer-immunology-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/sex-and-gender-in-cancer-population-sciences-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/strategies-to-address-global-health-inequities
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/structural-racism-triple-negative-breast-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/symposium-global-cancer-research-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/symposium-global-cancer-research-2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/symposium-global-cancer-research-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/tobacco-control-united-states-france
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/uicc-north-america-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/webinar-administrative-supplements-to-support-cancer-disparity-collaborative-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/wh-forum-advancing-cervical-cancer-prevention-early-detection-survival
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/world-cancer-congress-2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/world-cancer-congress-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/events/world-cancer-research-day-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/ca15007-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/cancer-detection-diagnostic-and-treatment.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/china-faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/clinical-trial-leadership-management
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/covid-cancer-nosi-faq.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/health-economics-fellowships
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/instructions
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/low-cost-technologies-overview.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/microbial-cancer-therapy.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/rcre-faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/rfa-faqs-technologies-global-health.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/summer-curriculum-prevention
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/survivorship-foa-faq.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/technologies
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/webinar-1
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/webinar-2
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/funding/webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-cancer-conversations
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-cancer-conversations/kamarulzaman-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-cancer-conversations/knaul-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-cancer-conversations/varmus-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-cancer-conversations/weiderpass-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-programs/affordable-cancer-technology
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-programs/global-tobacco-control
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-programs/implementation-science
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-training
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-training/capacity-building
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-training/career-development-awards
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/global-research-training/fellowships
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/asgcr-annual-symposium-global-cancer-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/cancer-centers-global-oncology-survey
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/cancer-centers-global-oncology-survey/2018-2019-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/cancer-centers-global-oncology-survey/2021/global-oncology-survey-nci-designated-cancer-centers-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/cancer-centers-global-oncology-survey/2022executivesummary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/iccp-international-cancer-control-partnership
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/icrp-international-cancer-research-partnership
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/icsn-international-cancer-screening-network
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/project-echo
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/who-collaborating-center
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/partnerships-dissemination/women-power-cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/about-cgh.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/academic-global-oncology-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/ccan
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/global-oncology-survey-2021-guidance
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/international-activities-of-nci-designated-cancer-centers.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/nccp-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/publications/non-dioxin-like-pbcs.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/research-training-programs/global-tobacco-control/tcrb.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/research-training-programs/international-bilateral-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/research-training-programs/international-bilateral-programs-china
|
||
|
|
https://www.cancer.gov/about-nci/organization/cgh/research-training-programs/us-china-preliminary-program-review.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs/contact/diane-palmieri-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs/research-initiatives/team-science-field-guide/collaboration-team-science-guide.epub
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs/research-initiatives/team-science-field-guide/collaboration-team-science-guide.mobi
|
||
|
|
https://www.cancer.gov/about-nci/organization/crs/research-initiatives/team-science-field-guide/collaboration-team-science-guide.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/andrew-kurtz
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/dinah-singer
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/frankie-cozzens-philips
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/juli-klemm
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/kelly-crotty
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/michelle-berny-lang
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/samantha-finstad
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/sean-hanlon
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/steven-cole
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/contact/tony-dickherber
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/about/mission
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/isolation-cryopreservation-pbmc-seronet.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/12th-imat-pi-meeting-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/12th-imat-program-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/17th-annual-imat-pi-meeting.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/2017-imat-pi-agenda-without-abstracts.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/2018-pi-meeting-book-without-abstracts-508.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/2019-imat-meeting-book-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/2021-imat-meeting-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/2022-imat-meeting-book-short.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2000-first-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2001-second-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2002-third-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2003-fourth-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2004-fifth-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2005-sixth-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2006-seventh-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2007-eighth-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2008-ninth-principal-investigators-meeting-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2009-tenth-annual-meeting-poster-presenter-titles.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2010-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2012-pi-retreat-summary-report-final.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2012-program-book-web.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2013-program-book.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2014-program-book-final-website.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/past-events/imat-2015-program-book-web.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/news-events/seminar-series
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/reporting-analysis
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/reporting-analysis/kmspb
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/bd-step
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/bd-step/bd-step-factsheet-2024.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/bd-step/bd-step-final-2021.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/bylaws
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/comets-membership-application-v4.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/comets-proposal-form-v4.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/comets-steering-committee-membership-application-v6.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/interest-groups
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/members
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/comets/projects
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/imat
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/imat/funded-projects
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/imat/funding
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/funded-projects
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/funding
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/guidelines-itcr-set-aside-funds
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/itcr-review-form
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/itcr-set-aside-review-form-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/itcr-set-aside-review-process.docx
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/set-aside-guidelines.docx
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/set-aside-review-form-2022.docx
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/itcr/set-aside-funds/set-aside-review-form-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/past-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/research/synbio
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2012-pq-pre-review-evaluation-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2013-imat-evaluation-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2013-imat-evaluation-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2014-imat-evaluation-summary.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2016-imat-final-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/2020-imat-evaluation.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/imat-evaluation-report-2023.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/itcr-2018-evaluation-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/itcr-2021-evaluation-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/evaluation-reports/pq-evaluation-report-2014.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/informatics-tools
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/ntrap
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/ntrap/advocate-partnership-guidelines
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/ntrap/sensitivity-expectations-of-imat-investigators.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/resources/research-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/seronet-cdes-august-2021-508.xlsx
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/seronet-serum-biospecimen-processing.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/seronet-study-template-vaccine-studies-2021.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/cssi/seronet-template-booster-sars-cov-2-2021.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/anowarul-amin
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/anu-sharman
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/bridgette-tobiassen
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/brunilde-gril
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/chamelli-jhappan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/cheryl-cero
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/christina-george
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/christine-nadeau
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/claire-mccarthy
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/dan-gallahan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/david-miller
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/elizabeth-read-connole
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/elizabeth-snyderwine
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/elizabeth-woodhouse
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/eric-graves
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/eric-johnson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/fanta-whiting
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/grace-ault
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/hannah-dueck
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/ian-fingerman
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/janice-embry
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/jason-bunting
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/jefferey-hildedsheim
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/jennifer-couch
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/jerry-li
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/joanna-watson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/justin-benavidez
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/kelly-dyott
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/keren-witkin
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/kevin-greene
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/kevin-howcroft
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/konstantin-salnikow
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/kristine-willis
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/lillian-kuo
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/linda-stephens
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/linda-zane
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/lisa-witzler
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/margaret-klauzinska
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/matthew-whithead
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/michael-weinreich
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/michelle-turner
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/mihoko-kai
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/monica-zamisch
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/natalia-mercer
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/paul-okano
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/phil-daschner
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/rebekah-mikeasky
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/riante-jones
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/rihab-yassin
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/robin-brown
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/ron-johnson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/ruibai-lao
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/shannon-hughes
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/sharmistha-ghosh-janjigian
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/soumya-korrapati
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/stefan-maas
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/steven-becker
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/tamika-carney
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/tapan-bera
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/tiffany-ferguson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/wanping-xu
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/yin-liu
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/yvette-butler
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/yvonne-duglas-tabor
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/about/contact/zulekha-sayyed
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/faq-metabolomics-program-2017-stage-2.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023-ngw-funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-comms-with-your-nci-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-dcb-outreach
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-nci-budget
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-nci-deia
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-nci-researcher-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-nih-grants
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-peer-review
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-post-award-administration
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-review-resubmissions-renewals
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2023ngw-trainee-awards
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-additional-funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-awards-to-support-trainees
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-communicating-with-your-pd
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-dcb-and-nci-outreach
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-diversity-training-and-cancer-disparities-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-intro-to-nih-grants
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-nci-commitment-to-dei
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-peer-review
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-post-award-administration
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-researcher-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/2024ngw-review-resubmissions-and-renewals
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/artnet-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/ascb-meet-the-funders-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/bartoschngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/bartoschngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/boglerngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/csbc-u54-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/dcb-guidance-for-nih-dms-policy
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/dcb-info-for-elemet1a-in-nih-dms-plans
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/estimating-volume-of-a-dataset
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/fingermanngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/fingermanngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/getting-a-grant-from-nci
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/gubanichngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/hughesngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/hughesngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/kuongw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/linngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/linngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/mc2-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/mccattyngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/millerngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/ngw-faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/ngw-nci-director-keynote
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/ngw2021agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/ngw2022janagenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/oberdoerfferng2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/psrc-webinar-8-31-2021.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/rnamodo-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/rubinsteinngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/schmidtngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/sivakumarangw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/tbel-u54-webinar-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/tfcc-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/tfcc-webinar-faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/webinar-csr
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/webinar-grantsmanship
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/webinar-intro
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/willisngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/zahirngw2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/funding/resources/zahirngw2022
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/fusion-oncoproteins-in-childhood-cancers-consortium-faqs.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/fusion-oncoproteins-in-childhood-cancers-consortium-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/fusonc2-consortium-slides-2018
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/iotn-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/40-years-of-cancer-epigenetics
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/40-years-of-cancer-epigenetics-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/40-years-of-cancer-epigenetics-speaker-bios
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/aacr-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/aacr-2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/aacr-2024-cip-net-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/aacr-2024-hido
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/agenda-gwh.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/agenda-idps-meeting-nciaa.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/branch-chief-vacancy
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/ciheb-po-job-announcement
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/comms-specialist
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/computational-io
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/computational-io-participant-list.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/computational-io-workshop-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/crta-announcement
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/dataviz4cancer
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/dcbsurp23
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/dcbsurp23-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/dcbsurp23-students-and-projects
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/deconstructing-tumor-heterogeneity-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/deconstructing-tumor-heterogeneity-speakers.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/dmtm
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/early-onset-crc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/eo-crc-planning-committee
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/eo-crc-speakers
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/eo-crc-think-tank-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/exploratory-workshop-on-math-theory-and-cancerbio
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/exploratory-workshop-on-math4cancerbio-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/geroscience-summit
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/hepatitis-elimination
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/htan-pre-application-webinar-faqs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/htan-pre-application-webinars
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/idp-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/idps-in-cancer-particiapnt-list.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/immune-privilege-of-stem-cells
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/immune-privilege-of-stem-cells-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/immune-privilege-of-stem-cells-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/io-think-tank-chairs-speakers
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/io-think-tank-questions-opportunities.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/io-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/iotn-capstone-meeting
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/iotn-capstone-meeting-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/iotn-capstone-meeting-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/math4cancerbio-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mds-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mds-workshop-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mds-workshop-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mds-workshop-speaker-bios
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mutation-signatures
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/mutation-signatures-speakers-moderators-panelists.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nci-io-models.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-diversity-statement
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-planning-committee
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-poster-sessions
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-session-descriptions
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-speaker-bios
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/nciji2024-talk-abstracts
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/optimize-the-workforce
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/participant-list-gwh.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-mte-on-ai-funding-opportunities-and-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-mte-on-basic-research-in-cancer-disparities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-mte-on-cancer-biology-advancing-the-national-cancer-plan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-mte-on-cancer-immunology-funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-mte-on-r15s
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/aacr-2024-nci-grants-session-slides
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/immune-privilege-of-stem-cells-workshop-summary
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/nciji2023-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/past-events/nciji2023-program-book
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/pre-application-webinar-slides-for-hta-centers
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/pre-application-webinar-slides-for-pca-centers
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/pson-2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/ptm-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/ptm-workshop-agenda-2022.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/ptm-workshop-participant-list-2022.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-abstracts
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-awards-to-support-trainees-in-health-disparities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-intro-to-nih-grants
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-nci-commitment-to-dei
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-nci-director-remarks
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-nci-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-nih-dms-policy-overview
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-overview-of-funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-peer-review-process
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-post-award-administration
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/r15-workshop-role-of-the-pd-and-pi-conversation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/rna-metabolism-and-genome-maintenance
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/rna-metabolism-genome-workshop-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/rna-metabolism-genome-workshop-participants
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/rna-metabolism-genome-workshop-summary
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/square-tables
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/stromal-mutations-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/stromal-mutations-workshop-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/stromal-mutations-workshop-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/stromal-mutations-workshop-talk-abstracts
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/symposium-on-mutation-signatures-and-cancer-agenda.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/systemic-effects-of-cancer-think-tank
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/systemic-effects-of-cancer-think-tank-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/systemic-effects-of-cancer-think-tank-participant-list
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/systemic-effects-of-cancer-think-tank-presentation-agendas
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/translationalsysbio
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/translationalsysbio-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/translationalsysbio-participants
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/tumor-heterogeneity-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/womens-health-workshop
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/workshops/diet-as-a-modifier-tumor-metabolism-speaker-list.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/news/workshops/diet-as-a-modifier-tumor-metabolism-workshop.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/pediatric-immunotherapy-discovery-and-development-network-faq.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/pediatric-immunotherapy-discovery-and-development-network-slides.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/pre-app-webinar-slides-metabolomics-program-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/advancing-cancer-biology-research-infographic
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/cancer-biology-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/cancer-biology-and-vorasidenib-development
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/andrew-gentles
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/anirban-maitra
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/bill-kaelin
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/congzhou-wang
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/jennifer-wargo
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/karuna-ganesh
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/renee-brady
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/selma-masri
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/meet-investigators/suzanne-baker
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/progress/milestones-timeline
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/bbcs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/ccbr
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/ciher
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/david-denardo
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/dcar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/erika-moore
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/investigator-highlights
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/kate-chiappinelli
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/sita-kugel
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/tbmr
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-portfolio/tumor-metastasis
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/alliance-glycobiologists
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/artnet
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/betrnet
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir/resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/cip-net
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/aaron-meyer
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/andrea-bild
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/andrea-califano
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/announcement
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/arjun-raj
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/ashley-laughney
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/associate-membership
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/christina-leslie
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/csbc-faqs-u24-rfa-ca-15-015.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/csbc-faqs-u54-webinar-092815.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/darry-shibata
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/diana-murray
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/doug-lauffenburger
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/ed-engleman
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/ellen-langer
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/evaluation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/evaluation-report
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/expert-panel
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/investigator-highlights
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/ji-diversity-statement
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/joe-gray
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/juan-fuxman-bass
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/kai-tan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/ken-lau
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/kevin-janes
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/marian-waterman
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/mark-lemmon
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/melissa-kemp
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/nate-reticker-flynn
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/nevan-krogan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/par-16-131
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/par-16-131-preapplication-webinar-slides-10-13-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/par-16-131-webinar-slides-05082017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/par-16-131-webinar-slides-101716.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/peter-sorger
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/portia-thomas
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/research-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/research-highlights
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/rfa-15-014-pre-application-webinar-slides-january-2017
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/rfa-ca-15-014-preapplication-webinar-092815.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/rfa-ca-15-015-preapplication-webinar-093015.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/scott-manalis
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/stacey-finley
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/sylvia-plevritis
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/tim-huang
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/trachette-jackson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/trey-ideker
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/u54-webinar-07-2016.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/vito-quaranta
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/dlt
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/ealc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/gej
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/htan
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/htan-research-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/metnet
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/oac
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/annual-meeting-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/fall-seminar-2021
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/omf-2023-meeting-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/research-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/summer-seminar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf/summer-seminar-2023
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/past-programs
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/past-programs/kras-network
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/past-programs/mcl
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/past-programs/tmen
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pdmc-meeting-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pin
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pson
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pson-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/pson/research-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/psrc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tbel
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec/associate-membership
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec/cancer-tec-faq
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec/research-advances
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tec/webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/research-programs/tfcc
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/2016-ngw-common-fund-funding-opportunities-presentation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/2016-ngw-communicating-with-your-program-director-presentation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/2016-ngw-diversity-training-opportunities-presentation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/2016-ngw-nci-awards-to-support-trainees-presentation
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/fingermanngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/gubanichngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/hughesngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/jhappenngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/lei-dcb-ngw2018.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/lin-dcb-ngw2018.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/linngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/mccarthy-dcb-ngw2018.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/mccarthyngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/mccatty-dcb-ngw2018.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/mccattyngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/mitchumngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw201-watson.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-espey.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-fingerman.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-jhappan.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-lin.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-mccarthy.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-mccatty.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-nyankale.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-schmidt.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2019-sesay.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/ngw2020agenda
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/schmidtngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/singhngw2020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/the-cooperative-human-tissue-network.ppt
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/watsonngw020
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/researcher-resources/zahir-bartoschngw2020.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/savethedate-aug4.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/dcb/webinar-alliance-of-glycobiologists-for-cancer-research-foa.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about-0
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about/campus
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about/campus/frederick-campus-map
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/about/organization
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/research
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/training
|
||
|
|
https://www.cancer.gov/about-nci/organization/nci-frederick/training/whksip-application
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/cptc-brochure.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/ncra
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates/advocate-engagement-researchers.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates/lowy-precision-medicine-video
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates/lowy-precision-medicine-webinar
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates/lowy-precision-medicine-webinar-transcript.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/news-updates/lowy-webinar-20150601.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oar/research-advocacy
|
||
|
|
https://www.cancer.gov/about-nci/organization/obf
|
||
|
|
https://www.cancer.gov/about-nci/organization/obf/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/obf/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/ocpl
|
||
|
|
https://www.cancer.gov/about-nci/organization/ocpl/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/oga
|
||
|
|
https://www.cancer.gov/about-nci/organization/oga/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/oga/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/oga/about/staff
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact/denise-jenkins
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact/geraldina-dominguez
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact/mostafa-nokta
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact/rebecca-huppi-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/about/contact/yarchoan-bio
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/funding-opportunities
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/how-cancer-research-led-to-aids-breakthroughs
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/nci-aids-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/nci-aids-research/hiv-research-nci-brochure.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/aids-malignancy-consortium
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/iamc-2000-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2001-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2002-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2003-abs
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2003-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2004-abs
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2004-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2006
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2008
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2010
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2011
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2014
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2015.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2017.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2019.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmaoi-2022.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/icmh-archives
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/international-conference/namc-1999-prog
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/specimen-resource
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/news-events
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/news-events/malignancies-in-people-with-hiv-abstract.pdf
|
||
|
|
https://www.cancer.gov/about-nci/organization/oham/research-resources
|
||
|
|
https://www.cancer.gov/about-nci/organization/om
|
||
|
|
https://www.cancer.gov/about-nci/overview
|
||
|
|
https://www.cancer.gov/about-nci/overview/breast-cancer-research-stamp-fy2014-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/breast-cancer-research-stamp-fy2015-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/breast-cancer-research-stamp-fy2016-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/breast-cancer-research-stamp-fy2017-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/breast-cancer-research-stamp-fy2018-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing-0
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing/breast-cancer-research-stamp-fy2019-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing/breast-cancer-research-stamp-fy2020-report.pdf
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing/common-issues-in-gift-agreements
|
||
|
|
https://www.cancer.gov/about-nci/overview/contributing/tissue-donation-video
|
||
|
|
https://www.cancer.gov/about-nci/overview/history
|
||
|
|
https://www.cancer.gov/about-nci/overview/history/fdr-building-dedication-video
|
||
|
|
https://www.cancer.gov/about-nci/overview/history/legislative-timeline
|
||
|
|
https://www.cancer.gov/about-nci/overview/history/national-cancer-act-1937
|
||
|
|
https://www.cancer.gov/about-nci/overview/history/national-cancer-act-1971
|
||
|
|
https://www.cancer.gov/about-nci/overview/history/public-health-service-act
|
||
|
|
https://www.cancer.gov/about-nci/overview/jnci
|
||
|
|
https://www.cancer.gov/about-nci/overview/medical-decision-making
|
||
|
|
https://www.cancer.gov/about-nci/overview/nci-at-a-glance
|
||
|
|
https://www.cancer.gov/about-nci/overview/strategic-planning
|
||
|
|
https://www.cancer.gov/about-nci/overview/training-the-workforce-infographic
|
||
|
|
https://www.cancer.gov/about-nci/visit
|
||
|
|
https://www.cancer.gov/about-nci/visit/shuttle-request-form.pdf
|
||
|
|
https://www.cancer.gov/about-nci/visit/tobacco-free-policy.pdf
|
||
|
|
https://www.cancer.gov/about-website
|
||
|
|
https://www.cancer.gov/about-website/sitemap
|
||
|
|
https://www.cancer.gov/annual-report
|
||
|
|
https://www.cancer.gov/asia-pacific-economic-cooperation.pdf
|
||
|
|
https://www.cancer.gov/braf.pdf
|
||
|
|
https://www.cancer.gov/ccg/
|
||
|
|
https://www.cancer.gov/ccg/about
|
||
|
|
https://www.cancer.gov/ccg/about/cancer-genomics-overview/louis-staudt-video
|
||
|
|
https://www.cancer.gov/ccg/about/ccg-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/ccg/about/history
|
||
|
|
https://www.cancer.gov/ccg/access-data
|
||
|
|
https://www.cancer.gov/ccg/blog/comprehensive-discovery-of-subsample-gene-expression-components-by-information-explanation.pdf
|
||
|
|
https://www.cancer.gov/ccg/blog/ctd2-dashboard-interactions
|
||
|
|
https://www.cancer.gov/ccg/blog/ctd2-dashboard-overview
|
||
|
|
https://www.cancer.gov/ccg/blog/ctd2-dashboard-search
|
||
|
|
https://www.cancer.gov/ccg/blog/gdan-funding-application-questions.pdf
|
||
|
|
https://www.cancer.gov/ccg/blog/gdan-pre-application-webinar.pdf
|
||
|
|
https://www.cancer.gov/ccg/blog/gdc-fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/ccg/blog/genomic-data-commons-genomic-cloud-pilots-google-hangout-video
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/another-shot-on-goal
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/daniela-gerhard
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/episode-five-stream
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/episode-four-stream
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/episode-one-stream
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/episode-three-stream
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/episode-two-stream
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/family-portraits
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/honey-badger
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/my-first-genomic-study
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/trailer
|
||
|
|
https://www.cancer.gov/ccg/blog/personal-genomics-podcast/trailer-stream
|
||
|
|
https://www.cancer.gov/ccg/contacts
|
||
|
|
https://www.cancer.gov/ccg/funding-opportunities
|
||
|
|
https://www.cancer.gov/ccg/research
|
||
|
|
https://www.cancer.gov/ccg/research/cancer-genomics-overview
|
||
|
|
https://www.cancer.gov/ccg/research/computational-genomics
|
||
|
|
https://www.cancer.gov/ccg/research/computational-genomics/gdc
|
||
|
|
https://www.cancer.gov/ccg/research/computational-genomics/gdc/genomic-data-commons-infographic
|
||
|
|
https://www.cancer.gov/ccg/research/computational-genomics/genomic-data-analysis-network
|
||
|
|
https://www.cancer.gov/ccg/research/computational-genomics/genomic-data-commons
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/about
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/about/centers
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/about/centers/current-phase
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/about/centers/preceding-phase
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/broad-institute
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/columbia-university
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/dana-farber-cancer-institute
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/emory-university
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/fred-hutchinson-cancer-research-center-1
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/fred-hutchinson-cancer-research-center-2
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/human-glioblastoma-cell-isolation-protocol.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/johns-hopkins-university
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/oregon-health-science-university-1
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/oregon-health-science-university-2
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/stanford-university
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/translational-genomics-research-institute
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/university-california-san-francisco
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/university-california-san-francisco-2
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/university-texas-md-anderson-cancer-center
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal/university-texas-southwestern-medical-center
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/publications/ctd2-publications-spreadsheet.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/analytical-tools
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/caveat-emptor.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/citing
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/data-release-policy-cancer-target-discovery-development.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/supported-reagents
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/supported-reagents/emory-ctd2-ppi-reagents.xlsx
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ctd2/using-ctd2-data/supported-reagents/mdacc-orf-clones.xlsx
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/about
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/about/about-next-gen-models
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/about/cancer-model-development
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/ampulla-vater-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/avc-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/brain-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/brain-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/breast-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/breast-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/colorectal-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/colorectal-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/endometrium-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/endometrium-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/esophageal-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/esophageal-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/ewing-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/ewing-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/glioblastoma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/glioblastoma-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/hcc-intrahepatic-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/hcc-intrahepatic-multi-enrollment-crf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/head-and-neck-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/head-and-neck-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/kidney-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/kidney-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/lung-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/lung-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/melanoma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/melanoma-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/mesothelioma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/mesothelioma-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/neuroblastoma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/neuroendocrine-enrollment-suppl-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/osteosarcoma-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/osteosarcoma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/ovarian-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/ovarian-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/pancreas-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/pancreas-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/pediatric-liver-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/pediatric-liver-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/prostate-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/prostate-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/rare-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/rare-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/rhabdomyosarcoma-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/rhabdomyosarcoma-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/stomach-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/stomach-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/wilms-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/case-report-forms/wilms-followup-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi-data/searchable-catalog/hcmi-searchable-catalog-user-guide.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/case-report-forms
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/case-report-forms/neuroblastoma-multi-enrollment-crf.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/citing
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/model-characterization
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/searchable-catalog
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/hcmi/using-hcmi/searchable-catalog/informed-consent-template-for-hcmi.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/functional-genomics/ngt
|
||
|
|
https://www.cancer.gov/ccg/research/genome-characterization-pipeline
|
||
|
|
https://www.cancer.gov/ccg/research/genome-characterization-pipeline/genome-characterization-pipeline-infographic
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/about
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/about/projects
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/publications
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/using-cgci
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/using-cgci/citing
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/using-cgci/data-types-collected
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/cgci/using-cgci/technology
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/ctsp
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/about
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/publications
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/acute-lymphoblasic-leukimia
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/acute-myeloid-leukemia
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/kidney-tumors
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/model-systems
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/neuroblastoma
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/osteosarcoma
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/using-target-data
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/using-target-data/citing
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/target/using-target-data/technology
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/history
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/history/ethics-policies
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/history/tcga-legacy-video
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/history/timeline-milestones
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/publications
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/acute-myeloid-leukemia-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/adrenocortical-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/bladder-urothelial-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/breast-ductal-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/breast-lobular-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/cervical-cancer-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/cholangiocarcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/chromophobe-renal-cell-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/clear-cell-renal-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/colorectal-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/cutaneous-melanoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/endometrial-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/esophageal-cancer-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/gastric-adenocarcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/glioblastoma-multiforme-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/head-neck-squamous-cell-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/hepatocellular-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/lower-grade-glioma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/lung-adenocarcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/mesothelioma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/ovarian-serous-adenocarcinoma
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/pancreatic-ductal-adenocarcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/paraganglioma-pheochromocytoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/prostate-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/sarcoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/testicular-germ-cell-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/thymoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/thyroid-cancer-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/uterine-carcinosarcoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/studied-cancers/uveal-melanoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/tcga-by-the-numbers-infographic
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/using-tcga-data
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/using-tcga-data/citing
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/using-tcga-data/technology
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/using-tcga-data/tools
|
||
|
|
https://www.cancer.gov/ccg/research/genome-sequencing/tcga/using-tcga-data/types
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/cgci/about/projects/blgsp-factsheet-06-2019.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/cgci/data-matrix/cgci-wgsaliquots-underanalysisatgdc.xlsx
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/cgci/using-cgci-data/blgsp-sop-manual.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/cgci/using-cgci-data/htmcp-sop-manual.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/alal-copy-number-illumina-omni2.5-exome8.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/alal-methylation-illumina-methylationepic.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/alal-mrnaseq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/alal-wgs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/alal-wxs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-nbl-rt-wt-mrnaseq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-all-p2-all-mdls-rna-prep-trizol.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-all-p2-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-all-p2-mdls-dna-prep-qiaamp.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-copy-number-affymetrix-snp-500k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-gene-expression-affymetrix-u133-plus-2.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-kinome-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-targeted-sanger-reseq.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p1-wgs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p2-mdls-gene-expression-affymetrix-u133-plus-2.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p2-methylation-help-roche-nimblegen.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/all-p2-mirnaseq.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-aml-if-dna-rna-prep-qiagen-mirvana.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-aml-if-mirnaseq.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-aml-if-mrnaseq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-gene-expression-affymetrix-gene-1.1-st.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-methylation-illumina-infinium27k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-methylation-illumina-infinium450k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/aml-nbl-wt-targeted-capture-seq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/ccsk-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/ccsk-gene-expression-affymetrix-u133-plus-2.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/ccsk-methylation-illumina-infinium450k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/ccsk-mrnaseq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/ccsk-nbl-os-rt-wt-dna-rna-prep.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-copy-number-illumina-humanhap-500k-beadchip.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-gene-expression-affymetrix-exon-st.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-methylation-illumina-infinium450k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-mrnaseq-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-rna-prep-trizol.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-wgs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-wt-dna-prep-genomic-tips.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/nbl-wxs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/os-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/os-gene-expression-affymetrix-exon-st.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/os-methylation-illumina-infinium450k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/os-mirna-taqman.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/pptp-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/pptp-copy-number-illumina-omni5-beadchip.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/pptp-gene-expression-affymetrix-u133-plus-2.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/pptp-gene-expression-agilent-sureprint-g3.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/rt-mirnaseq.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/rt-wgs-illumina.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/technology/all-p2-aml-nbl-mdls-pptp-wt-wxs.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/wt-copy-number-affymetrix-snp-6.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/wt-gene-expression-affymetrix-u133-plus-2.0.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/wt-methylation-illumina-infinium450k.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/target/using-target-data/wt-mirnaseq.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/history/policies/biological-data-sharing-principles.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/history/policies/ccle-open-release-justification.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/history/policies/suggested-prospective-informed-consent.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/history/policies/tcga-data-use-certification-agreement.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/history/policies/tcga-human-subjects-data-policies.pdf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/studied-cancers/lung-squamous-cell-carcinoma-study
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/studied-cancers/papillary-renal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/abi-3730-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/abi-solid3plus-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetric-u133-plus2-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetric-u133-plus2-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetric-u133a-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-exon-1.0st-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-exon-1st-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-exon-1st-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-snp6-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-snp6-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-snp6-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-u133-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/affymetrix-u133a-tsv
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-244a-hms-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-244a-hms-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-244a-mskcc-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-244a-mskcc-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g3-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4124a-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4124a-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4447a-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4447a-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-1-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-1-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-2-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-2-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-3-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-g4502a-07-3-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-microrna-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-microrna-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-microrna-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-microrna-r12-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/agilent-microrna-r12-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-1m-duo-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-1m-duo-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-gaiix-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-goldengate-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-hd-beadchip-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-hiseq2000-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanhap550-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanhap550-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanmethylation27-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanmethylation27-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanmethylation450-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-humanmethylation450-data-sheet
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-oma002-adf
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-oma002-fasta
|
||
|
|
https://www.cancer.gov/ccg/research/structural-genomics/tcga/using-tcga-data/technology/illumina-oma003-adf
|
||
|
|
https://www.cancer.gov/ccg/sitemap
|
||
|
|
https://www.cancer.gov/cclf.pdf
|
||
|
|
https://www.cancer.gov/cell-lines
|
||
|
|
https://www.cancer.gov/cgh-cuervo-video
|
||
|
|
https://www.cancer.gov/cgh-edwards-video
|
||
|
|
https://www.cancer.gov/cgh-glass-video
|
||
|
|
https://www.cancer.gov/cgh-harford-video
|
||
|
|
https://www.cancer.gov/cgh-loehrer-video
|
||
|
|
https://www.cancer.gov/cgh-martin-video
|
||
|
|
https://www.cancer.gov/cgh-mullen-video
|
||
|
|
https://www.cancer.gov/cgh-nelson-video
|
||
|
|
https://www.cancer.gov/cgh-shiffman-video
|
||
|
|
https://www.cancer.gov/cgh-vinson-video
|
||
|
|
https://www.cancer.gov/cgh-welch-video
|
||
|
|
https://www.cancer.gov/clinical-trial-randomization-infographic
|
||
|
|
https://www.cancer.gov/clinical-trials-pamela-video
|
||
|
|
https://www.cancer.gov/clinical-trials-video
|
||
|
|
https://www.cancer.gov/clinical-trials-video-playlist
|
||
|
|
https://www.cancer.gov/connect-prevention-study/
|
||
|
|
https://www.cancer.gov/connect-prevention-study/about
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/acerca-del-estudio
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/inscripcion/requisitos-inscripcion-estudio
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/noticias
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/noticias/cientifica-senior
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/noticias/devolver-resultados
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/noticias/kirsti-autio
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/participacion
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/participacion-0
|
||
|
|
https://www.cancer.gov/connect-prevention-study/espanol/proteccion-datos
|
||
|
|
https://www.cancer.gov/connect-prevention-study/news
|
||
|
|
https://www.cancer.gov/connect-prevention-study/news/kirsti-autio
|
||
|
|
https://www.cancer.gov/connect-prevention-study/news/return-results
|
||
|
|
https://www.cancer.gov/connect-prevention-study/news/senior-scientist
|
||
|
|
https://www.cancer.gov/connect-prevention-study/privacy
|
||
|
|
https://www.cancer.gov/connect-prevention-study/what-to-expect
|
||
|
|
https://www.cancer.gov/connect-prevention-study/what-to-expect-0
|
||
|
|
https://www.cancer.gov/connect-prevention-study/who-can-join
|
||
|
|
https://www.cancer.gov/contact
|
||
|
|
https://www.cancer.gov/contact/anna-calls-cis-video
|
||
|
|
https://www.cancer.gov/contact/answer-questions-fb-live-video
|
||
|
|
https://www.cancer.gov/contact/anthony-calls-cis-video
|
||
|
|
https://www.cancer.gov/contact/anthony-chats-cis-video
|
||
|
|
https://www.cancer.gov/contact/carla-calls-cis-video
|
||
|
|
https://www.cancer.gov/contact/carla-chats-cis-video
|
||
|
|
https://www.cancer.gov/contact/cis-short-video
|
||
|
|
https://www.cancer.gov/contact/cis-staff-video
|
||
|
|
https://www.cancer.gov/contact/cis-video
|
||
|
|
https://www.cancer.gov/contact/email-us
|
||
|
|
https://www.cancer.gov/contact/emergency-preparedness
|
||
|
|
https://www.cancer.gov/contact/jade-chats-cis-video
|
||
|
|
https://www.cancer.gov/contact/oscar-calls-cis-video
|
||
|
|
https://www.cancer.gov/contact/thomas-chats-cis-video
|
||
|
|
https://www.cancer.gov/contactenos/emergencia/tarjeta-bolsillo.pdf
|
||
|
|
https://www.cancer.gov/covid-19-info-for-applicants-recipients.pdf
|
||
|
|
https://www.cancer.gov/crchd-brochure.pdf
|
||
|
|
https://www.cancer.gov/ctd2-dashboard-interactions
|
||
|
|
https://www.cancer.gov/ctd2-dashboard-overview
|
||
|
|
https://www.cancer.gov/ctd2-dashboard-search
|
||
|
|
https://www.cancer.gov/data-management-sharing-presentation.pptx
|
||
|
|
https://www.cancer.gov/digital-standards
|
||
|
|
https://www.cancer.gov/egfr.pdf
|
||
|
|
https://www.cancer.gov/espanol
|
||
|
|
https://www.cancer.gov/espanol/acerca-sitio
|
||
|
|
https://www.cancer.gov/espanol/acerca-sitio/mapa-sitio
|
||
|
|
https://www.cancer.gov/espanol/cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/conversacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/cuidado-propio
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/planificacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/planificacion/etapa-final-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/planificacion/etapa-final-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/planificacion/perdida-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/cuidadores/planificacion/perdida-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/opciones-de-cuidado
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/opciones-de-cuidado/hoja-informativa-cuidado
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/opciones-de-cuidado/hoja-informativa-cuidados-paliativos
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/planes
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/planes/etapa-final-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/planes/etapa-final-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/preguntas
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/proposito-y-sentido-de-la-vida
|
||
|
|
https://www.cancer.gov/espanol/cancer/cancer-avanzado/sentimientos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/aspectos-generales-prevencion-paciente-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/aspectos-generales-prevencion-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/aspectos-generales-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/cancer-gastrico-difuso-hereditario-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/evaluacion-del-riesgo-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/hoja-informativa-brca
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/genetica/hoja-informativa-pruebas-geneticas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/investigacion/aspirina
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alcohol
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alcohol/canceres-relacionados-alcohol-infografia
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alcohol/hoja-informativa-alcohol
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-acrilamida
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-antioxidantes
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-carne-cocinada
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-edulcorantes-artificiales
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-plantas-cruciferas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-te
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/alimentacion/hoja-informativa-vitamina-d
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/edad
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-h-pylori
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-vacuna-vph
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-vih
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/vph-vacuna-captacion-infografico
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/vph-y-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/hormonas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/hormonas/hoja-informativa-antecedentes-reproduccion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/hormonas/hoja-informativa-des
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/hormonas/hoja-informativa-hormonas-menopausia
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/hormonas/hoja-informativa-pildoras-anticonceptivas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/inflamacion-cronica
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/inmunosupresion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/luz-solar
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/mitos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/mitos/hoja-informativa-agua-fluorada
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/mitos/hoja-informativa-antitranspirantes
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/obesidad
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/obesidad/actividad-fisica-hoja-informativa
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/obesidad/canceres-asociados-sobrepeso-infografia
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/obesidad/hoja-informativa-obesidad
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/radiacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/radiacion/hoja-informativa-accidentes-plantas-nucleares
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/radiacion/hoja-informativa-campos-electromagneticos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/radiacion/hoja-informativa-telefonos-celulares
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/aceites-minerales
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/acido-inorganico
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/acidos-aristoloquicos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/aflatoxinas/aflatoxinas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/alquitran-de-hulla
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/arsenico
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/asbesto
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/asbesto/hoja-informativa-asbesto
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/benceno
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/benzidina
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/berilio
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/butadieno
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/cadmio
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/carbon-en-viviendas
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/carcinogenos
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/cloruro-vinilico
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/cromo
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/erionita
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/exposicion-pasiva
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/formaldehido
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/formaldehido/hoja-informativa-formaldehido
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/hoja-informativa-brotes
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/hoja-informativa-tintes-para-cabello
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/hollin
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/hornos-de-coque
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/niquel
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/oxido-de-etileno
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/polvo-de-madera
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/radon
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/radon/hoja-informativa-radon
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/silice-cristalina
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/torio
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/sustancias/tricloroetileno
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/dejar-fumar-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/dejar-fumar-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-abstinencia
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-ayuda-dejar-fumar
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-cigarillos-light
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-cigarros-puros
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-dejar-de-fumar
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-humo-tabaco-ambiente
|
||
|
|
https://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/tabaco/hoja-informativa-tabaco-sin-humo
|
||
|
|
https://www.cancer.gov/espanol/cancer/control-dolor.epub
|
||
|
|
https://www.cancer.gov/espanol/cancer/control-dolor.mobi
|
||
|
|
https://www.cancer.gov/espanol/cancer/control-dolor.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/coronavirus
|
||
|
|
https://www.cancer.gov/espanol/cancer/coronavirus/coronavirus-informacion-personas-con-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/coronavirus/vacunas-covid-19-para-personas-con-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/cuidadores.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/dar-sus-tejidos.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/aspectos-generales-deteccion-paciente-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/aspectos-generales-deteccion-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/examenes-de-deteccion
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/investigacion/que-dicen-estadisticas-de-deteccion
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/significado-cambios-seno.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/significado-cambios-senos.epub
|
||
|
|
https://www.cancer.gov/espanol/cancer/deteccion/significado-cambios-senos.mobi
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/diagnostico/grado-del-tumor
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/diagnostico/hoja-informativa-informes-de-patologia
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/diagnostico/hoja-informativa-marcadores-de-tumores
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/diagnostico/lista-marcadores-tumorales
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/estadificacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/estadificacion/hoja-informativa-ganglio-centinela
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/hoja-informativa-tomografia-computarizada
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/preguntas
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/pronostico
|
||
|
|
https://www.cancer.gov/espanol/cancer/diagnostico-estadificacion/sintomas
|
||
|
|
https://www.cancer.gov/espanol/cancer/fraude-en-la-salud-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/busqueda-tratamiento-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/busqueda-tratamiento-cancer/apoyo
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/busqueda-tratamiento-cancer/proveedores
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/registro-atencion-medica.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/registro-conversaciones-sobre-cuentas-medicas.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/tabla-de-costos
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/tabla-de-financiales.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/toxicidad-financiera-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/costos/toxicidad-financiera-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/encontrar-recursos-confiables
|
||
|
|
https://www.cancer.gov/espanol/cancer/manejo-del-cancer/instrucciones-adelantadas
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza/desigualdades
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza/desigualdades/desigualdades-en-salud-por-cancer-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza/desigualdades/diversidad-en-investigacion-fb-live
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza/estadisticas
|
||
|
|
https://www.cancer.gov/espanol/cancer/naturaleza/que-es
|
||
|
|
https://www.cancer.gov/espanol/cancer/prevenir-cancer-estudios-clinicos.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/quimioterapia-y-usted.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/radioterapia-y-usted.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/cambios-para-la-familia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/comunicacion-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/comunicacion-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/conyuge-o-pareja
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/grupos-de-apoyo
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/hablar-con-hijos
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/adaptacion-al-cancer/hablar-con-medicos
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/adolescentes
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/caregiver-spanish-jan2014.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/caregiver-spanish.epub
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/caregiver-spanish.mobi
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/cuidado-despues-del-tratamiento
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/apoyo-a-quien-cuida/padres
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/consejos-de-alimentacion.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/beneficios-ejercicio-infografia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/fe-y-espiritualidad
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/fe-y-espiritualidad/espiritualidad-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/fe-y-espiritualidad/espiritualidad-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/regreso-al-trabajo
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/dia-a-dia/rutina-diaria
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/eatinghints-es.epub
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/eatinghints-es.mobi
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/familia-y-amigos/familiares-a-cargo-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/familia-y-amigos/familiares-a-cargo-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/imagen-propia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/preguntas
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/ansiedad-sufrimiento-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/ansiedad-sufrimiento-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/depresion-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/depresion-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/hoja-informativa-estres
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/sentimientos/relajarse
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/cuidados-de-seguimiento
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/efectos-tardios
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/facingforward-sp.epub
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/facingforward-sp.mobi
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/infancia
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/nueva-normalidad
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/nueva-normalidad/ptsd-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/nueva-normalidad/ptsd-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/preguntas
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/problemas-familiares
|
||
|
|
https://www.cancer.gov/espanol/cancer/sobrellevar/supervivencia/sigaadelante.pdf
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/centro-clinico
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/anemia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/ascitis
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/boca-garganta
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/boca-garganta/complicaciones-orales-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/boca-garganta/complicaciones-orales-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/caida-pelo
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/cambios-piel-unas
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/cambios-piel-unas/prurito-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/cambios-piel-unas/prurito-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/caquexia-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/cardiopulmonares-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/cardiopulmonares-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/delirio
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/diarrea
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/dolor
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/dolor/dolor-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/dolor/dolor-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/edema
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/estrenimiento
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/estrenimiento/complicaciones-gi-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/fatiga
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/fatiga/fatiga-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/fecundidad-hombres
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/fecundidad-mujeres
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/infecciones
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/inflamacion-de-organos
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/insomnio
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/insomnio/trastornos-del-sueno-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/insomnio/trastornos-del-sueno-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/linfedema
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/linfedema/linfedema-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/memoria
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/memoria/deterioro-cognitivo-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/memoria/deterioro-cognitivo-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nauseas-vomitos
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nauseas/nauseas-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/alimentos-dieta-baja-fibra
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/alimentos-dieta-liquida-completa
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/alimentos-dieta-rica-fibra
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/alimentos-faciles-digerir
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/alimentos-faciles-masticar-tragar
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/anadir-calorias-alimentacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/anadir-proteinas-alimentacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/nutricion/liquidos-claros-dieta
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/obstruccion-intestinal
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/perdida-apetito
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/perdida-apetito/nutricion-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/problemas-nervios
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/problemas-urinarios
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sangrado-moretones
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sexualidad-hombres
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sexualidad-mujeres
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sexualidad-mujeres/sofocos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sexualidad-mujeres/sofocos-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/sintomas-pseudogripales
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/video-cambios-gusto-y-olfato-durante-tratamiento-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/video-formas-mejorar-apetito-durante-tratamiento-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/efectos-secundarios/video-precauciones-al-preparar-comida-si-tienes-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/caquexia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/cardiotoxicidad
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/celulas-t-y-car
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/cerebro-en-quimio
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/respuestas-excepcionales-preguntas-respuestas
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/dietas-suplementos
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/714-x-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/acupuntura-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/antineoplastones-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/aromaterapia-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cancell-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cannabis-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cardo-mariano-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/coenzima-q10-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cohosh-negro-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/curcuma-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/essiac-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/gerson-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/gonzalez-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/hongos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/interacciones-alimentos-suplementos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/laetrilo-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/pc-spes-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/prostata-suplementos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/sulfato-hidracina-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/suns-soup-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/ven-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/714-x-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/acupuntura-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/antineoplastones-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/aromaterapia-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/cancell-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/cannabis-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/cardo-mariano-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/cartilago-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/cimicifuga-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/coenzima-q10-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/curcuma-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/essiac-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/gerson-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/gonzalez-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/hongos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/interacciones-alimentos-suplementos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/laetrilo-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/muerdago-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/pc-spes-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/prostata-suplementos-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/sulfato-hidracina-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/suns-soup-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/ven-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos/acceso-fase-investigacion
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos/enfermedades-relacionadas-con-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos/medicamentos-aprobados-fda-canceres-infantiles
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos/tipos-de-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/medicamentos/uso-extraoficial
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/preguntas
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/cirugia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/cirugia/crioterapia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/cirugia/terapia-laser
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/anticuerpos-monoclonales
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/efectos-secundarios
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/estimulacion-inmunitaria-noespecifica-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/hoja-informativa-inhibidores-angiogenesis
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/inhibidor-puntos-de-control-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/inhibidores-de-puntos-de-control
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/inmunomodulador
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/inmunoterapia-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/terapia-transferencia-de-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/transferencia-de-celulas-t-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/inmunoterapia/vacunas-tratamiento-contra-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/pruebas-de-biomarcadores-tratamiento-cancer
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/quimioterapia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/radioterapia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/radioterapia/braquiterapia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/radioterapia/efectos-secundarios
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/radioterapia/haz-externo
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-de-hipertermia
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-dirigida
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-dirigida/anticuerpos-monoclonales-video
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-fotodinamica
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-hormonal
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/trasplante-de-celulas-madre
|
||
|
|
https://www.cancer.gov/espanol/cancer/tratamiento/tipos/trasplante-de-celulas-madre/donacion-celulas-madre-sanguineas
|
||
|
|
https://www.cancer.gov/espanol/contactenos
|
||
|
|
https://www.cancer.gov/espanol/contactenos/correo-electronico
|
||
|
|
https://www.cancer.gov/espanol/contactenos/emergencia
|
||
|
|
https://www.cancer.gov/espanol/contactenos/millan
|
||
|
|
https://www.cancer.gov/espanol/contactenos/responde-preguntas-fb-live-video
|
||
|
|
https://www.cancer.gov/espanol/contactenos/video-cis
|
||
|
|
https://www.cancer.gov/espanol/estudio-clinicos-video
|
||
|
|
https://www.cancer.gov/espanol/estudios-clinicos-coleccion-de-videos
|
||
|
|
https://www.cancer.gov/espanol/instituto
|
||
|
|
https://www.cancer.gov/espanol/instituto/directora
|
||
|
|
https://www.cancer.gov/espanol/instituto/general
|
||
|
|
https://www.cancer.gov/espanol/instituto/general/capacitacion-de-la-fuerza-laboral-infografia
|
||
|
|
https://www.cancer.gov/espanol/instituto/general/contribuciones
|
||
|
|
https://www.cancer.gov/espanol/instituto/general/historia
|
||
|
|
https://www.cancer.gov/espanol/instituto/general/infografia-nci
|
||
|
|
https://www.cancer.gov/espanol/instituto/general/toma-decisiones-medicas
|
||
|
|
https://www.cancer.gov/espanol/instituto/organizacion
|
||
|
|
https://www.cancer.gov/espanol/instituto/organizacion/salud-mundial/programas-iniciativas-de-investigacion/us-la-crn
|
||
|
|
https://www.cancer.gov/espanol/investigacion
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/biologia
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/cancer-infantil
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/cancer-infantil/infografia
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/causas
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/desigualdades
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/genomica
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/prevencion
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/salud-mundial
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/salud-publica
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/investigacion/areas/tratamiento/inmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/centros-oncologicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/financiados-por-nci
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/financiados-por-nci/match-infantil/match-infantil-infografia
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/financiados-por-nci/nci-match
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/ncorp
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/nctn
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/nctn/estructura-nctn-grupos-cooperativos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/nctn/financiamiento-nctn
|
||
|
|
https://www.cancer.gov/espanol/investigacion/infraestructura/estudios-clinicos/nctn/nctn-estructura-red-nacional
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/iniciativas-investigacion-covid-19
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/iniciativas-investigacion-covid-19/nccaps
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/mision-contra-cancer
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/mision-contra-cancer/panel-liston-azul-video
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/programa-de-equidad-e-inclusion-nci
|
||
|
|
https://www.cancer.gov/espanol/investigacion/iniciativas-clave/programa-de-equidad-e-inclusion-nci/acerca-del-programa
|
||
|
|
https://www.cancer.gov/espanol/investigacion/papel-del-nci
|
||
|
|
https://www.cancer.gov/espanol/investigacion/papel-del-nci/tipos-investigacion-cancer-infografia
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/como-buscar-un-estudio-clinico
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos/como-funcionan-los-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos/para-que-sirve-participar-en-un-estudio-clinico-de-tratamiento
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos/que-son-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos/quien-paga-por-los-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/estudios-clinicos/son-seguros-los-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/que-son-los-estudios-de-investigacion-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/que-son-los-estudios-de-observacion
|
||
|
|
https://www.cancer.gov/espanol/investigacion/participe/que-son-los-estudios-de-observacion/estudios-de-observacion-seleccionados
|
||
|
|
https://www.cancer.gov/espanol/lista-detallada.pdf
|
||
|
|
https://www.cancer.gov/espanol/listadetalladadelcancer.pdf
|
||
|
|
https://www.cancer.gov/espanol/lo-que-deberia-saber-sobre-los-estudios-clinicos.pdf
|
||
|
|
https://www.cancer.gov/espanol/multimedia
|
||
|
|
https://www.cancer.gov/espanol/news-events/press-releases/2019/analisis-impacto-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/noticias
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2012
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2013/transcript-anuncio-servicio
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2013/transcript-nuevo-sitio
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/asco-estudio-cancer-de-seno-sensible-a-hormonas
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/asco-estudionci8348-cancer-de-ovario-recidivante
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/asco-estudiopoems-cancer-de-seno-fertilidad
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/asco-estudios-del-nci-canceres-en-mujeres
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/aspirina-reduccion-cancerdeovario
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/cancercenterpuertoricospanish
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/declaracion-sobre-red-nctn
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/estudio-lungmap
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/estudiompact
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/estudiortog9802
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/informe-tabaco-sin-humo-nci-y-cdc
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/lanzamiento-alchemist
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/obesidad-claseiii
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/predictor-riesgo-de-vph
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/programa-ncorp
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/se-lanza-red-nctn
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2014/subvenciones-cgh
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2015
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2015/comunicado-de-prensa-del-informe-anual
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2015/estudio-anchor-cancer-ano
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2015/nci-match
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016/fumar-baja-intensidad-riesgo
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016/informe-anual-nacion-1975-2012
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016/mayor-actividad-fisica-asociada
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016/ncab-nci-acepta-informe-brp
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2016/se-anuncia-panel-liston-azul
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2017
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2017/indices-muerte-prematura-desviacion
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2017/informe-anual-a-la-nacion-1975-2014
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/informe-anual-al-pais-2018
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/llc-ibrutinib-estudio
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/lowy-schiller-premio-szent-gyorgyi
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/oropharyngeal-hpv-cisplatin
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/tailorx-cancer-seno-quimioterapia
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2018/tmds-aml-riesgo-quimio
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2019
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2019/anual-informe-nacion-2019
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2019/aprendizaje-profundo-cancer-cuello-uterino-examenes-de-deteccion
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2020
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2020/reporte-anual-nacion-2020
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2020/selumetinib-ninos-nf1
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2021
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2021/alimentacion-mucha-fibra-mejora-inmunoterapia-melanoma
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2021/desigualdad-exceso-de-muertes-pandemia-covid-19
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2021/informe-anual-nacion-2021
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2021/informe-anual-nacion-2021-parte-2-carga-economica
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/actividad-fisica-adultos-mayores
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/bertagnolli-directora-nci
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/diagnostico-cancer-mama-directora-nci-monica-bertagnolli
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/director-nci-norman-sharpless-deja-su-cargo
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/estilo-de-vida-saludable-y-riesgo-de-muerte-exfumadores
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2022/informe-anual-a-la-nacion-2022
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/citocinas-aumentan-eficacia-terapias-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/datos-proteogenomicos-cptac
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/nci-inaugura-iniciativa-contra-pobreza-persistente
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/oportunidades-para-disminuir-tasa-de-muertes-por-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/parte-2-informe-anual-a-la-nacion-diagnostico-cancer-pandemia
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2023/rathmell-directora-nci
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/efecto-pandemia-covid-nuevos-diagnosticos-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/grandes-desafios-del-cancer-selecciona-cinco-nuevos-equipos
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/herramienta-ia-pronostica-respuesta-inmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/multivitaminicos-no-disminuyen-riesgo-muerte
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/nuevos-estudios-red-del-atlas-de-tumores-humanos
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/pembrolizumab-cancer-vejiga-riesgo-alto
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/proteinas-ras-mutadas-nueva-funcion-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/red-investigacion-deteccion-sistematica-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/comunicados-de-prensa/2024/vipor-combinacion-medicamentos-dirigidos-tratar-linfomas-celulas-b
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/50-aniversario-ley-nacional-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/el-regalo-del-tiempo-video
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/avances-en-tratamientos-y-atencion
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/causas-y-factores-de-riesgo-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/centros-oncologicos
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/descubrimientos-sobre-el-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/desigualdades-en-salud-por-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/el-poder-de-los-datos
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/fuerza-laboral-de-investigacion-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/investigacion-cancer-defensores
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/investigacion-canceres-infantiles
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/prevencion-cancer-cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/prevencion-y-examenes-de-deteccion
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/red-de-estudios-clinicos
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/supervivencia
|
||
|
|
https://www.cancer.gov/espanol/noticias/nca50/historias/tecnologia-e-innovacion
|
||
|
|
https://www.cancer.gov/espanol/participo-estudio-clinico-video
|
||
|
|
https://www.cancer.gov/espanol/politicas
|
||
|
|
https://www.cancer.gov/espanol/politicas/accesibilidad
|
||
|
|
https://www.cancer.gov/espanol/politicas/comentarios
|
||
|
|
https://www.cancer.gov/espanol/politicas/confidencialidad-seguridad
|
||
|
|
https://www.cancer.gov/espanol/politicas/declaraciones-omb
|
||
|
|
https://www.cancer.gov/espanol/politicas/derechos-de-autor-y-uso
|
||
|
|
https://www.cancer.gov/espanol/politicas/enlaces
|
||
|
|
https://www.cancer.gov/espanol/politicas/exoneracion
|
||
|
|
https://www.cancer.gov/espanol/politicas/foia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/boletin-instituto-nacional-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/123i-mibg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/131i-mibg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/18f-colina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/18f-fluorotimidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/3-galato-de-epigalocatequina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/34-benzopireno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/368445
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/368447
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/5-fluorouracilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/5-hidroxitriptamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/752840
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/abdominal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-de-la-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-ovarica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-por-alcohol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-por-etanol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-por-radiofrecuencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-termica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ablacion-transuretral-con-aguja
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/abraxane
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/absorciometria-de-rayos-x-de-energia-dual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/abuso-de-drogas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/abvd
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/accidente-cerebrovascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aceite-de-vaselina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aceite-yodado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acelerador-lineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetaminofeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-abiraterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-goserelina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-lanreotida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-leuprolida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-medroxiprogesterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetato-de-megestrol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetil-l-carnitina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetilacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetilcisteina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acetilcolina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-5-hidroxiindolacetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-acetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-ascorbico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-carbolico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-desoxirribonucleico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-fitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-folico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-folinico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-fosforico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-glicolico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-glucuronico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-glutamico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-hidroxamico-suberoilanilida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-holo-trans-retinoico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-lactico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-nicotinico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-nitrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-paraaminobenzoico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-retinoico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-ribonucleico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-sialico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-sulfurico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-urico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acido-valproico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aclorhidria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acth
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/actinomicina-d
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/activador-del-plasminogeno-tipo-urocinasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/activador-del-plasminogeno-tisular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/actividad-mitotica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/acv
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adderall
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenocarcinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenocarcinoma-de-celulas-claras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenocarcinoma-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenoma-tubulovelloso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenoma-velloso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenomatosis-endocrina-multiple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenopatia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenosis-esclerosante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adenovirus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/administracion-de-alimentos-y-medicamentos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adn-de-la-linea-germinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adn-no-codificante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ado-trastuzumab-emtansina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adolescente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adrenalectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adrenocortical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adulterante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adyuvante-incompleto-de-freund
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/adyuvante-inmunologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aferesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/afp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aglutinina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agonista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agonista-de-la-hormona-liberadora-de-gonadotropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agonista-de-la-hormona-liberadora-de-hormona-luteinizante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agranulocitosis-genetica-infantil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/agresivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aguja-de-jamshidi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aha
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ahc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/akt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alanina-transferasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcali
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcalinizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcaloide-de-vinca
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcanfor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcohol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcohol-de-madera
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alcohol-metilico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aldosterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aleatorizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alectinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alendronato-sodico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alfafetoproteina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alfatocoferol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alimentacion-por-sonda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alimento-denso-en-nutrientes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alimento-fortificado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/almacenamiento-de-espermatozoides
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/almacenamiento-de-tejido-testicular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aloe-emodina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alogenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aloinjerto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alopurinol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alquilante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alquitran-del-tabaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alteracion-epigenetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/alveolos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amianto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amigdalina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amikacina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amiloidosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amina-heterociclica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aminoglutetimida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aminopterina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amoniaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amoxicilina-clavulanato-de-potasio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amplificacion-de-genes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ampolla-de-vater
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/amputacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analgesico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-bioquimico-de-la-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-de-cancer-de-mama-oncotype-dx
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-de-glicanos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-de-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-de-sangre-oculta-en-la-materia-fecal-mediante-inmunoensayo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-histologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-inmunologico-de-sangre-oculta-en-la-materia-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-inmunoquimico-de-sangre-oculta-en-la-materia-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analisis-multigenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analogo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/analogo-de-la-geldanamicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anaplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anastomosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anastomosis-coloanal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anastomosis-colorrectal-con-bolsa-en-forma-de-j
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anastomosis-colorrectal-directa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anastrozol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anatomico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anatomista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/androblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/androgeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/androstanolona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anemia-aplasica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anemia-de-celulas-falciformes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anemia-de-diamond-blackfan
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anemia-hemolitica-autoinmunitaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anemia-hipoplasica-congenita
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesia-espinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesia-general
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesia-local
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesia-regional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anestesiologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiofibroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiogenesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angioma-en-penacho
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiomiolipoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/angiostatina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anillo-de-waldeyer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anorexia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ansiolisis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antagonista-de-la-hormona-liberadora-de-hormona-luteinizante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antagonista-del-acido-folico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antagonista-del-calcio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antagonista-del-folato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antagonista-del-receptor-5-ht3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antecedentes-medicos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antecedentes-medicos-personales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antecedentes-personales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antenatal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiandrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiangiogenesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiapoptotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antibacteriano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antibiotico-antineoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antibiotico-antitumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticancerigeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticoagulante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-biespecifico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal-anti-cd45
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal-biespecifico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal-humanizado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal-quimerico-anti-il-6
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-monoclonal-totalmente-humano-anti-vegfr-2-imc-1121b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/anticuerpo-neutralizante-de-virus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiepileptico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiestrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antifibrinolitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antifolato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-carcinoembrionario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-cd20
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-cd34
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-leucocitario-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-linfocitario-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-mart-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-prostatico-especifico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antigeno-tumoral-especifico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antihipertensor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antimetabolito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antimicrotubulo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antimitotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antineoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antioncogen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antioxidante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiparasitario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antiprogestina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antipsicotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antituberculoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antitumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antivirico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/antraciclina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aorta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aparato-de-golgi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aparato-digestivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aparato-reproductor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aparato-respiratorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aparato-urinario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/apc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aplasia-pura-de-celulas-rojas-adquirida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aplasia-pura-de-celulas-rojas-congenita
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aplicacion-de-ventosas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/apoptosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/apoyo-de-celulas-madre-perifericas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arbol-genealogico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arcadas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/areola
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arn-de-antisentido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arn-mensajero
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arnm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aromaterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arrenoblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arteria-carotida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arteria-hepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/arteria-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/artritis-reumatoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asbestosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asc-h
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asc-us
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ascitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ascus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asesor-nutricional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asesoramiento-genetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asintomatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asociado-medico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asparaginasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/asparaginasa-de-erwinia-chrysanthemi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aspartato-aminotransferasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aspiracion-con-aguja-fina-guiada-por-ecografia-endoscopica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aspiracion-de-la-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/aspirado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/astrocitoma-de-grado-iv
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/astrocitoma-pilocitico-juvenil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/astrocitoma-subependimario-de-celulas-gigantes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atelectasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atencion-en-la-etapa-final-de-la-vida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atencion-primaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atenuado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atipia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atomo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atra
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atrofia-gastrica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/atrofia-muscular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/autoanticuerpo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/autoexamen-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/autofagia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/axitinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/azacitidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/azoximetano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/azul-de-isosulfan
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bacilo-de-calmette-guerin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bacterias
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/barrera-hematoencefalica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/basicidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/basofilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/baya-del-arbol-casto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bazo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bcl2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/benigno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/benzoapireno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/benzodiacepina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/beta-glucano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/betacaroteno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/betaendorfina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/betasitosterol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bevacizumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bhe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bi-rads
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bien-diferenciado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bilirrubina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biodisponible
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biomarcador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biomedicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-abierta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-asistida-por-vacio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-con-aguja
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-con-sacabocados
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-de-cono
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-de-ganglio-linfatico-centinela
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-de-la-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-de-la-vesicula-seminal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-de-pulmon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-estereotactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-liquida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-aaf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-aspiracion-con-aguja-fina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-excision
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-incision
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-puncion-con-aguja-gruesa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-por-rasurado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-quirurgica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-transperineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-transperineal-de-la-prostata-guiada-mediante-cartografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-transrectal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biopsia-transuretral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bioterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/biotina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bitartrato-de-hidrocodona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/blastoma-pleuropulmonar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/blinatumomab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/blincyto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bloqueador-adrenergico-beta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bloqueo-subaracnoideo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bombesina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bortezomib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/botox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/braquiterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/brca1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/brcapro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/brentuximab-vedotina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/briostatina-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bromhidrato-de-halofuginona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/broncodilatador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/broncoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/broncoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bronquial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bronquiolitis-obliterante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bronquitis-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bsa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bulbo-olfatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/bursitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/butano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/c-abl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/c-erbb-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ca-125
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ca-2729
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cabazitaxel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cadmio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/calbindina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/calcificacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/calcitonina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/calcitriol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/calidad-de-vida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cambios-fibroquisticos-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/canal-del-parto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-ampular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-avanzado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-bilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-colorrectal-en-estadio-b-de-dukes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-colorrectal-en-estadio-c-de-dukes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-colorrectal-en-estadio-iiia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-colorrectal-hereditario-no-poliposico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-colon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-corazon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-cuello-uterino-en-estadio-i
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-cuello-uterino-en-estadio-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-endometrio-en-estadio-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-faringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-garganta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-hueso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-la-ampolla-de-vater
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-la-boca
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-la-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-laringe-en-estadio-iva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-laringe-en-estadio-ivb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-lengua
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-en-estadio-temprano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-infiltrante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-invasivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-multicentrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-multifocal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-negativo-para-er-pr-y-her2-neu
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-mama-triple-negativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-ojo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-orofaringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-ovario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-piel-no-melanoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-prostata-resistente-a-la-castracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-pulmon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-rinon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-vejiga-en-estadio-0
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-de-vesicula-biliar-irresecable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-en-estadio-tardio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-en-estadio-terminal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-endocrino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-esporadico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-familiar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-gastrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-gastrico-en-estadio-0-carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-ginecologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-hematologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-infantil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-infiltrante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-invasivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-localmente-avanzado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-que-recidiva-localmente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-recidivante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-secundario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-terminal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-trabecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cancer-urotelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/candidiasis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cannabis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/canula-de-traqueotomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/canula-esofagica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/capecitabina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/capilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/capox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/capsula
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/capsula-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/caquexia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carboplatino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carboplatino-y-taxol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinogenesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-adenoescamoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-broncogenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-corionico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-basales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-en-anillo-de-sello
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas-de-cabeza-y-cuello
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas-de-esofago-en-estadio-ii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas-de-esofago-en-estadio-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas-de-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-escamosas-del-cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-celulas-renales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-esofago-in-situ-en-estadio-0
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-mama-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-de-vulva-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-del-conducto-de-bellini
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-ductal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-ductal-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-ductal-infiltrante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-epidermoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-epitelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-escirroso-gastrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-hepatocelular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-intraductal-de-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-leptomeningeo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-lobulillar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-lobulillar-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-lobulillar-infiltrante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-medular-de-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-metaplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-mucinoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-neuroendocrino-de-la-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-papilar-seroso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-sarcomatoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinoma-timico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinomatosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinomatosis-linfangitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinomatosis-meningea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carcinosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cardiopatia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cardo-santo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carga-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carina-traqueal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carmustina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/carotenoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/castracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/castracion-quirurgica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/catecol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/catecolamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/catequina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cateter-central-de-acceso-venoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cateter-implantable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cateter-venoso-periferico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cauterizar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cavidad-oral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cavidad-peritoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cavidad-pleural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cd117
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cd20
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cdc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cdis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cec
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-anfitriona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-basal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-c
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-cromafinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-de-la-neuroglia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-de-merkel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-de-reed-sternberg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-de-transicion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-del-islote
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-dendritica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-efectora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-endotelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-ependimaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-escamosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-estromal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-folicular-de-la-tiroides
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-germinativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-madre-hematopoyetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-madre-pluripotente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-nerviosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-plasmatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-presentadora-de-antigeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-reproductora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-t-auxiliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-t-citolitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-t-citotoxica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-t-supresora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celula-tumoral-autogena
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celulas-escamosas-atipicas-de-significado-indeterminado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celulas-glandulares-atipicas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/celulas-glandulares-atipicas-de-significado-incierto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centellografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centellografia-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centellografia-de-receptores-de-somatostatina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centellografia-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centimetro-cubico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/centros-para-el-control-y-la-prevencion-de-enfermedades
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cepillado-bronquial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cerebelo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cerebro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cervarix
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cervicectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cervicectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cervicectomia-uterina-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cetuximab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/chop
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cianuro-de-hidrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciclina-d1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciclo-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciclo-menstrual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciclo-mitotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciclofosfamida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciego
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cientifico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cigarrillo-de-clavo-de-olor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cigarrillo-light
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cigarro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cinasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ciprofloxacino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-curativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-de-conservacion-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-de-mohs
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-minimamente-invasiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-profilactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-robotica-transoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirugia-transesfenoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirujano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cirujano-oncologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cisplatino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistectomia-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistitis-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistoprostatectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cistoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citarabina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citocina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citogenetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citoma-fibroso-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citomegalovirus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citometria-de-flujo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citopenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citoplasma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citoqueratina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citorreduccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citosina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citostatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citotoxicidad-celular-dependiente-de-anticuerpos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citotoxicidad-celular-mediada-por-anticuerpos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citotoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citrato-de-fentanilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citrato-de-tamoxifeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/citrato-sodico-y-potasico-con-acido-citrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clasificacion-de-dukes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clodronato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-bupropion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-clormetina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-diacetilmorfina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-diamorfina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-doxorrubicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-doxorrubicina-liposomal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-duloxetina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-gemcitabina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-irinotecan
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-loperamida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-metadona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-ondansetron
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-oxicodona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-oximorfona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-paroxetina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-raloxifeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorhidrato-de-tamsulosina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cloroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/clorotoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cloruro-de-estroncio-sr-89
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cmf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/coagulo-de-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cobalamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cociente-de-riesgos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cociente-de-riesgos-instantaneos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cocultivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/codigo-de-reglamentos-federales-titulo-45-parte-46
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/coenzima-q10
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cognicion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cohorte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colagenasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colangiografia-transhepatica-percutanea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colangiosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colchicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colecalciferol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colelito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colgajo-de-diep
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colgajo-libre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colgajo-pediculado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colgajo-tram
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colon-distal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colon-espastico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colon-proximal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colon-sigmoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colonoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colposcopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/colposcopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/comedo-carcinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/comorbilidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/compatibilidad-de-hla
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/competencia-cultural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/complejo-de-carney
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/complejo-de-golgi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/complejo-de-vitamina-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/complicacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/compuesto-bioactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/comunicacion-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/comunicacion-cruzada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/comunicacion-intercelular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/concerta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/condrosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducta-expectante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conductividad-de-la-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-biliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-cistico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-colector
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-coledoco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-deferente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-galactoforo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-hepatico-comun
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conducto-pancreatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/congelamiento-de-embriones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/conjugado-anticuerpo-farmaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/consentimiento-informado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/contraccion-mioclonica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/contralateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/controlado-con-placebo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cordoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cordon-espermatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cordon-testicular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/corioadenoma-destruens
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/coriocarcinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/corioepitelioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/coroides
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/corticoesteroide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/corticoliberina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/corticotropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cortisol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cortisona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cpt-11
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/craneotomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crema-biafine
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crema-con-base-de-acido-lactico-o-urea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cribiforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crioablacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criocirugia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crioconservacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crioterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cripta-del-colon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criptorquidia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criptorquidismo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crisis-blastica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crisis-convulsiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crisis-de-dolor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/crisoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criterio-de-valoracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criterio-principal-de-valoracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/criterios-de-evaluacion-de-respuesta-en-tumores-solidos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cromogranina-a
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cromosoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cromosoma-17
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cromosoma-filadelfia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ctla-4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ctx
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuadrantectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuerpo-de-golgi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuerpo-del-psamoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuestionario-breve-del-dolor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuidados-medicos-de-apoyo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cuidados-paliativos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cultivo-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cultivo-de-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cumarina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/curcumina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cureta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/cvp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dacarbazina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dactinomicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/daidzeina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/daratumumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/darzalex
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dasatinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/de-crecimiento-lento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/de-novo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/defensor-del-paciente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/deficiencia-de-glucosa-6-fosfato-deshidrogenasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/delecion-genica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/demerol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/denosumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/densidad-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/densidad-mineral-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/depakene
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/departamento-de-salud-y-servicios-humanos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dependencia-del-alcohol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dependencia-fisica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dependiente-de-la-dosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/deposito-biologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/depresor-del-sistema-nervioso-central
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/depsipeptido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derivacion-aortocoronaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derivacion-biliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derivacion-del-liquido-cefalorraquideo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derivado-de-la-hematoporfirina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermatitis-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermatitis-precancerosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermatofibrosarcoma-protuberante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermis-papilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dermis-reticular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derrame-peritoneal-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derrame-pleural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/derrame-pleural-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/deseo-sexual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/desequilibrio-quimico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/deshidrogenasa-lactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/desmoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dexametasona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dextroanfetamina-anfetamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dhl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diafragma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diagnostico-definitivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diagnostico-molecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diagrama-de-flujo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diclofenaco-sodico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diclorhidrato-de-cep-2563
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diclorhidrato-de-histamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dicloruro-de-radio-ra-223
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dietilestilbestrol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dietista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diferenciacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/digestivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dihidrotestosterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diindolilmetano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dilatacion-y-legrado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dimaleato-de-afatinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dioxido-de-carbono
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diseccion-axilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diseccion-de-ganglios-linfaticos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diseminar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/disestesia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/disfagia-sideropenica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/disfosfonato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/disgenesia-gonadal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/disgerminoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/displasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/displasia-de-cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/displasia-mamaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dispositivo-intrauterino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dispositivo-medico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dispositivo-microfluidico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/distal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/diuretico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dmo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/docetaxel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dolor-agudo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dolor-intercurrente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dosimetria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dosis-acumulativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dosis-en-bolo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dosis-maxima-tolerada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/doxil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dr4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/drenaje-biliar-transhepatico-percutaneo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/drenar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/droperidol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/duodenitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/duodeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/duramadre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/dxa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eac
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eag
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-abdominal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-endorrectal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-endovaginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-transabdominal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-transrectal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecografia-transvaginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ecograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ectasia-ductal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ectocervix
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/edb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/edema-pulmonar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/edr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/edta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/efecto-adverso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/efecto-secundario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/efecto-tardio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eich
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrocirugia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrocoagulacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrodesecacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrodo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrodo-superficial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrofulguracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrolito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/electrovaporizacion-transuretral-de-la-prostata
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/elisa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/elotuzumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eltrombopag-olamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/embarazo-molar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/embolizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/embolizacion-arterial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/embolizacion-transarterial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/embrioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/emesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/emetogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enalapril
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/encapsulado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/encondroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endocervix
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endocrino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endocrinologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endometrio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endoprotesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endorfina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/endostatina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enema-de-bario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enema-de-bario-de-doble-contraste
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-arterial-coronaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-benigna-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-cardiovascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-bowen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-castleman
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-celulas-falciformes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-cowden
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-crohn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-hirschsprung
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-hodgkin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-injerto-contra-huesped
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-kahler
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-de-menetrier
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-degenerativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-del-colageno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-estable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-progresiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-proliferativa-benigna-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-residual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-respiratoria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-sistemica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermedad-venooclusiva-hepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermero-coordinador-asistencial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermero-de-oncologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermero-de-practica-avanzada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfermero-de-radioterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enfisema
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-clinico-controlado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-clinico-de-fase-ii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-clinico-de-fase-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-clinico-no-aleatorizado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-de-ca-19-9
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensayo-de-diagnostico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ensure
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enteritis-regional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enteroscopia-de-doble-balon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enucleacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/enzimoinmunoanalisis-de-adsorcion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eosinofilia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eosinofilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ependimo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epidemiologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epidermis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epigenomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epiglotis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epimutacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epiplon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epipodofilotoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epitelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epitelio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epitopo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/epotilona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/equimosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/equinacea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ergocalciferol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritroblastopenia-hereditaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritrocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritrodisestesia-palmoplantar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritrogenesis-imperfecta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritroleucemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritroleucoplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritroplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritropoyesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eritropoyetina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/escala-de-rendimiento-de-karnofsky
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/escala-visual-analogica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esclerosis-multiple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/escleroterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esofagectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esofagogastroduodenoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esofagograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esofagoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esomeprazol-de-magnesio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/espacio-pretraqueal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/espacio-prevascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/especialista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/especialista-en-farmacia-oncologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/especialista-en-medicina-fisica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/especificidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/espectroscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/espina-dorsal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esplenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estadificacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estadificacion-patologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estadio-clinico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estadisticamente-significativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estado-funcional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estado-nutricional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estandar-de-atencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estasis-sanguinea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estaurosporina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estenosis-vaginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ester
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/esternon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estertor-de-muerte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estimulacion-electrica-terapeutica-subumbral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estimulante-del-sistema-nervioso-central
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estimulo-condicionado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estomago
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estomatitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estradiol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estreptavidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estreptococo-beta-hemolitico-del-grupo-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estres-oxidativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-citologico-del-esputo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-clinico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-con-enmascaramiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-con-enmascaramiento-doble
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-con-ingesta-de-bario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-controlado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-asociacion-del-genoma-completo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-casos-y-controles
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-cohorte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-cohorte-historico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-investigacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-laboratorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-observacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-de-poblacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-ecologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-multicentrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-no-controlado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-piloto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-preclinico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-prospectivo-de-cohorte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-retrospectivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/estudio-retrospectivo-de-cohorte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/etapa-del-desarrollo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/etg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/etiologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/etoposido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/eva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/evacuacion-intestinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/evento-adverso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/everolimus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ex-vivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-clinico-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-digital-del-recto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-fisico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-interno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-pelvico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/examen-radiologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/excretar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/exenteracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/exenteracion-pelvica-anterior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/exenteracion-pelvica-posterior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/expresion-de-un-gen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/expresion-de-una-proteina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extirpacion-local-amplia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extirpacion-local-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extraccion-de-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extracraneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extracto-de-coriolus-versicolor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extraganglionar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extrahepatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extravasacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/extravasacion-vesicante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-agravante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento-de-queratinocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento-derivado-de-plaquetas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento-endotelial-vascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento-hematopoyetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-crecimiento-similar-a-la-insulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-necrosis-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-proteccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-riesgo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-de-transferencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-estimulante-de-colonias
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-estimulante-de-colonias-de-granulocitos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-estimulante-de-colonias-de-granulocitos-y-macrofagos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-nuclear-derivado-de-eritroide-2-similar-al-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-nuclear-kappa-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-predictivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/factor-pronostico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fagocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fagocitosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/familia-del-gen-ras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/familiar-de-primer-grado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/faringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/farmaceutico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/farmacogenetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/farmacogenomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fascia-de-gerota
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fascia-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fase-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fatiga
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fec
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fecundacion-in-vitro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fenetil-isotiocianato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fenol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fenotiacina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/feocromocitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fetal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibra-optica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrinogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibroadenoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibroblasto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibroblastoma-de-celulas-gigantes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibroide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibromatosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibromatosis-agresiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibromatosis-tipo-desmoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosarcoma-congenito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosarcoma-de-tipo-adulto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosarcoma-infantil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosis-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibrosis-quistica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fibroso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/filgrastim
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fisiatra
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fisiologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fisioterapeuta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fitohemaglutinina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fitol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fitosterol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/flavopiridol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/flebotomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/flema
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/flomax
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/flora-microbiana
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fluoropirimidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fluorouracilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fluoruro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fnt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fnt-conjugado-con-oro-coloidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fobt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/focal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/focos-de-cripta-aberrantes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfiri
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfiri-y-bevacizumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfiri-y-cetuximab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfox-4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfox-6
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folfox-6-modificado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/foliculo-ovarico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/foliculo-piloso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/folitropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fondo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fondo-de-ojo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/formula-enteral-polimerica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/formulacion-de-nanoparticulas-de-paclitaxel-estabilizadas-con-albumina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/formulario-1572-de-la-fda-declaracion-del-investigador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosaprepitant-dimeglumina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosfatasa-acida-prostatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosfato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosfato-de-combretastatina-a4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosfato-de-etoposido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosforilacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosforo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fosforo-p-32
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fotoaferesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fotosensibilizador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fototoxicidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fraccion-de-fase-s
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fractura-patologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fractura-por-compresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fragmin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frecuencia-cardiaca
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frijol-mungo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frotis-de-guayacol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frotis-de-pap
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frotis-de-pap-anal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/frotis-de-sangre-periferica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fsh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fulguracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/funcionamiento-intestinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/fundoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/furoato-de-mometasona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/g-csf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gadopentetato-de-dimeglumina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/galactografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gammagrafia-con-radionuclido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gammagrafia-con-sestamibi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gammagrafia-de-higado-y-bazo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gammagrafia-de-mama-con-sestamibi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-axilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-axilar-positivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-negativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-regional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-supraclavicular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ganglio-linfatico-supraclavicular-medial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gangliosido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/garantia-de-calidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gardasil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastrinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastritis-hipertrofica-gigante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastroenteritis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastroenterologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gastroscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gd-dtpa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gelclair
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gemcitabina-y-oxaliplatino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gemox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gemtuzumab-ozogamicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-alk
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-braf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-de-fusion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-de-fusion-bcr-abl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-de-la-cinasa-del-linfoma-anaplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-kras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-kras-natural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-mpl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-p53
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-ros1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gen-supresor-de-tumores
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/genetista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/genisteina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/genoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/genomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/germicida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/germinoma-pineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ginkgo-biloba
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-adrenal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-apocrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-de-lieberkuhn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-ecrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-lagrimal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-mamaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-pineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-salival
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glandula-tiroidea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glaucoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glioblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glioblastoma-multiforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glioma-mixto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glioma-pontino-intrinseco-difuso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/globulina-antilinfocitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/globulina-antitimocitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/globulo-blanco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/globulo-rojo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glomerulo-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glosectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glotis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucocorticoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucogenosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucolisis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gluconato-de-calcio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gluconeogenesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucophage
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucosa-radiactiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glucosaminoglucano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glutation
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/glutation-s-transferasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gm-csf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gnrh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gonadotropina-corionica-humana-beta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gonioscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grado-histologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grado-intermedio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grado-nuclear
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gramo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/granulocitopenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/granuloma-piogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/granulomatosis-linfomatoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grasa-saturada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grosor-de-breslow
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-acetilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-de-control
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-de-intervencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-de-riesgo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-experimental
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/grupo-metilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/guanina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/guayacol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/gwas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hacer-frente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/haloperidol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hamartoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/haz-de-electrones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hcl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hct
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/he4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heces
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/helicobacter-pylori
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemaferesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemaglutinina-neuraminidasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioblastoma-cerebeloso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioendotelioma-epitelioide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioma-capilar-lobulillar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioma-congenito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioma-epitelioide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangioma-fusocelular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangiopericitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemangiosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematologo-pediatra
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hematopoyesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemihiperplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemihipertrofia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemilaringectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemisferio-cerebral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemocianina-de-lapa-californiana
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemofilia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hemoglobina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heparina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hepatectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hepatobiliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hepatoblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hepatoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/her1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/her2-neu
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heredable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heredado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hereditario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heterogeneo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/heterogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hexafosfato-de-inositol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hibrido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiclato-de-doxiciclina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hidrocortisona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hidroureter
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hidroxido-de-potasio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hidroxiurea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hierro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/higado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperalimentacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperfraccionamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipernefroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-angiofolicular-linfoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-angiolinfoide-con-eosinofilia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-atipica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-de-ganglio-linfatico-gigante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-del-endometrio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-ductal-atipica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-ductal-atipica-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-lobulillar-atipica-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperplasia-prostatica-benigna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hiperqueratosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipertrofia-de-la-mucosa-gastrica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipertrofia-prostatica-benigna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipervascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipofaringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipofraccionamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipogammaglobulinemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipotalamo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipotesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hipoxico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histerectomia-completa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histerectomia-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histerectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histerectomia-radical-modificada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histerectomia-total
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histiocitoma-fibroso-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histona-desacetilasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/histopatologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/historia-familiar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hitos-de-crecimiento-y-desarrollo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hnp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hoja-de-flujo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/homeostasis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hongo-levaduriforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-adrenocorticotropica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-del-crecimiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-estimulante-de-la-tiroides
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-estimulante-de-las-celulas-intersticiales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-foliculoestimulante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-liberadora-de-gonadotropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-liberadora-de-hormona-luteinizante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-paratiroidea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hormona-piv
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hortaliza-no-feculenta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hpb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hpt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hsil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hsp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/hueso-coccigeo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ibp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ibrance
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/icc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ictus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ifosfamida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/il-1-alfa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/il-1-beta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/il-12
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/il-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ileo-paralitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ileon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ileostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/imagen-por-resonancia-magnetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/imagen-por-resonancia-magnetica-nuclear
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/imagenes-por-resonancia-magnetica-de-3-teslas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/imaginologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/impactacion-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/impulso-sexual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ims
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/in-vitro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/in-vivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/incidencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/incision-transuretral-de-la-prostata
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/incubado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/independiente-del-androgeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indice-de-masa-corporal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indice-de-proliferacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indice-mitotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indiferenciado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indol-3-carbinol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/indometacina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inestabilidad-microsatelital
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infeccion-oportunista
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inflamatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/informe-de-caso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/informe-de-patologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infratentorial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion-arterial-hepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion-continua
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion-de-linfocitos-de-un-donante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion-intraperitoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/infusion-intravenosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ingesta-calorica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ingestion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-concentrado-de-bowman-birk
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-5-alfa-reductasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-ace
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-aromatasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-bomba-de-protones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-ciclooxigenasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-dihidrofolato-reductasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-hidroximetilglutaril-coenzima-a-reductasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-histona-desacetilasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-hmg-coa-reductasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-proteasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-topoisomerasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-la-topoisomerasa-ii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-mtor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-parp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-puntos-de-control-inmunitario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-de-tirosina-cinasas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-del-proteasoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-enzimatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-mitotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inhibidor-selectivo-de-la-recaptacion-de-serotonina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunocompetencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunocompetente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunodeficiente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunodepresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunodepresor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunoensayo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunoestimulante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunofenotipificacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunoglobulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunomodulacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunomodulador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunoterapia-celular-adoptiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunotoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inmunotoxina-anti-cd19
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inoperable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inositol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/instilacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/instituto-nacional-del-cancer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/insuficiencia-cardiaca-congestiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/insuficiencia-cardiaca-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/insuficiencia-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/insulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/insulinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interaccion-de-medicamentos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interferon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interferon-alfa-2b-recombinante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-10
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-11
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-12
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-6
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/interleucina-7
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intervalo-de-referencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intestino-delgado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intestino-grueso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intoxicacion-de-la-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intoxicacion-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intraarterial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intracavitario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intradermico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intraespinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intrahepatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intralesional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intrapelvico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intraperitoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intrapleural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intratecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intratumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intravaginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intravasacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/intravenoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inulina-enriquecida-con-oligofructosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/investigacion-aplicable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/investigacion-clinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/investigador-principal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/involuntario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inyeccion-intramuscular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inyeccion-intravenosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/inyeccion-percutanea-de-etanol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/iobenguano-i-123
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ipilimumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ipsilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/irm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/irradiacion-craneal-profilactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/irradiacion-parcial-acelerada-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/irresecable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/irrigacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/isointenso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/isomero
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/isquemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/istmo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ixabepilona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/jalea-de-petroleo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/jugo-pancreatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/kadcyla
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/kava-kava
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ketalar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ketoconazol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ketoprofeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ketorolaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/keytruda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/kps
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/kretek
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/l-asparaginasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/l-carnitina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/laboratorio-de-hematopatologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lactato-deshidrogenasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lactobacillus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lactobacillus-rhamnosus-gg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lactoferrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lamina-propia-de-la-mucosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lanoxin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/laparoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/laringectomia-supraglotica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/laringectomizado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lasitud
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/latente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lavado-bronquial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lavado-peritoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ldh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lectina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leep
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/legrado-endocervical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leiomioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leiomiosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lenvima
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leptomeningeo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leptomeningitis-linfomatosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion-escamosa-intraepitelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion-escamosa-intraepitelial-de-alto-grado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion-escamosa-intraepitelial-de-bajo-grado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion-fungosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lesion-litica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/letrozol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-aguda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-de-burkitt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-de-celulas-pilosas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-eosinofilica-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-granulocitica-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-linfoblastica-aguda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-linfoblastica-de-celulas-b-precursoras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-linfocitica-aguda-de-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-linfocitica-cronica-y-linfoma-linfocitico-de-celulas-pequenas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-linfocitica-granular-de-celulas-t-grandes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-meningea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-mieloide-aguda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-neutrofilica-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-o-linfoma-de-celulas-t-en-adultos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-prolinfocitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucemia-promielocitica-aguda
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucocitaferesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucocito-granular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucocito-polimorfonuclear
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucopenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucoplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/leucovorina-calcica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/levonorgestrel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ley-de-portabilidad-y-responsabilidad-de-seguros-medicos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lh-rh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lhh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lhrh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/licopeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lidocaina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ligamento-umbilical-medio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ligando-inductor-de-apoptosis-relacionada-con-el-factor-de-necrosis-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ligando-kit
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lignano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/limitante-de-dosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/limite-de-referencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/limite-normal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linea-celular-de-cultivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linea-de-celulas-cancerosas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfadenectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfadenectomia-pelvica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfadenopatia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfangiografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfangiosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfangitis-carcinomatosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfedema
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoblasto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocentellografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-citolitico-natural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-granular-grande
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-infiltrante-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-t-cd4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocito-t-citotoxico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfocitosis-monoclonal-de-celulas-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoepitelioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfohistiocitosis-hemofagocitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-anaplasico-de-celulas-grandes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-angioinmunoblastico-de-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-cutaneo-de-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-burkitt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-celulas-b
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-celulas-b-de-zona-marginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-celulas-de-manto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-celulas-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-celulas-t-maduras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-grado-bajo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-hodgkin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-hodgkin-con-predominio-linfocitico-nodular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-de-zona-marginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-difuso-de-celulas-b-grandes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular-de-celulas-grandes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular-de-celulas-mixtas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular-de-grado-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular-de-grado-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-folicular-de-grado-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-histiocitico-verdadero
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-linfoblastico-de-celulas-t-precursoras
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-linfocitico-bien-diferenciado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-linfocitico-de-celulas-pequenas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-linfoplasmocitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-malt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-mediastinico-primario-de-celulas-b-grandes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-mixto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfoma-primario-de-efusiones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfopenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linfosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/linitis-plastica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lipiodol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lipofilico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lipoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liposarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liposarcoma-mixoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liposoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liposomal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-cefalorraquideo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-intersticial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-peritoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-seminal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/liquido-tisular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lisis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/litico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/litio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/llc-y-llcp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/llgg-cn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lmmj
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lnla
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lobectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lobulillo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lobulillo-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lobulo-mamario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/localizado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/locion-liposomal-t4n5
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lomustina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lonsurf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/losartan-potasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lpa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lsil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lumpectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lunar-atipico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/lyrica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ma-huang
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/macrocalcificacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/macrofago
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/macroglobulinemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/malato-de-sunitinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/malondialdehido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mammosite
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mammotome
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mamografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mamografia-de-deteccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mamografia-de-diagnostico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mamograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/manitol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mapeo-de-ganglio-linfatico-centinela
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mapeo-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcador-fiduciario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcador-genetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcador-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcadores-fiduciales-de-oro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcapasos-artificial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marcapasos-cardiaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/marihuana
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/masa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/masa-anexial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/masa-cubierta-de-espiculas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/masa-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/masa-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-radical-de-halsted
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-radical-modificada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-segmentaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-simple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastectomia-total
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mastocitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/materia-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/matriz
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mc1r
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/media-de-supervivencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mediana-de-supervivencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mediastinoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mediastinoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mediastinotomia-anterior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-ansiolitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-antiangiogenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-antiinflamatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-biologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-en-fase-de-investigacion-clinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-en-fase-experimental
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-huerfano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-inmunodepresor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-micromolecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-quimioterapeutico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicamento-radiactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-alopatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-alternativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-ayurvedica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-complementaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-convencional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-corriente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-de-precision
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-interna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-molecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-occidental
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-oriental
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-ortodoxa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-reproductiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medicina-tradicional-china
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medico-orl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medula-espinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/medula-suprarrenal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meduloblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meiosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanoma-amelanotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanoma-desmoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanoma-en-estadio-iiia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/melanoma-in-situ
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/membrana-mucosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/membrana-serosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/membrana-sinovial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meninges
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningioma-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningitis-carcinomatosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningitis-leucemica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningitis-linfomatosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meningitis-neoplasica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mentol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesenquimatoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesilato-de-eribulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesilato-de-imatinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesilato-de-osimertinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesotelina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mesotelioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metabolico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metabolismo-aerobico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metabolismo-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metabolismo-oxidativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metabolito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metahemoglobina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metaloproteinasa-de-matriz
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metanalisis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metanol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metaplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metaplasia-mieloide-agnogena
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-a-distancia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-el-encefalo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-el-hueso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-el-sistema-nervioso-central
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-la-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-las-leptomeninges
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-las-meninges
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastasis-en-transito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metastatizar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/meteorismo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metilacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metilasa-de-adn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metiltransferasa-de-adn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metoclopramida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metotrexato-sodico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/metronidazol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/miarn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/micela
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/micosis-fungoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microambiente-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microarn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microbicida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microcalcificacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microflora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microglobulina-beta-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microlitro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/micromatriz
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/micrometastasis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/micromol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microscopico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microscopio-de-campo-oscuro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microscopio-de-fluorescencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microsfera
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/microtubulo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloblasto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielodepresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielodepresion-grave
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielodisplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloesclerosis-con-metaplasia-mieloide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielofibrosis-primaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloma-de-celulas-plasmaticas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloma-latente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mieloma-multiple-en-estadio-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielomatosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielomonocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mielosupresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mifamurtida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/milimetro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/milimol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mioinositol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/miometrio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/miopericitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mitocondria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mitomicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mitosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mitramicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mixofibrosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-animal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-de-claus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-de-gail
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-de-riesgo-de-gail
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-murino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modelo-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/modificacion-del-comportamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mola-hidatiforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/molecula
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/monocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/monoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/monoxido-de-carbono
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/montanide-isa-51
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mopp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/morbilidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mortalidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/motilidad-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mtor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mtx
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/muc-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mucinoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mucosa-labial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mucosa-yugal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mucositis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/muerte-celular-programada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/muerte-por-piedad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/muerte-prematura
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/muestra-biologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/multidisciplinario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mutacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mutacion-braf-v600
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mutacion-de-la-linea-germinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mutacion-somatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/mutageno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nabilona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nacl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nanomol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nanoparticula
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nanosensor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/naproxeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/narguile
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nasofaringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nasoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/naturoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/necrosis-aseptica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/necrosis-avascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/necrosis-grasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/necrosis-isquemica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/necrosis-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrectomia-bilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefroblastomatosis-perilobular-hiperplasica-difusa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrotomografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nefrotoxico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/negativa-para-el-receptor-de-estrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/negativa-para-el-receptor-de-progesterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/negativa-para-pr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-cervical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-cervical-escamosa-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-cervical-escamosa-2-y-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-cervical-escamosa-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-ductal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-lobulillar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intraepitelial-vaginal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-intratubular-de-celulas-germinativas-de-testiculo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-lobulillar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-maligna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-mieloproliferativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-mieloproliferativa-cronica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasia-prostatica-intraepitelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neoplasma-de-celulas-de-hurthle
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neulasta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neumega
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neumologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neumonectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neumonectomia-extrapleural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neumonitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuroblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurocirujano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuroconductual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuroendocrino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuroepitelial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurofibroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurofibroma-plexiforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuromiotonia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuropatia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuropatia-periferica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neuropatologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurotoxicidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neurotropismo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neutrofilo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neutropenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neutropenia-ciclica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neutropenia-congenita
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/neutropenia-febril
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nevo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nevo-compuesto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nevo-de-union
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nevo-displasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nexium
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nf-kb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ng-nitro-l-arginina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nic-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nic-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nic-2-y-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nic-3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nicotinamida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nih
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nimotuzumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrato-de-galio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrogeno-ureico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrogeno-ureico-sanguineo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrosamina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrosamina-especifica-del-tabaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nitrosourea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nivel-de-clark-iii-de-cancer-de-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nivel-de-clark-iv-de-cancer-de-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/niveles-de-clark
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/niveles-de-evidencia-cientifica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nmp22
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/no-seminoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/no-toxico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nodulo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nodulo-caliente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nodulo-frio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nodulo-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nomograma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/norepinefrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/novobiocina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/np
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/npo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/npt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nrf2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nucleolo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nucleotido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nutricion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nutricion-parenteral-total
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nutricion-suplementaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/nutrigenomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/obstetra
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/olaparib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oligoastrocitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oligodendroglioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oligometastasis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/omentectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oms
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncaspar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncogen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncolisis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncologia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oncologo-medico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/onda-de-radio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ooforectomia-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ooforectomia-profilactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ooforopexia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/opdivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/opiaceo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/opioide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oportunidad-relativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/organulo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/orientacion-alimentaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/orofaringe
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/orquidectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/orquiectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ortotopico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osmotico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteocondroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteolitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteomielitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteomuscular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteonecrosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteosarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/osteosarcoma-extraesqueletico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oxaliplatino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oxidacion-reduccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oxido-de-zinc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oxidorreduccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/oxigeno-hiperbarico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paciente-ambulatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paclitaxel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paf-clasica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paladar-blando
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paladar-duro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/palbociclib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paliacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/palifermina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pamidronato-disodico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pancreas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pancreatectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pancreatectomia-distal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pancreatectomia-total
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pancreatoduodenectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/papiledema
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/papiloma-intraductal-de-la-mama
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/papiloma-invertido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paquete-ano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/par-de-bases
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paracentesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paraganglioma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paraganglios
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parageusia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parametrio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paramixovirus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parasitario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/paratirina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pared-toracica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parenquima-nodular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parotidectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/parp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/patognomonico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/patologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pc-spes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pcv
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pd-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pecoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pediculada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peg-asparaginasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pegfilgrastim
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pelvico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pelvis-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pene
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/penetrancia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pepsina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pepsinogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peptido-intestinal-vasoactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/percutaneo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfil-biologico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfil-de-expresion-genica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfil-de-expresion-proteica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfil-genetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfil-proteomico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfusion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfusion-hepatica-aislada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perfusion-hipertermica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pericardio-parietal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perimenopausico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perineo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perineural
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/periodo-de-latencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/periodo-silente-del-vih
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perioperatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peristaltismo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peritonitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perjeta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/peroxido-de-hidrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/perspectiva-global-del-paciente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/petequias
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pezon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pge1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/piel-de-naranja
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pielografia-intravenosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pielograma-intravenoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pilocitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pimiento-de-los-monjes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pinealoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pineoblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pineocitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pipa-de-agua
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/piperacilina-tazobactam
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/piridoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pirimidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/piv
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plan-de-tratamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/planta-crucifera
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plaqueta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plasmacito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plasmocitoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/platinol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pleomorfico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plerixafor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pleura-mediastinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pleurectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pleurodesis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plexo-coroideo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plexopatia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plexopatia-braquial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/plicamicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ploidia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pmn
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pnp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pnt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/poder-notarial-permanente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/poli-adp-ribosa-polimerasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/policitemia-vera
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polimorfismo-de-un-solo-nucleotido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polineuritis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polipectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polipeptido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polipeptido-pancreatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polipo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polipos-precancerosos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/poliposis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/poliposis-adenomatosa-familiar-clasica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/polvo-esteril-de-talco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pontino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/positiva-para-c-erbb-2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/positiva-para-el-receptor-de-estrogeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/positiva-para-el-receptor-de-progesterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/posmenopausico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/precanceroso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/predisposicion-genetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prednisona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pregabalina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prenatal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/presion-arterial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/privacion-de-androgenos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/probabilidad-relativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/procedimiento-de-chamberlain
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/procedimiento-de-whipple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/procedimiento-diagnostico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/procedimiento-estereotaxico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/procedimiento-normalizado-de-trabajo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proceso-continuo-de-atencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proceso-neoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proctoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proctoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proctosigmoidoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/producto-en-fase-de-investigacion-clinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/profilaxis-del-sistema-nervioso-central
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/profilaxis-del-snc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/progesterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/progestina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/programa-de-cuidados-paliativos-terminales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/progresion-de-la-enfermedad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proliferacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proliferacion-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/promocion-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pronostico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prooxidante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prospectivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostaglandina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostata
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostatectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostatectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostatectomia-radical-abierta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostatectomia-radical-retropubica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prostatitis-inflamatoria-asintomatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteccion-de-los-seres-humanos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/protector-solar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-bence-jones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-choque-termico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-complemento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-estres
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-fusion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-de-fusion-bcr-abl
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-m
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-matriz-nuclear-22
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-melan-a
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteina-monoclonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteoglucano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proteoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/protooncogen
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/protozoario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/protuberancia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proveedor-de-atencion-de-la-salud
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proximal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/proyecciones-de-eklund
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-complementaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-ace
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-adn-del-vih
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-antigeno-carcinoembrionario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-antiglobulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-arn-del-vih
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-estimulacion-con-secretina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-genes-multiples
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-guayacol-en-heces
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-her2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-inhibicion-con-atropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-la-funcion-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-laboratorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-pap
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-papanicolaou
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-papanicolaou-anal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-papanicolaou-de-base-liquida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-privacion-de-agua
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-psa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-respuesta-auditiva-del-tronco-encefalico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-sangre-oculta-en-la-materia-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-saturacion-de-oxigeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-de-schiller
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-del-adn-del-virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-del-arn-del-vph
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-del-funcionamiento-pancreatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-diagnostica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-inmunocitoquimica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-inmunohistoquimica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-inmunoquimica-fecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-molecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/prueba-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psa-libre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psa-total
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psicoestimulante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psicosocial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psilocibina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psiquiatra
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/psoraleno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pten-tirosina-fosfatasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pti
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/pulmonologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/puncion-lumbar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/puncion-venosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/puntaje-de-gleason
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/purina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/purpura-trombocitopenica-idiopatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/purpura-trombocitopenica-inmunitaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/q10
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/qeta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/queratina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/queratoacantoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/queratosis-actinica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/queratosis-senil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioembolizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioembolizacion-transarterial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioexfoliacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioinmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioprevencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioprotector
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimiorradiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimiosensibilidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-citotoxica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-combinada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-con-dosis-densa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-de-dosis-alta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-intratecal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-intravenosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-metronomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-mielosupresora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-sistemica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quimioterapia-topica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quinona-reductasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quiste
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/quiste-dermoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/r-chop
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/r-ice
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-dispersa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-ionizante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-por-radiofrecuencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-ultravioleta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-uva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-uvb
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiacion-uvc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radical-libre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiocirugia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiofarmaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiografia-del-torax
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioinmunoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioisotopo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiomarcado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioncologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radionuclido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioprotector
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radiosensibilizador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-con-emisores-alfa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-con-haz-de-protones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-con-particulas-cargadas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-con-placa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-conformada-tridimensional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-corporal-estereotactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-de-haz-externo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-de-intensidad-modulada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-estereotactica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-estereotaxica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-externa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-fraccionada-acelerada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-hiperfraccionada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-hipofraccionada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-interna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-intersticial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-intracavitaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/radioterapia-total-de-la-piel-con-haz-de-electrones
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ramucirumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ran
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rapamicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rape
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rasburicasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/raton-atimico-desnudo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rayo-x
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rcp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reabsorcion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reaccion-de-alarma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reaccion-en-cadena-de-la-polimerasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reacciones-bioquimicas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recaida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-2-del-factor-de-crecimiento-epidermico-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-androgenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-c-kit
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-de-progesterona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-del-factor-de-crecimiento-epidermico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/receptor-hormonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recidiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recidiva-bioquimica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recidivar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recist
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rectal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rectitis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recuento-absoluto-de-neutrofilos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recuento-de-celulas-sanguineas-completo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recuento-sanguineo-completo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/recurrencia-bioquimica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reflujo-gastroesofagico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regenecare
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-abvd
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-ac-taxol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-beacopp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-de-acondicionamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-de-gemcitabina-y-cisplatino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-de-gramont
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-epoch
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-folfiri-y-avastin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-folfirinox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-folfox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-folfox-6
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-mopp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-r-cvp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-r-epoch
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regimen-stanford-v
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/registro-personal-de-salud
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reglan
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regorafenib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regulacion-de-la-natalidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/regulacion-del-ciclo-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/remision
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/remision-completa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/remision-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resecable
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resecado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reseccion-abdominoperineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reseccion-en-cuna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reseccion-en-manguito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reseccion-segmentaria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reseccion-transuretral-de-la-prostata
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resectoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reservorio-de-ommaya
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resistencia-farmacologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respiracion-aerobica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respiracion-celular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-completa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-condicionada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-de-hipersensibilidad-retardada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-electrodermica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-galvanica-de-la-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-objetiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/respuesta-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resultado-negativo-de-una-prueba
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resultado-negativo-falso-de-una-prueba
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resultado-positivo-de-una-prueba
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/resultado-positivo-falso-de-una-prueba
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/reticulo-endoplasmatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retinoblastoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retinol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retinol-palmitato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retroperitoneal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retrospectivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retrotranscripcion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/retrovirus
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/revision-del-comite-de-tumores
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/riboflavina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/riesgo-absoluto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/riesgo-acumulado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/riesgo-de-por-vida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/riesgo-relativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rifampicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rinon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rinoscopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/risperidona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ritalin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rituximab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ronchas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rosuvastatina-calcica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rotoplastia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rps
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rtc-3d
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/rtup
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sacro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/salicilato-de-sodio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/salpingooforectomia-bilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/salpingooforectomia-unilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/samario-sm-153
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/samario-sm-153-lexidronam-pentasodico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sangre-periferica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/saponina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoidosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-alveolar-de-partes-blandas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-de-celulas-claras-de-rinon
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-de-celulas-claras-de-tejido-blando
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-de-celulas-fusiformes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-de-kaposi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-epitelioide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-fibromixoide-de-grado-bajo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-granulocitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-indiferenciado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-osteogenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-pleomorfico-indiferenciado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sarcoma-sinovial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/schwannoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/secretina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/secuencia-de-aminoacido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sedacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sedacion-paliativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/segmentectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/segundo-cancer-primario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sellador-de-fibrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/semilla-radiactiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seminoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seno-paranasal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seno-paranasal-esfenoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seno-paranasal-etmoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seno-paranasal-frontal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sensibilidad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/serie-de-casos-consecutivos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seroalbumina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seroma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/serosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/seroso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/serotonina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sesgo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sesgo-de-seleccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sgot
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sgpt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sigmoidoscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/signo-de-lhermitte
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sil
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/silybum-marianum
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/simultaneo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sincicio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-agudo-por-radiacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-bloom-torre-machacek
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-cancer-de-mama-y-ovario-hereditario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-cancer-hereditario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-cmoh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-denys-drash
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-edwards
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-evacuacion-gastrica-rapida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-fammm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-fuga-capilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-hamartoma-multiple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-isaac
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-kasabach-merritt
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-klinefelter
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-kostmann
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-leiomiomatosis-hereditaria-y-cancer-de-celulas-renales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-li-fraumeni
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-lisis-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-lynch
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-melanoma-familiar-con-lunares-atipicos-multiples
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-mutismo-cerebeloso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-neoplasia-endocrina-multiple-de-tipo-2a
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-neumonia-idiopatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-nevo-de-celulas-basales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-obstruccion-sinusoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-paterson-kelly
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-plummer-vinson
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-richter
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-sipple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-sobrecrecimiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-turcot
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-de-wermer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-paraneoplasico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sindrome-shwachman-diamond
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sinergico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/singenico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sintetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sipuleucel-t
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-biliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-circulatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-de-estadificacion-de-jewett
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-de-estadificacion-del-ajcc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-de-estadificacion-tnm
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-de-grupos-sanguineos-abo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-endocrino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-enzimatico-del-citocromo-p450
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-genitourinario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-hepatobiliar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-nervioso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-nervioso-central
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-nervioso-involuntario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-nervioso-parasimpatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistema-nervioso-simpatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sistemico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sobreexpresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sobretratamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sobreviviente
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sofoco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/solucion-salina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/somatomedina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sonda-de-alimentacion-gastrica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sonda-de-gastrostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sonda-nasogastrica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/soya
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sris
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ssc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ssp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ssr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/stivarga
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/subependimario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/subglotis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/submucosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/subserosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sueno-de-movimientos-oculares-rapidos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sueno-mor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-atropina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-bario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-magnesio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-morfina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-selumetinib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-vinblastina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-vincristina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-de-zinc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulfato-ferroso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sulindaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supervivencia-general
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supervivencia-por-causa-especifica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supervivencia-sin-enfermedad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/suplemento-nutricional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supraglotis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supratentorial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/supresion-ovarica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/susceptibilidad-genetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sustancia-biologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sustancia-controlada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/sustancia-toxica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/t-dm1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/t4
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tabaco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tabaco-para-mascar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tabicado
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tag
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tagrisso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/talidomida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tarc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/targa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-de-la-dosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-de-respuesta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-de-supervivencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-de-supervivencia-general
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-de-supervivencia-por-una-enfermedad-especifica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-mitotica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tasa-relativa-de-supervivencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/taurolidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/taxano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tc
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tc-99m-dextran
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tc-en-espiral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tcg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tcr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teaflavina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tecentriq
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tecnecio-tc-99m-azufre-coloidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tecnica-diagnostica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-blando
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-cicatricial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-gingival
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-hematopoyetico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-mamario-fibroglandular-disperso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-mamario-graso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tejido-mamario-heterogeneamente-denso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/telangiectasia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/telomerasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/telomero
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/temozolomida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teobromina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tep
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapeuta-enterostomal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-adyuvante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-antihormonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-antirretrovirica-de-gran-actividad
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-biologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-celular-adoptiva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-cognitivo-conductual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-combinada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-con-gamma-knife
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-con-puva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-convencional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-celulas-t-con-car
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-celulas-t-con-receptor-de-antigeno-quimerico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-consolidacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-conversacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-fotones-de-energia-alta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-induccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-induccion-de-la-remision
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-luz
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-mantenimiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-primera-linea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-reemplazo-de-estrogenos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-reemplazo-hormonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-rescate
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-segunda-linea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-tercera-linea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-de-vacuna
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-del-humor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-diferida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-dirigida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-endocrina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-farmacologica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-hormonal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-inmunodepresora
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-metabolica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-molecular-dirigida
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-multimodal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-neoadyuvante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-nutricional-medica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-paliativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-por-captura-de-neutrones-de-boro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-recreativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-respiratoria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-sistemica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terapia-virica-oncolitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teratocarcinoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teratoma
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teratoma-inmaduro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/teratoma-maduro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/termografia-infrarroja
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/terpeno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/testiculo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tetratiomolibdato-de-amonio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiazida-diuretica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiempo-de-duplicacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiempo-de-isquemia-fria
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiempo-de-isquemia-tibia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiempo-transcurrido-hasta-la-progresion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/timidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/timo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/timocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/timoma-tipo-c
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/timpanismo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiosulfato-de-sodio-anhidro
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiroglobulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tiroiditis-de-hashimoto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tirotropina-alfa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tnep
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tolerancia-a-un-medicamento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tolueno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tomografia-computarizada
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tomografia-computarizada-helicoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tomografia-computarizada-por-emision-de-foton-unico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tomoterapia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tomoterapia-helicoidal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/toracalgia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/toracodinia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tosilato-de-sorafenib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/toxemia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/toxina-bacteriana
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/toxoide-tetanico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tpf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trabajador-social
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tracto-aerodigestivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tracto-digestivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tracto-optico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tracto-uveal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trail-r2
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transaminasa-glutamico-oxalacetica-serica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transcriptomica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transdermico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transduccion-de-la-senal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transduccion-olfativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transductor-de-ecografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transferencia-de-genes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transfusion-de-sangre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/transito-digestivo-superior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/traquelectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-alogenico-de-celulas-madre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-alogenico-de-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-autogeno-de-celulas-madre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-de-celulas-madre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-de-celulas-madre-de-sangre-periferica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-de-medula-osea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trasplante-singenico-de-celulas-madre
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastorno-de-estres-postraumatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastorno-del-sistema-inmunitario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastorno-del-sueno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastorno-linfoproliferativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastorno-neurodegenerativo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trastuzumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tratamiento-accesorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tratamiento-convencional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tratamiento-definitivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tratamiento-estandar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tratamiento-local
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trazador
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tremelimumab
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/triada-de-carney
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tributirina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trifosfato-de-adenosina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trigono-retromolar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trimetoprima-sulfametoxazol
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trombocito
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trombocitopenia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trombopoyetina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/trompa-de-falopio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tronco-encefalico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tsh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ttp
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tuberculosis
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tubo-digestivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tubo-intestinal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tubulina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tubulo-colector-renal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-benigno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-carcinoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-beta-del-pancreas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-de-la-granulosa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-fusiformes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-germinativas-del-ovario-en-estadio-iii
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-gigantes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-celulas-plasmaticas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-cordon-sexual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-dabska
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-estroma-de-cordon-sexual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-estroma-gonadal-de-cordon-sexual
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-klatskin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-krukenberg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-la-region-pineal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-mastocitos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-muller-mixto-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-plexo-coroideo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-de-wilms
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-desmoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-embrionario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-endocrino-de-pancreas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-endocrino-inactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-ependimario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-extracraneal-de-celulas-germinativas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-fibrohistiocitico-plexiforme
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-funcionante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-maligno-de-vaina-de-nervio-periferico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-miofibroblastico-inflamatorio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-neuroectodermico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-neuroectodermico-primitivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-neuroendocrino
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-no-funcionante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-pancreatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-papilar
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-primario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-primario-oculto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-rabdoide
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-satelite
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-solido
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-teratoide-rabdoide-atipico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-triton-maligno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-vascular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/tumor-vascular-benigno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ubiquinona
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ulcera-peptica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ulceracion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ultrasonografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/umbral-de-dolor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/unidad-internacional
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/unilateral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/union-entre-la-dermis-papilar-y-reticular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/union-gastroesofagica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uraco
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urato-oxidasa-recombinante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ureter
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/ureteroscopia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uretra-distal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uretra-proximal
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urinario
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urologo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uroquinasa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/urotelio
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uso-compasivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uspstf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/utero
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/uvula-palatina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-antiidiotipica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-bcg
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-contra-el-virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-contra-la-hepatitis-a
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-del-bacilo-de-calmette-guerin
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-recombinante-bivalente-contra-el-virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-recombinante-nonavalente-contra-el-virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vacuna-recombinante-tetravalente-contra-el-virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vaginectomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/valium
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/valor-inicial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/valores-de-referencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vancomicina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/variacion-epigenetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vaselina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vaso-linfatico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vaso-sanguineo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vasoactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vector-virico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vegetariano-estricto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vejiga
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/veliparib
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vellosidades-intestinales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/velocidad-de-sedimentacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vena-cava-inferior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vena-cava-superior
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vena-porta
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vena-porta-hepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vesicula-cutanea
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vhh
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vhh8
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vhs
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vhsk
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-biliar-extrahepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-biliar-intrahepatica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-central-de-acceso-subcutaneo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-de-senalizacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-del-mevalonato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/via-molecular
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vias-respiratorias
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vigilancia-activa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/viroterapia-oncolitica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virulento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-de-epstein-barr
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-de-la-hepatitis-g
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-de-la-leucemia-humana-de-celulas-t-de-tipo-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-del-herpes-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-del-herpes-humano-8
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-del-papiloma-humano
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-envuelto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-linfotropico-humano-de-celulas-t-de-tipo-1
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/virus-oncolitico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/visceral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/viscotoxina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-b12
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-b3
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-b5
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-b6
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-k
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-soluble-en-agua
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitamina-soluble-en-grasas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vitex
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/volumen-tumoral
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vph
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vulva
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vulvectomia-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vulvectomia-radical
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vulvectomia-radical-parcial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/vulvectomia-simple
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/wobe-mugos-e
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xanax
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xeliri
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xelox
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xenoinjerto
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xeroderma-pigmentoso
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xerorradiografia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/xofigo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/yeyuno
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/yeyunostomia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/yodo-i-123-metayodobencilguanidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/yodo-i-131-metayodobencilguanidina
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/yodo-radiactivo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/zaltrap
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/zoledronato
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/diccionarios/diccionario-cancer/def/zometa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/boca-garganta.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/como-contribuir-a-la-investigacion-medica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/como-cuidarse
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/consejos-de-alimentacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/control-del-dolor
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/ctes-prevbrochspanishapp11.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/cualquiera-padecer-cancer-piel
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/cualquiera-padecer-cancer-piel.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/donar-tejidos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/estudios-de-prevencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/estudios-de-tratamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/ncisurgerychoices.epub
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/ncisurgerychoices.mobi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/padres-con-cancer
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/quimioterapia-y-usted
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/quimioterapia-y-usted.epub
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/quimioterapia-y-usted.mobi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/radioterapia-y-usted
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/radioterapia-y-usted.epub
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/radioterapia-y-usted.mobi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/siga-adelante
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/significado-cambios-en-cuello-uterino-epub
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/significado-cambios-en-cuello-uterino-mobi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/significado-cambios-en-cuello-uterino.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/significado-cambios-en-los-senos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/sp-chemosheets-caida-pelo.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/surgery-choices-spanish.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/teen-guide-sp2016
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/teen-guide-sp2016-mobile
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/teen-guide-spanish
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/tomese-su-tiempo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/tomese-su-tiempo.epub
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/tomese-su-tiempo.mobi
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/tomese-su-tiempo.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/educacion-para-pacientes/wyntk-hodgkin-sp-web.pdf
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/hojas-informativas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/cuidados-medicos-apoyo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/deteccion-prevencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/especialistas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/genetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/tratamiento-adultos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/tratamiento-pediatrico
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/evaluacion-de-evidencia
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/idiomas
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/niveles-de-evidencia/cam
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/niveles-de-evidencia/cuidados-medicos-apoyo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/niveles-de-evidencia/deteccion-prevencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/niveles-de-evidencia/genetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/niveles-de-evidencia/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/proceso-editorial
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/proceso-editorial/el-proceso-de-los-consejos-editoriales-del-pdq
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/cuidados-medicos-apoyo
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/deteccion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/genetica
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/medicina-complementaria-alternativa
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/prevencion
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/tratamiento-adultos
|
||
|
|
https://www.cancer.gov/espanol/publicaciones/pdq/sumarios-de-informacion/tratamiento-pediatrico
|
||
|
|
https://www.cancer.gov/espanol/questions-guideline-spanish.pdf
|
||
|
|
https://www.cancer.gov/espanol/randomization-in-clinical-trials-video
|
||
|
|
https://www.cancer.gov/espanol/recursos-para
|
||
|
|
https://www.cancer.gov/espanol/recursos-para/cuidadores
|
||
|
|
https://www.cancer.gov/espanol/recursos-para/investigadores
|
||
|
|
https://www.cancer.gov/espanol/recursos-para/pacientes
|
||
|
|
https://www.cancer.gov/espanol/recursos-para/profesionales-de-salud
|
||
|
|
https://www.cancer.gov/espanol/recursos-para/socios-internacionales
|
||
|
|
https://www.cancer.gov/espanol/redes-sociales
|
||
|
|
https://www.cancer.gov/espanol/seguridad-paciente-video
|
||
|
|
https://www.cancer.gov/espanol/sindicacion
|
||
|
|
https://www.cancer.gov/espanol/sindicacion/rss
|
||
|
|
https://www.cancer.gov/espanol/sindicacion/widgets
|
||
|
|
https://www.cancer.gov/espanol/subvenciones-capacitacion
|
||
|
|
https://www.cancer.gov/espanol/tipos
|
||
|
|
https://www.cancer.gov/espanol/tipos/adolescentes-adultos-jovenes
|
||
|
|
https://www.cancer.gov/espanol/tipos/adolescentes-adultos-jovenes/apoyo-emocional
|
||
|
|
https://www.cancer.gov/espanol/tipos/adolescentes-adultos-jovenes/final-de-la-vida
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano/paciente/prevencion-ano-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano/paciente/tratamiento-ano-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano/pro/prevencion-ano-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ano/pro/tratamiento-ano-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/hoja-informativa-cabeza-cuello
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-escamoso-metastasico-cuello-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-glandulas-salivales-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-hipofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-labio-boca-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-laringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-nasofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-orofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/adulto/tratamiento-seno-paranasal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/deteccion-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil/tratamiento-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil/tratamiento-estesioneuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil/tratamiento-glandula-salival-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil/tratamiento-laringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/infantil/tratamiento-nasofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/paciente/prevencion-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-escamoso-metastasico-cuello-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-glandulas-salivales-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-hipofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-labio-boca-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-laringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-nasofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-orofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/adulto/tratamiento-seno-paranasal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/deteccion-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil/tratamiento-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil/tratamiento-estesioneuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil/tratamiento-glandula-salival-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil/tratamiento-laringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/infantil/tratamiento-nasofaringe-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cabeza-cuello/pro/prevencion-cavidad-oral-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cancer-metastatico
|
||
|
|
https://www.cancer.gov/espanol/tipos/cancer-metastatico/metastasis-de-cancer-video
|
||
|
|
https://www.cancer.gov/espanol/tipos/cancer-que-regresa
|
||
|
|
https://www.cancer.gov/espanol/tipos/cardiaco/paciente-tratamiento-cardiaco-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cardiaco/pro-tratamiento-cardiaco-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/investigacion/predice-beneficio-tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/investigacion/quimioterapia-mejora-supervivencia
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/ependimoma-infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/glioma-pontino-intrinseco-difuso
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/gliomas-infantiles-astrocitomas
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/tratamiento-atrt-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/tratamiento-celulas-germinativas-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/tratamiento-cerebro-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/tratamiento-craneo-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/paciente/tratamiento-embrionarios-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-atrt-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-celulas-germinativas-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-cerebro-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-cerebro-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-craneo-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-embrionarios-snc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-ependimoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cerebro/pro/tratamiento-gliomas-astrocitomas-infantiles-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/avances-investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/avances-investigacion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/colorrectal-video
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/hoja-informativa-deteccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/investigacion/colografia-tomografia-computarizada-respuestas
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/paciente/deteccion-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/paciente/prevencion-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/paciente/tratamiento-colorrectal-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/paciente/tratamiento-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/paciente/tratamiento-rectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/prevencion-deteccion-colorrectal
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro/deteccion-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro/prevencion-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro/tratamiento-colorrectal-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro/tratamiento-colorrectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/pro/tratamiento-rectal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/colorrectal/sabia-usted-cancer-colorrectal-video
|
||
|
|
https://www.cancer.gov/espanol/tipos/comunes
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/cancer-cuello-uterino-vagina-infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/causas-factores-riesgos-prevencion
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/deteccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/deteccion/resultados-anormales-pruebas-vph-pap
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/estadios
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/hacer-frente
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/pro/deteccion-cuello-uterino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/pro/prevencion-cuello-uterino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/pro/tratamiento-cuello-uterino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/pro/tratamiento-cuello-uterino-vagina-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/sabia-usted-vph-video
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/sintomas
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/supervivencia
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/tratamiento/segun-estadio
|
||
|
|
https://www.cancer.gov/espanol/tipos/cuello-uterino/tratamiento/tratamiento-cancer-durante-embarazo
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/paciente/deteccion-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/paciente/prevencion-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/paciente/tratamiento-esofago-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/paciente/tratamiento-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/pro/deteccion-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/pro/prevencion-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/pro/tratamiento-esofago-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/esofago/pro/tratamiento-esofago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/afrontar
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/causas-factores-riesgo
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/deteccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/estadios
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro/deteccion-estomago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro/genetica-cancer-gastrico-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro/prevencion-estomago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro/tratamiento-estomago-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/pro/tratamiento-estomago-pediatria-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/sintomas
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/supervivencia
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/estomago/tratamiento/segun-estadio
|
||
|
|
https://www.cancer.gov/espanol/tipos/extracraneal-celulas-germinativas
|
||
|
|
https://www.cancer.gov/espanol/tipos/extracraneal-celulas-germinativas/paciente/tratamiento-celulas-germinativas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/extracraneal-celulas-germinativas/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/extracraneal-celulas-germinativas/pro/tratamiento-celulas-germinativas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/extragonadal-celulas-germinativas
|
||
|
|
https://www.cancer.gov/espanol/tipos/extragonadal-celulas-germinativas/paciente/tratamiento-extragonadal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/extragonadal-celulas-germinativas/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/extragonadal-celulas-germinativas/pro/tratamiento-extragonadal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma/paciente/tratamiento-feocromocitoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma/paciente/tratamiento-feocromocitoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma/pro/tratamiento-feocromocitoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/feocromocitoma/pro/tratamiento-feocromocitoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-higado-infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-higado-infantil/carcinoma-hepatocelular
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-higado-infantil/coriocarcinoma-lactantes
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-higado-infantil/hepatoblastoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-higado-infantil/sarcoma-embrionario-indiferenciado
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-vias-biliares
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-vias-biliares/causas-factores-riesgos
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-vias-biliares/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-vias-biliares/estadios
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/cancer-vias-biliares/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/estudios-clinicos-cancer-higado-ccr-video
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro/deteccion-higado-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro/prevencion-higado-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro/tratamiento-higado-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro/tratamiento-higado-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/pro/tratamiento-vias-biliares-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado/causas-factores-de-riesgo
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado/deteccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado/estadios
|
||
|
|
https://www.cancer.gov/espanol/tipos/higado/que-es-cancer-de-higado/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/hipofisis
|
||
|
|
https://www.cancer.gov/espanol/tipos/hipofisis/paciente/tratamiento-hipofisis-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hipofisis/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/hipofisis/pro/tratamiento-hipofisis-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/hoja-informativa-hueso
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/paciente/tratamiento-cordoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/paciente/tratamiento-ewing-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/paciente/tratamiento-osteosarcoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/pro/tratamiento-cordoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/pro/tratamiento-ewing-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/hueso/pro/tratamiento-osteosarcoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/efectos-tardios-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/efectos-tardios-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/genomica-infantil-pro-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/hoja-informativa-ninos-adolescentes
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/paciente/canceres-infantiles-raros-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/pro/canceres-infantiles-raros-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/trasplante-celula-madre-pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/trasplante-celulas-madre-pro/alogenico
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/trasplante-celulas-madre-pro/autogeno
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/trasplante-celulas-madre-pro/eich
|
||
|
|
https://www.cancer.gov/espanol/tipos/infantil/trasplante-celulas-madre-pro/terapia-celula-t-car
|
||
|
|
https://www.cancer.gov/espanol/tipos/intestino-delgado
|
||
|
|
https://www.cancer.gov/espanol/tipos/intestino-delgado/paciente/tratamiento-intestino-delgado-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/intestino-delgado/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/intestino-delgado/pro/tratamiento-intestino-delgado-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/langerhans
|
||
|
|
https://www.cancer.gov/espanol/tipos/langerhans/paciente/tratamiento-langerhans-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/langerhans/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/langerhans/pro/tratamiento-langerhans-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-celulas-pilosas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-lla-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-lla-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-llc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-lma-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-lma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/paciente/tratamiento-lmc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-all-adulto-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-celulas-pilosas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lla-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-llc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq/tratamiento-lmc-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq/tratamiento-lmmj-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq/tratamiento-lpa-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq/tratamiento-neoplasias-mielodisplasicas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lma-infantil-pdq/tratamiento-proliferaciones-mieloides-sindrome-down-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/leucemia/pro/tratamiento-lmc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linea-media/paciente-tratamiento-carcinoma-linea-media-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linea-media/pro-tratamiento-carcinoma-linea-media-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/investigacion/efectos-tardios-radioterapia
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-hodgkin-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-hodgkin-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-linfoma-primario-snc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-lnh-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-lnh-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-micosis-fungoide-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/paciente/tratamiento-relacionado-sida-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-hodgkin-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-hodgkin-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-linfoma-celulas-b-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-linfoma-no-hodgkin-durante-embarazo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-linfoma-periferico-celulas-t-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-linfoma-primario-snc-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-lnh-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-micosis-fungoide-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/linfoma/pro/tratamiento-relacionado-sida-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma/paciente/tratamiento-mesotelioma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma/paciente/tratamiento-mesotelioma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma/pro/tratamiento-mesotelioma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mesotelioma/pro/tratamiento-mesotelioma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloma-multiple
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloma-multiple/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloma-multiple/paciente/tratamiento-mieloma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloma-multiple/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloma-multiple/pro/tratamiento-mieloma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/paciente/tratamiento-cronicas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/paciente/tratamiento-mds-mpd-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/paciente/tratamiento-mielodisplasicos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/pro/tratamiento-cronicas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/pro/tratamiento-mds-mpd-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/mieloproliferativas/pro/tratamiento-mielodisplasicos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neoplasia-endocrina-multiple/paciente-tratamiento-sindromes-nem-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neoplasia-endocrina-multiple/pro-tratamiento-sindromes-nem-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma/paciente/deteccion-neuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma/paciente/tratamiento-neuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma/pro/deteccion-neuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/neuroblastoma/pro/tratamiento-neuroblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo/paciente/tratamiento-melanoma-ocular-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo/paciente/tratamiento-melanoma-ocular-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo/pro/tratamiento-melanoma-ocular-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ojo/pro/tratamiento-melanoma-ocular-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/deteccion-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/prevencion-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/tratamiento-celulas-germinativas-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/tratamiento-epitelial-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/tratamiento-ovario-bajo-potencial-maligno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/paciente/tratamiento-ovario-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/deteccion-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/prevencion-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/tratamiento-celulas-germinativas-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/tratamiento-epitelial-ovario-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/tratamiento-ovario-bajo-potencial-maligno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/ovario/pro/tratamiento-ovario-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/avances-investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/avances-investigacion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/paciente/tratamiento-pancreas-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/paciente/tratamiento-pancreas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/paciente/tratamiento-tne-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/pro/tratamiento-pancreas-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/pro/tratamiento-pancreas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pancreas/pro/tratamiento-tne-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/paratiroides
|
||
|
|
https://www.cancer.gov/espanol/tipos/paratiroides/paciente/tratamiento-paratiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/paratiroides/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/paratiroides/pro/tratamiento-paratiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pene
|
||
|
|
https://www.cancer.gov/espanol/tipos/pene/paciente/tratamiento-pene-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pene/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/pene/pro/tratamiento-pene-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/cualquiera-padecer-cancer-piel
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/hoja-informativa-lunares
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/deteccion-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/prevencion-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/tratamiento-celulas-de-merkel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/tratamiento-melanoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/tratamiento-melanoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/tratamiento-piel-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/paciente/tratamiento-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/deteccion-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/genetica-cancer-de-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/prevencion-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/tratamiento-celulas-de-merkel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/tratamiento-melanoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/tratamiento-melanoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/tratamiento-piel-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/piel/pro/tratamiento-piel-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/por-partes-cuerpo
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido/paciente/tratamiento-primario-desconocido-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido/paciente/tratamiento-primario-desconocido-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido/pro/tratamiento-primario-desconocido-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/primario-desconocido/pro/tratamiento-primario-desconocido-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/avances-investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/avances-investigacion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/hoja-informativa-psa
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/hoja-informativa-terapia-hormonal
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/investigacion/resultados-deteccion-plco-respuestas
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/paciente/deteccion-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/paciente/prevencion-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/paciente/tratamiento-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/pro/deteccion-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/pro/prevencion-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/pro/tratamiento-prostata-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/prostata/significado-cambios-en-la-prostata
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/avances-investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/avances-investigacion/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/investigacion/alchemist
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/investigacion/lanzamiento-alchemist-preguntas-respuestas
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/investigacion/lung-map
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/investigacion/nlst-respuestas
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/deteccion-pulmon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/prevencion-pulmon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/tratamiento-blastoma-pleuropulmonar-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/tratamiento-pulmon-celulas-no-pequenas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/tratamiento-pulmon-celulas-pequenas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/paciente/tratamiento-traqueobronquial-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/deteccion-pulmon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/prevencion-pulmon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/tratamiento-blastoma-pleuropulmonar-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/tratamiento-pulmon-celulas-no-pequenas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/tratamiento-pulmon-celulas-pequenas-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/tratamiento-traqueobronquial-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/pulmon/pro/tratamiento-tumor-miofibroblastico-inflamatorio-pulmonar-ninez-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/retinoblastoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/retinoblastoma/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/retinoblastoma/paciente/tratamiento-retinoblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/retinoblastoma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/retinoblastoma/pro/tratamiento-retinoblastoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/paciente/genetica-de-rinon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/paciente/tratamiento-celulas-de-transicion-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/paciente/tratamiento-rinon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/paciente/tratamiento-wilms-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/genetica-del-carcinoma-de-celulas-renales
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/genetica-del-carcinoma-de-celulas-renales/enfermedad-de-vhl
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/genetica-del-carcinoma-de-celulas-renales/sindrome-de-bhd
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/genetica-del-carcinoma-de-celulas-renales/sindrome-de-hlrcc
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/genetica-del-carcinoma-de-celulas-renales/sindrome-de-hprc
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/tratamiento-celulas-de-transicion-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/tratamiento-rinon-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/rinon/pro/tratamiento-wilms-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-kaposi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-rabdomiosarcoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-tegi-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-tegi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-tejido-blando-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-tejido-blando-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/paciente/tratamiento-tumores-vasculares-infantiles-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-kaposi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-rabdomiosarcoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-tegi-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-tegi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-tejido-blando-adultos-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-tejido-blando-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/sarcoma-de-tejido-blando/pro/tratamiento-tumores-vasculares-infantiles-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-mamografias
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-mastectomia-preventiva
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-paget-seno
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-probabilidad
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-reconstruccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-seno-inflamatorio
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/hoja-informativa-terapia-hormonal-seno
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion/ert-beneficios-riesgos-edad
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion/estudio-tmist
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion/resultados-star-respuestas
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion/t-dm1
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/investigacion/tailorx-riesgo-bajo
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/opciones-de-cirugia
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/deteccion-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/prevencion-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-embarazo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-masculino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/paciente/tratamiento-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/deteccion-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/prevencion-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/tratamiento-seno-embarazo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/tratamiento-seno-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/tratamiento-seno-masculino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/pro/tratamiento-seno-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/significado-cambios-en-los-senos
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/significado-cambios-en-los-senos/diagnostico-con-una-biopsia
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/significado-cambios-en-los-senos/hablar-de-cambios-en-los-senos
|
||
|
|
https://www.cancer.gov/espanol/tipos/seno/significado-cambios-en-los-senos/senos-densos
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal/paciente/tratamiento-corteza-suprarrenal-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal/paciente/tratamiento-corteza-suprarrenal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal/pro/tratamiento-corteza-suprarrenal-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/suprarrenal/pro/tratamiento-corteza-suprarrenal-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/paciente/deteccion-testiculo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/paciente/tratamiento-testiculo-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/paciente/tratamiento-testiculo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/pro/deteccion-testiculo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/pro/tratamiento-testiculo-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/testiculo/pro/tratamiento-testiculo-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma/paciente/tratamiento-timoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma/paciente/tratamiento-timoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma/pro/tratamiento-timoma-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/timoma/pro/tratamiento-timoma-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/paciente/deteccion-tiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/paciente/tratamiento-tiroides-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/paciente/tratamiento-tiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/pro/deteccion-tiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/pro/tratamiento-tiroides-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tiroides/pro/tratamiento-tiroides-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/trofoblastico-gestacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/trofoblastico-gestacion/paciente/tratamiento-etg-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/trofoblastico-gestacion/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/trofoblastico-gestacion/pro/tratamiento-etg-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi/paciente/tratamiento-neuroendocrino-gi-infantiles-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi/paciente/tratamiento-neuroendocrinos-gi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi/pro/tratamiento-neuroendocrinos-gi-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/tumores-neuroendocrinos-gi/pro/tratamiento-neuroendocrinos-gi-pediatria-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uretra
|
||
|
|
https://www.cancer.gov/espanol/tipos/uretra/paciente/tratamiento-uretra-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uretra/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/uretra/pro/tratamiento-uretra-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/paciente/deteccion-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/paciente/prevencion-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/paciente/tratamiento-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/paciente/tratamiento-sarcoma-uterino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/pro/deteccion-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/pro/prevencion-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/pro/tratamiento-endometrio-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/uterino/pro/tratamiento-sarcoma-uterino-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vagina
|
||
|
|
https://www.cancer.gov/espanol/tipos/vagina/paciente/tratamiento-vagina-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vagina/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/vagina/pro/tratamiento-vagina-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/afrontar
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/causas-factores-riesgo
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/deteccion
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/diagnostico
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/estadios
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/infantil
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/investigacion
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/pro/deteccion-vejiga-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/pro/tratamiento-vejiga-infantil-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/pro/tratamiento-vejiga-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/sintomas
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/supervivencia
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/tratamiento
|
||
|
|
https://www.cancer.gov/espanol/tipos/vejiga/tratamiento/segun-estadio
|
||
|
|
https://www.cancer.gov/espanol/tipos/vesicula-biliar
|
||
|
|
https://www.cancer.gov/espanol/tipos/vesicula-biliar/paciente/tratamiento-vesicula-biliar-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vesicula-biliar/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/vesicula-biliar/pro/vesicula-biliar-tratamiento-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vulva
|
||
|
|
https://www.cancer.gov/espanol/tipos/vulva/paciente/tratamiento-vulva-pdq
|
||
|
|
https://www.cancer.gov/espanol/tipos/vulva/pro
|
||
|
|
https://www.cancer.gov/espanol/tipos/vulva/pro/tratamiento-vulva-pdq
|
||
|
|
https://www.cancer.gov/espanol/video
|
||
|
|
https://www.cancer.gov/espanol/video-fases
|
||
|
|
https://www.cancer.gov/global/files/ctep483
|
||
|
|
https://www.cancer.gov/global/files/p20awardees.pdf
|
||
|
|
https://www.cancer.gov/global/files/revised483.pdf
|
||
|
|
https://www.cancer.gov/global/flash
|
||
|
|
https://www.cancer.gov/global/flash/jplayer.swf
|
||
|
|
https://www.cancer.gov/grants-training
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/award-issuance
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/cover-letter-tips.pdf
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/development
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/grants-application-infographic
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/peer-review
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/receipt
|
||
|
|
https://www.cancer.gov/grants-training/apply-grant/resources
|
||
|
|
https://www.cancer.gov/grants-training/contracts-business
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/cancer-grand-challenges
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/cancer-grand-challenges/nci-cruk-partnership-announcement-video
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/contacts
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/merit
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/merit/extension-process
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/merit/faqs
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/nci-funding-opportunities-for-cancer-training
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients/2018
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients/2019
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients/2020
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients/2021
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/award-recipients/2022
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/faq
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/oia/r35-video
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-opportunities/r50
|
||
|
|
https://www.cancer.gov/grants-training/grants-funding/funding-strategy
|
||
|
|
https://www.cancer.gov/grants-training/manage-award
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/contacts
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/grant-closeout
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/grant-transfer
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/monitoring
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/prior-approvals
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/prior-approvals/carryover-requests
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/prior-approvals/carryover-requests/sample-carryover-request-letter.docx
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/report-audit
|
||
|
|
https://www.cancer.gov/grants-training/manage-award/report-audit/rppr
|
||
|
|
https://www.cancer.gov/grants-training/nci-bottom-line-blog-0
|
||
|
|
https://www.cancer.gov/grants-training/nci-bottom-line-blog/frederick-national-laboratory-for-cancer-research-resources-infographic
|
||
|
|
https://www.cancer.gov/grants-training/nci-bottom-line-blog/nci-support-for-cancer-research-enterprise
|
||
|
|
https://www.cancer.gov/grants-training/policies-process
|
||
|
|
https://www.cancer.gov/grants-training/policies-process/legal
|
||
|
|
https://www.cancer.gov/grants-training/policies-process/nci-policies
|
||
|
|
https://www.cancer.gov/grants-training/policies-process/overview
|
||
|
|
https://www.cancer.gov/grants-training/policies-process/overview/grants-process-overview-infographic
|
||
|
|
https://www.cancer.gov/grants-training/policies-process/overview/grants-process.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training
|
||
|
|
https://www.cancer.gov/grants-training/training/about
|
||
|
|
https://www.cancer.gov/grants-training/training/about/cancer-community-partnership
|
||
|
|
https://www.cancer.gov/grants-training/training/about/cct-brochure.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/rising-scholars-cancer-research-seminar-series-february-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-1-1
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-1-2
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-1-3
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-2-2
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-2-3
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-2-4
|
||
|
|
https://www.cancer.gov/grants-training/training/about/events/tcd-workshop-day-2-5
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/2022-summer-handbook.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/cpfp-video
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/crta
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/crta/2024-crta-manual.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/eop
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/eop/collaborations
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/eop/contact-info
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/eop/outreach-opportunities
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/eop/what-we-do
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/bc-oncologists
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/cancer-prevention-fellows
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/iotf-alumni-fellows.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/iotf-application-guidelines2020.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/iotf-current-fellows
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/iotf-flyer.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/mentors-track-1-2
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/mentors-tracks-3-4
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/oncology-fellows
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/iotf/postdoc-research-fellows
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/jhu-nci/chris-larrimore-video
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip-0
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/2021-summerinters-vdi.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/2022-sip-events.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/2023-sip-all-trainings.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/current-interns
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/current-interns/2024-sip-all-trainings.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/sip/sip-mentorship-2023.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/srk
|
||
|
|
https://www.cancer.gov/grants-training/training/at-nci/srk/2024-2025-srk-agenda.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/contact
|
||
|
|
https://www.cancer.gov/grants-training/training/contact/nastaran-zahir
|
||
|
|
https://www.cancer.gov/grants-training/training/funding
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/2024-k99-r00-eval.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/cancer-training-funding-opportunities
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99-faqs
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99/2021-earlyk99-slides.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99/early-k99-webinar-dec2023
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99/early-k99-webinar-december2021.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99/early-k99-webinar-november-7-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/early-k99/earlyk99-webinar-november-7-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f30
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f31
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f32
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f33
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/f99-k00-1st-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/f99-k00-2nd-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/f99-k00-fact-sheet
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/f99-k00-webinar-1-24-19
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/predoc-to-postdoc-transition
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/f99/writing-grant-application
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/general-career-development-faq
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/general-faqs
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/general-fellowships-faq
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k-award-administrative-supplements
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k01
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k05
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k07
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k07/ncik07faqs
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k08
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k12
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k12-mccaskill-stevens
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k12/instructions-k12-supplement.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k22
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k22-faqs
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k23
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k24
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k25
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k99
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/k99-r00-faqs
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/kaward-report
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/kaward-report/full-kaward-report.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/nci-essp
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/nci-essp-0
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/nci-essp/2021-essp-webinar.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/nrsa-2023-guidance.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/nrsa-fellowships-termination-guidance-2023.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/r00-activation.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/r25e
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/r25e/r25-courses-skills-development-opportunities
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/r25t
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/resources
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/t32
|
||
|
|
https://www.cancer.gov/grants-training/training/funding/ue5/nasdc-webinar
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/2023-idwb-loi.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/bcr
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-interns-programs
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-interns-programs/cri-2023-fes.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-interns-programs/cri-flyer.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-interns-programs/cri-frequently-asked-questions
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-interns-programs/cri-pre-application-webinar-slides-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-postbac-program
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-postbac-program/crp-frequently-asked-questions
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/cancer-research-postbac-program/crp-pre-application-webinar-slides-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/career-enrichment-program
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/dcd-program
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/dcd-program/2020-dcdp-agenda.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/dcd-program/2025-dcdp-agenda.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/diversity-programs
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/postdoc-recruitment-event
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/postdoc-recruitment-event/2021-gsrp-schedule.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/postdoc-recruitment-event/gsrp-tips-applying.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/postdoc-recruitment-event/pre-frequently-asked-questions
|
||
|
|
https://www.cancer.gov/grants-training/training/idwb/postdoc-recruitment-event/pre-pre-application-webinar-slides-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/discovering-your-professional-motto
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/ep7-grad-studies-video
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-10
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-12
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-13
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-14
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-15
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-16
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-17
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-18
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-3
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-4
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-5
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-6
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-7
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-8
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/episode-9
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/exclusive-brawley
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/exclusive-hopkins
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/exclusive-knudsen
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/exclusive-tyler-jacks
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/giving-and-getting-a-grant
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/inside-cancer-careers-episodes-season-one
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-1
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-10
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-11
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-12
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-13
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-14
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-15
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-16
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-17
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-18
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-19
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-2
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-20
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-21
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-22
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-23
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-3
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-4
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-5
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-6
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-7
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-8
|
||
|
|
https://www.cancer.gov/grants-training/training/inside-cancer-careers/season-2-episode-9
|
||
|
|
https://www.cancer.gov/grants-training/training/nanci-app
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/2021-four-must-haves-talk.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/2021-presentation-skills.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/directors-innovation-awards
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/past-recipients
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/submit-editorial-board
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/submit-editorial-board/feb-manuscriptsubmissionform-pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/submit-editorial-board/feb-resubmissionform
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/career-planning/submit-editorial-board/manuscript-preparation-guidelines
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/ccr-fyi-colloquium-abstract-book-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2020-intergrative-med.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-epigenetics-and-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-nanotechnology
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-ras-oncogene
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-retroviruses
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-traco-breast-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-traco-genomics
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2021-traco-non-small-lung-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-pancreatic-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-small-molecules.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-topoisomerase
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-traco-clinical-trials
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-traco-immune-checkpoints.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2022-traco-ovarian-cancer.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2023-car-t-cell-therapy
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/2023-imaging-of-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/cancer-biotechnology
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/impain-opiods2020.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/integrative-medicine
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/k-grant-writing-workshop
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/redox-biology
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2023-agenda.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2023-first-assignment.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2023-thurman-bio.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2024-agenda.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2024-first-assignment.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/sard-2024-paul-thurman-bio
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/science-based-non-traditional-careers
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/science-based-non-traditional-careers/2024-speakers
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/scientific-management-training
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/statistical-analysis-research-data
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/statistical-tutorial
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/teaching-medical-education
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-breast-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-breast-cancer-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-cancer-health-disparities-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-cancer-health-disparities2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-cancerimaging-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-car-t-cell-therapy-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-cervical-cancer-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-cervical-cancer-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-clinical-trials-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-epigenetics-and-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-epigenetics-and-cancer-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-genomics-2022
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-hiv.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-immune-checkpoint-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-nanotechnology-for-medical-applications
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-ovarian-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-precision-medicine
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-precision-medicine-2023
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-prostate-cancer
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-prostate-cancer-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-prostate.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-radiation-oncology
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-radiation-oncology-2022.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-radiation-oncology2021.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-ras-oncogene
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-small-cell-lung-cancer-2024
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-small-molecule
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/traco-tumorimaging2021.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/tracointro2024.ppt
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/translational-research-clinical-oncology
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/courses-fellowships/womens-health
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/2024-ccrfyi-summer-newsletter.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/ccr-fyi-2018.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/ccr-fyi-2019.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/editorial-board
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/editorial-board/by-laws
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/editorial-board/editorial-process
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/get-involved/fellows-young-investigators-association
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/mentoring
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci-0
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/child-care-fellowsprograms.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/eidp-at-a-glance.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/eidp-brief-guide-for-form.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/eidp-faq.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/eidp-trainee-user-guide.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/ethics-outside-activitychart.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/faes-election-form.pdf
|
||
|
|
https://www.cancer.gov/grants-training/training/resources-trainees/new-to-nci/post-doc-infographic
|
||
|
|
https://www.cancer.gov/healthcare-delivery-research-program-video
|
||
|
|
https://www.cancer.gov/hras.pdf
|
||
|
|
https://www.cancer.gov/immunotherapy-cervical-cancer-survivor-video
|
||
|
|
https://www.cancer.gov/kras.pdf
|
||
|
|
https://www.cancer.gov/media/1165071
|
||
|
|
https://www.cancer.gov/micro-dose-calibrator-video
|
||
|
|
https://www.cancer.gov/molecular-diagnostics-for-cancer-treatment-infographic
|
||
|
|
https://www.cancer.gov/multimedia
|
||
|
|
https://www.cancer.gov/multimedia-0
|
||
|
|
https://www.cancer.gov/multimedia/apps
|
||
|
|
https://www.cancer.gov/nano/
|
||
|
|
https://www.cancer.gov/nano/about
|
||
|
|
https://www.cancer.gov/nano/about/contact
|
||
|
|
https://www.cancer.gov/nano/about/contact/avula-leela
|
||
|
|
https://www.cancer.gov/nano/about/contact/grodzinski-piotr
|
||
|
|
https://www.cancer.gov/nano/about/contact/hartshorn-christopher
|
||
|
|
https://www.cancer.gov/nano/about/contact/morales-carolina
|
||
|
|
https://www.cancer.gov/nano/about/contact/wu-yicong
|
||
|
|
https://www.cancer.gov/nano/about/factsheet
|
||
|
|
https://www.cancer.gov/nano/about/factsheet/alliance-factsheet-2016.pdf
|
||
|
|
https://www.cancer.gov/nano/about/nanotechnology-journey-video
|
||
|
|
https://www.cancer.gov/nano/about/nci-initiatives
|
||
|
|
https://www.cancer.gov/nano/about/publications-presentations
|
||
|
|
https://www.cancer.gov/nano/about/publications-presentations/2013-nci-alliance-bulletin.pdf
|
||
|
|
https://www.cancer.gov/nano/about/publications-presentations/information-response.pdf
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/benefits
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/current-treatments
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/detection-diagnosis
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/research
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/safety
|
||
|
|
https://www.cancer.gov/nano/cancer-nanotechnology/treatment
|
||
|
|
https://www.cancer.gov/nano/events
|
||
|
|
https://www.cancer.gov/nano/events/2019-alliance-pi-meeting
|
||
|
|
https://www.cancer.gov/nano/events/2022-alliance-pi-meeting
|
||
|
|
https://www.cancer.gov/nano/events/2023-alliance-pi-meeting
|
||
|
|
https://www.cancer.gov/nano/events/2024-alliance-pi-meeting
|
||
|
|
https://www.cancer.gov/nano/events/2024-alliance-pi-meeting-article
|
||
|
|
https://www.cancer.gov/nano/grants-training
|
||
|
|
https://www.cancer.gov/nano/grants-training/apply-alliance
|
||
|
|
https://www.cancer.gov/nano/grants-training/funding
|
||
|
|
https://www.cancer.gov/nano/grants-training/training-grants
|
||
|
|
https://www.cancer.gov/nano/news-events/events/pi2019-meeting-book.docx
|
||
|
|
https://www.cancer.gov/nano/news-events/events/pi2019-poster-list.pdf
|
||
|
|
https://www.cancer.gov/nano/news-events/news/alliance-phase-2-summary.pdf
|
||
|
|
https://www.cancer.gov/nano/research
|
||
|
|
https://www.cancer.gov/nano/research/alliance
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/cal-tech-ucla
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/northwestern
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/sloan-kettering-cornell
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/stanford
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/unc
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ccne/washington
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/california
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/carolina
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/johns-hopkins
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/northwestern
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/stanford
|
||
|
|
https://www.cancer.gov/nano/research/alliance/cntc/texas
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/case-western
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/chicago
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/emory
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/harvard
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/masimocorporation
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/osu
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/texas
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/uc-davis
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/ucla
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/ucla-cedars-sinai
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ircn/unc
|
||
|
|
https://www.cancer.gov/nano/research/alliance/previous-grantees
|
||
|
|
https://www.cancer.gov/nano/research/alliance/ttnci
|
||
|
|
https://www.cancer.gov/nano/research/data-sharing
|
||
|
|
https://www.cancer.gov/nano/research/nanotechnology-industrialization
|
||
|
|
https://www.cancer.gov/nano/research/ncl
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about-0
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/alison-vermilya
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/barry-neun
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/chantel-brown
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/collaborators
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/edward-cedrone
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/hannah-newton
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/jeffrey-clogston
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/jie-xu
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/kelsie-snapp
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/krishna-kattel
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/marina-dobrovolskaia
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/matthew-hansen
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/nanotechnology-characterization-lab-services-video
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/publications
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/rachael-crist
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/ruvanthi-kularatne
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/sarah-skoczen
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/shanna-marcelino
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/staff
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/stephan-stern
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/teagan-ware
|
||
|
|
https://www.cancer.gov/nano/research/ncl/about/timothy-potter
|
||
|
|
https://www.cancer.gov/nano/research/ncl/assay-cascade
|
||
|
|
https://www.cancer.gov/nano/research/ncl/assay-cascade/application-process
|
||
|
|
https://www.cancer.gov/nano/research/ncl/assay-cascade/application-process/white-paper-application
|
||
|
|
https://www.cancer.gov/nano/research/ncl/assay-cascade/application-process/white-paper-application-ac
|
||
|
|
https://www.cancer.gov/nano/research/ncl/assay-cascade/application-process/white-paper-application-sar
|
||
|
|
https://www.cancer.gov/nano/research/ncl/ccrada
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/dynamic-light-scattering-video
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/endotoxin-depyrogenation-tips.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/in-vivo-guide.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-11.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-12.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-14.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-4.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-5.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-6.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-gta-7.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-iea-1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-10.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-11.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-12.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-14.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-17.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-18.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-2.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-2.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-22.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-23.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-24.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-25.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-26.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-27.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-29.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-31.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-32.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-33.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-34.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-35.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-36.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-37.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-37.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-4.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-40.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-5.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-5.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-6.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-6.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-6.3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-7.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-8.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-8.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-9.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ita-9.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-10.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-11.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-12.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-13.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-14.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-15.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-16.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-17.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-18.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-19.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-20.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-21.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-22.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-23.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-6.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-7.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-8-pcc-9-supplement.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-8.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pcc-9.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pha-1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-pha-2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-1.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-1.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-1.3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-1.4.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-2.1.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-2.2.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-2.3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-2.4.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-3.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/ncl-method-ste-4.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/physicochemical-characterization-liposomal-products.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/physicochemical-characterization-polymeric-nanoparticles.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/protocols-capabilities/physicochemical-characterizations-colloidal-metal-nanoparticle.pdf
|
||
|
|
https://www.cancer.gov/nano/research/ncl/technical-services
|
||
|
|
https://www.cancer.gov/nano/research/ncl/technical-services/situa
|
||
|
|
https://www.cancer.gov/nano/research/partners-collaborators/tonic-federal-register.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-complete.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-front-matter.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-five.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-four.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-one.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-six.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-three.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cananoplan-2015-section-two.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cancer-nanotechnology-plan-2005.pdf
|
||
|
|
https://www.cancer.gov/nano/research/plan/cancer-nanotechnology-plan-2010.pdf
|
||
|
|
https://www.cancer.gov/nano/sitemap
|
||
|
|
https://www.cancer.gov/news-events
|
||
|
|
https://www.cancer.gov/news-events/cancer-currents-blog/about
|
||
|
|
https://www.cancer.gov/news-events/cancer-currents-blog/affordable-access-to-cancer-drugs-infographic
|
||
|
|
https://www.cancer.gov/news-events/cancer-currents-blog/car-t-cell-manufacturing-cancer-clinical-trials-video
|
||
|
|
https://www.cancer.gov/news-events/cancer-currents-blog/connected-health-infographic
|
||
|
|
https://www.cancer.gov/news-events/events
|
||
|
|
https://www.cancer.gov/news-events/events/advisory-board-meetings
|
||
|
|
https://www.cancer.gov/news-events/events/conferences
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2020/dr-singer-nci-activities-video
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2020/dr-singer-nci-activities.pdf
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2020/virtual-meeting-ii/facing-new-challenges-together.pdf
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2020/virtual-meeting-ii/nci-directors-address-managing-the-now-focused-on-the-future
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2021
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2021/meet-the-experts
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2021/virtual-meeting-i
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2021/virtual-meeting-ii
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2022
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2022/nci-booth
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2022/nci-meeting-room
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2022/nci-sessions
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2023
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2023/nci-booth
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2023/nci-meeting-room
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2023/nci-sessions
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2024
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2024/activities-nci-booth-1319
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/aacr-2024/nci-sessions
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/apha-2022
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/apha-2023
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2019
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2021
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2021/sharpless-asco-2021
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2022
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2022/asco-2022-leadership-presentation
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2023
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/asco-2024
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/nih-grants-conference
|
||
|
|
https://www.cancer.gov/news-events/events/conferences/srnt-2021
|
||
|
|
https://www.cancer.gov/news-events/events/scientific-meetings
|
||
|
|
https://www.cancer.gov/news-events/events/social-media
|
||
|
|
https://www.cancer.gov/news-events/events/social-media-0
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/2014
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/2015
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/2016
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/2017
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/2018
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/breaking-bias
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/cancer-prevention-and-screening
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/community-conversations-event-2024-07
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/conversation-nci-director-2019
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/disparities-prevention-research-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/dna-informs-diagnosis-treatment-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/doubling-clinical-trial-accrual-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/dr-lowy-talking-basic-science-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/equity-in-healthcare-workforce-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/genomic-data-commons-genomic-cloud-pilots-google-hangout-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/how-young-patients-families-cope-with-covid-video
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/lung-cancer-clinical-trials
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/psychosocial-pediatric-adolescent-cancer
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/rathmell-live-event-2024-02
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/sbir-youtube-live
|
||
|
|
https://www.cancer.gov/news-events/events/social-media/submit-research-ideas-google-hangout
|
||
|
|
https://www.cancer.gov/news-events/media-resources
|
||
|
|
https://www.cancer.gov/news-events/media-resources/pragmatica-lung-study.mp3
|
||
|
|
https://www.cancer.gov/news-events/media-resources/reporting-fellowships
|
||
|
|
https://www.cancer.gov/news-events/nca50
|
||
|
|
https://www.cancer.gov/news-events/nca50/commemorate-national-cancer-act-50-years
|
||
|
|
https://www.cancer.gov/news-events/nca50/ending-cancer-as-we-know-it
|
||
|
|
https://www.cancer.gov/news-events/nca50/gift-of-time-video
|
||
|
|
https://www.cancer.gov/news-events/nca50/nothing-will-stop-us
|
||
|
|
https://www.cancer.gov/news-events/nca50/patients-as-partners
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/advances-in-treatment-and-care
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/cancer-centers
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/cancer-health-disparities
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/cancer-research-advocacy
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/cancer-research-workforce
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/causes-and-risk-factors-for-cancer
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/cervical-cancer-prevention
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/childhood-cancer-research
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/clinical-trials-network
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/power-of-data
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/screening-and-prevention
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/survivorship
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/technologies-and-innovations
|
||
|
|
https://www.cancer.gov/news-events/nca50/stories/understanding-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2012
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2012/ibrutinibaacrvideo
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/aacr2014annualmeetingperspective
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/actepithelial
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/alchemistlaunch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/ascopoems
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/ascosoftandtext
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/aspirinreducedovariancancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/bcscwinners
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/breastcancermalepoolingstudy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/calltoactiontopreventskincancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/cancercenterpuertorico
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/car-tleukemia
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/ccitla
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/cghportabilityawards
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/classobesity
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/geneticriskprostate
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/genomicdatacommonsnewsnote
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/glutamatereceptors
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/hivdnainsertionsites
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/hpvscreeningpredictor
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/icorpsnihnsf
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/lungmaplaunch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/mpactlaunch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/multiplecolposcopyjco
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nationalmedaltechnologylowyschiller
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nciandcdcsmokelesstobaccoreport
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/ncorp01aug2014
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nctnlaunch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nctnstatement
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nhlinterlymphmonograph
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/nos2breastcancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/ovariannct01116648asco
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/progeriabrdr
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/proteogenomicanalysis
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/rhabdomyosarcomagenemap
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/rrsoovarian
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/rtog9802
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/sdhcepimutantgist
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/smokinglungcancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/softtrialresult
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/tcgabladder
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/tcgagastric
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/tcgakidneychromophobe
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/tcgalungadeno
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/tcgathyroidnewsnote
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2014/varmusopenletter
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/anchor-trial-launch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/cellular-factors-shape-3d-landscape-genome
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/changing-survival-patterns-breast
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/cryo-electron-microscopy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/ctdna-dlbcl-detection-lancet-oncology
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/donor-telomere-length-saa
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/exceptional-responders-initial-feasibility-results
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/fewer-doses-hpv-vaccine
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/hiv-excess-cancers-jnci
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/ibrutinib-lymphoma-subtype
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/ilc-2015
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/lowy-named-acting-nci-director-april-2015
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/lung-cancer-indicators-recurrence
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/nci-match
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/osteosarcoma-tp53-inherited-gene-mutation-adolescents
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/peak-longevity-physical-activity
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/prostatefusiontargetedbiopsyjama
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/report-nation-march-2015-press-release
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/report-nation-march-2015-qanda
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/signaling-and-cancer-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/tcga-cutaneous-melanoma-mutated-genes
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/tcga-lowergradegliomas
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/tcga-prcc-prostate-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2015/tcgaheadneck
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/annual-report-nation-1975-2012
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/bladder-cancer-risk-arsenic-private-wells
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/blue-ribbon-panel-announced
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/breast-cancer-genetics-black-women
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/cryo-electron-microscopy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/cryo-em-visualize-proteins
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/gdc-data-expansion-fmi
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/gdc-data-expansion-mmrf
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/genomic-data-commons-launch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/hcmi-cancer-models
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/immunotherapy-targets-kras
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/low-intensity-smoking-risk
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/moonshot-get-involved
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/ncab-nci-accept-brp-report
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/new-principle-chemo-resistance-breast-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/oxygen-impair-cancer-immune-response-in-mice
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/physical-activity-lowers-cancer-risk
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/selumetinib-shrinks-pediatric-tumors
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/selumetinib-shrinks-pediatric-tumors-video
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2016/tcga-adrenocortical
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/annual-report-to-nation-1975-2014
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/detroit-cancer-survivors-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/immunotherapy-genes-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/li-fraumeni-syndrome-screening-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/lowy-schiller-lasker-award
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/metastatic-breast-cancer-survival-rates
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/nci-formulary-launch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/nci-pediatric-match-trial-opens
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/premature-death-rates-diverge
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/sharpless-nci-director
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/tcga-cervical-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/tcga-liver-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2017/tmist-mammography-trial
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/annual-report-nation-2018
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/cll-ibrutinib-trial
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/gut-microbiome-liver-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/immunotherapy-targets-breast-cancer-case-report
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/lowy-schiller-szent-gyorgyi-prize
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/lymphoma-genetic-subtypes
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/melanoma-immunotherapy-predictor
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/navigate-va-clinical-trials
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/nci-match-first-results
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/oropharyngeal-hpv-cisplatin
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/respond-prostate-black-men
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/rosenberg-albany-prize
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/sorafenib-desmoid-trial
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/statement-senator-mccain-passing
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/tailorx-breast-cancer-chemotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/tcga-pancancer-atlas
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2018/tmds-aml-risk-chemo
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/annual-report-nation-2019
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/blinatumomab-relapsed-all
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/brca-exchange
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/clinical-trial-impact-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/deep-learning-cervical-cancer-screening
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/radioactive-iodine-hyperthyroidism-cancer-death-risk
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/rate-aggressive-uterine-cancers-rising
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/stemness-potassium-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2019/szent-gyorgyi-prize-rosenberg
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/acalabrutinib-covid-19
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/annual-report-nation-2020
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/automated-dual-stain-cervical
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/breast-cancer-treament-postmenopausal-women-may-forgo-chemotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/burkitt-lymphoma-adult
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/cancer-exceptional-responders-study-genetic-alterations-may-contribute
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/cancer-grand-challenges
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/combined-prostate-biopsy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/covid-19-digital-health-technology
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/daily-step-count-mortality
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/liver-cancer-screening-test
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/lung-cancer-treatments-mortality-drop
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/nci-statement-clinical-trials-during-covid-19
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/osteosarcoma-genetic-variants
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2020/selumetinib-nf1-children
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/annual-report-nation-2021
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/annual-report-nation-part-2-economic-burden
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/childhood-cancer-rhabdomyosarcoma
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/covid-19-pandemic-disparities-excess-deaths
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/engineered-myeloid-cells-prevent-cancer-spread
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/fecal-transplants-cancer-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/genetic-effects-chernobyl-radiation-exposure
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/high-fiber-diet-melanoma-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/ibrutinib-diffuse-large-b-cell-lymphoma
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/lung-cancer-never-smokers
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/nci-statement-unite-end-structural-racism
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/neurofibromatosis-cancer-blood-test
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/sars-cov-2-antibodies-protect-from-reinfection
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2021/treatment-helps-children-apl-avoid-chemotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/annual-report-to-the-nation-2022
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/bertagnolli-nci-director
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/cancer-death-rates-black-people
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/cancer-grand-challenges-funded-teams
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/childhood-cancer-molecular-characterization-initiative
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/covid-interferon-oas1-gene-variants
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/covid-third-leading-cause-death
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/former-smokers-healthy-lifestyle-risk-of-death
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/gene-expression-profile-personalized-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/health-benefits-black-tea
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/hiv-hsil-anal-cancer-anchor-study
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/nci-director-monica-bertagnolli-breast-cancer-diagnosis
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/nci-director-norman-sharpless-steps-down
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/nci-trial-atezolizumab-approval-alveolar-soft-part-sarcoma
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/personalized-immunotherapy-metastatic-breast-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/physical-activity-older-adults
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/telehealth-centers-of-excellence-awards
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2022/uterine-cancer-deaths-black-women
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023-0
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/annual-report-to-the-nation-part-2-pandemic-cancer-diagnoses
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/cancer-grand-challenges-new-funding-opportunity
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/combomatch-jeffrey-moscow-soundbite.mp4
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/combomatch-precision-medicine-cancer-initiative
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/cptac-proteogenomic-dataset
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/cytokines-supercharge-t-cell-therapies
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/dr-serban-negoita-soundbite-diagnoses.mp4
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/dr-srinivasan-soundbite-persistent-poverty.mp4
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/immunotherapy-lymphomatoid-granulomatosis
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/nci-launches-persistent-poverty-initiative
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/opportunities-to-reduce-cancer-death-rate
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/pragmatica-lung-study-begins-enrollment
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/rathmell-nci-director
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/reversing-cell-division-process
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2023/rosenberg-national-medal-of-technology-and-innovation
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/ai-tool-matches-cancer-drugs-to-patients
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/ai-tool-predicts-response-to-immunotherapy
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/cancer-grand-challenges-selects-five-new-teams
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/cancer-screening-research-network-launches
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/covid-pandemic-impact-on-new-cancer-diagnoses
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/disadvantaged-neighborhoods-west-african-ancestry-prostate-cancer-risk
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/genetic-factors-predict-x-chromosome-loss
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/genomic-analysis-kidney-cancer-risk
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/high-risk-bladder-cancer-pembrolizumab
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/multivitamins-do-not-lower-risk-of-death
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/mutant-ras-proteins-new-role-in-cancer
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/myelomatch-precision-medicine-treatment-trial-launch
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/new-studies-from-human-tumor-atlas-network
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/personalized-immunotherapy-shrinks-solid-tumors
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/polygenic-risk-scores-for-childhood-cancer-survivors
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/vipor-combination-therapy-b-cell-lymphoma
|
||
|
|
https://www.cancer.gov/news-events/press-releases/2024/virtual-clinical-trials-office-launches
|
||
|
|
https://www.cancer.gov/nras.pdf
|
||
|
|
https://www.cancer.gov/number-of-us-cancer-survivors-infographic
|
||
|
|
https://www.cancer.gov/obesity-and-cancer-infographic
|
||
|
|
https://www.cancer.gov/options
|
||
|
|
https://www.cancer.gov/pathology-poster
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/-1
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/about
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/about/contact
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/about/team
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/about/what-is-mypart
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/apoyo
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/apoyo/cuidados-ninos-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/apoyo/funcion-familiares-cuidadores
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/apoyo/pacientes-cuidadores
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/apoyo/recursos-jovenes
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/investigacion
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/investigacion/publicaciones
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/investigacion/retos-investigacion-tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/investigacion/talleres-tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/noticias
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/noticias/boletin
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/noticias/noticias-tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/noticias/noticias-tumores-raros/primera-sesion-clinica-cordoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/noticias/sesiones-clinicas-tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/grupos-representativos-pacientes
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/informacion-ensayos-clinicos
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/natural-history
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/natural-history/muestras-encuestas-para-aprender-sobre-tumores-raros-infografia
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/natural-history/preguntas-frecuentes-natural-history-study-infografia
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/participacion-ensayo
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/participacion/socios
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/quienes-somos
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/quienes-somos/comuniquese
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/quienes-somos/equipo
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/quienes-somos/que-es-mypart
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/canceres-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/canceres-raros-infografia
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/canceres-raros-infografia-2
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/otros-tumores-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/otros-tumores-raros/neuroblastoma-olfatorio
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/cancer-anaplasico-tiroides
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/cancer-medular-tiroides
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/carcinoma-corteza-suprarrenal
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/feocromocitoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/paraganglioma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumor-endocrino-raro/tumor-carcinoide
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros/adamantinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros/condrosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros/cordoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros/fibroma-condromixoide
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-oseos-raros/osteosarcoma-periostico
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/adenocarcinoma-gastrico-y-poliposis-proximal
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/cancer-apendice
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/cancer-gastrico-difuso-hereditario
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/carcinoma-fibrolamelar
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/colangiocarcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/esofago
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-aparato-digestivo/tumor-estroma-gastrointestinal-deficiencia-sdh
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/carcinoma-nut
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/fibrosarcoma-epitelioide-esclerosante
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/leiomiosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/liposarcoma-mixoide-celulas-redondas
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/miofibromatosis-infantil
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/sarcoma-alveolar-partes-blandas
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/sarcoma-celulas-claras
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/sarcoma-sinovial
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/schwannoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/tumor-desmoide
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/tumor-maligno-vaina-nervio-periferico
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/tumor-miofibroblastico-inflamatorio
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/tumor-rabdoide-maligno-extracraneal
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-raros-tejidos-blandos/tumores-desmoplasicos-celulas-redondas-pequenas
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-renales-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-renales-raros/carcinoma-celulas-renales-translocacion
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-renales-raros/carcinoma-medular-renal
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-renales-raros/carcinoma-papilar-celulas-renales
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-renales-raros/carcinoma-renal-celulas-claras
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-vasculares-raros
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-vasculares-raros/angiosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-vasculares-raros/hemangioendotelioma-epitelioide
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/espanol/tumores-raros/tumores-vasculares-raros/hemangioendotelioma-kaposiforme
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/newsletter
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/rare-tumor-clinics
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/rare-tumor-clinics/2024-chordoma-clinic
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/rare-tumor-news
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/rare-tumor-news/first-chordoma-clinic
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/selumetinib-pediatric-tumors-video
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/upcoming-events
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/news/upcoming-events/childhoodcancerawarenessmonth
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/onbmeetinginspanish
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/featured-clinical-trials
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/natural-history
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/natural-history/natural-history-study-infographic
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/naturalhistorystudyvideoparticipate
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/participate-trial
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/participate-trial-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/participate-trial/autumn-hope-video
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/participate-trial/pediatric-oncology-tour-video
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/participate-trial/what-are-clinical-trials-video
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/partners
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/role-advocacy
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/participate/types-of-samples-infographic
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/about-rare-cancers
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/mypart-focus-rare-cancer-research-infographic
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors/olfactory-neuroblastoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors/olfactory-neuroblastoma-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors/olfactory-neuroblastoma/4thannualonbmeeting
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors/olfactory-neuroblastoma/5thannualonbpatienteducationmeeting
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/other-rare-tumors/olfactory-neuroblastoma/olfactoryneuroblastomacommunityconferenceseries2021
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/adamantinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chondromyxoid-fibroma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chondrosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chordoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chordoma/chordomafoundationnhsvideo
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/periosteal-osteosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/appendiceal-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/cholangiocarcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/esophageal
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/fibrolamellar-hepatocellular-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/gastric-adenocarcinoma-and-proxymal-polyposis
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/hereditary-diffuse-gastric-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-digestive-system-tumors/sdh-deficient-gastrointestinal-stromal-tumor-gist
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/adrenocortical-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/anaplastic-thyroid-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/carcinoid-tumor
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/medullary-thyroid-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/paraganglioma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/pheochromocytoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors/clear-cell-renal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors/papillary-renal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors/renal-medullary-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-kidney-tumors/translocation-renal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/alveolar-soft-part-sarcomas
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/clear-cell-sarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/desmoid-tumor
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/desmoplastic-small-round-cell-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/extra-cranial-rhabdoid-tumor
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/infantile-myofibromatosis
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/inflammatory-myofibroblastic-tumor
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/leiomyosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/myxoid-round-cell-liposarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/nut-carcinoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/schwannoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/sclerosing-epithelioid-fibrosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/synovial-sarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors/angiosarcoma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors/epithelioid-hemangioendothelioma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors/kaposiform-hemangioendothelioma
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research-0
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research/ccdisharing
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research/challenges-rare-tumor-research
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research/publications
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/research/rare-tumor-workshops
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/sitemap
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/caring-children-cancer
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/coping-young-adults
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/patients-caregivers
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/patients-caregivers/copingwithcovid19
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/role-family-caregivers
|
||
|
|
https://www.cancer.gov/pediatric-adult-rare-tumor/support/transitioningtoadultcare
|
||
|
|
https://www.cancer.gov/pembrolizumab-first-precision-immunotherapy
|
||
|
|
https://www.cancer.gov/pepke-manuscript
|
||
|
|
https://www.cancer.gov/phases-video
|
||
|
|
https://www.cancer.gov/pik3ca.pdf
|
||
|
|
https://www.cancer.gov/pnrp-brochure.pdf
|
||
|
|
https://www.cancer.gov/policies
|
||
|
|
https://www.cancer.gov/policies/accessibility
|
||
|
|
https://www.cancer.gov/policies/comments
|
||
|
|
https://www.cancer.gov/policies/copyright-reuse
|
||
|
|
https://www.cancer.gov/policies/disclaimer
|
||
|
|
https://www.cancer.gov/policies/foia
|
||
|
|
https://www.cancer.gov/policies/linking
|
||
|
|
https://www.cancer.gov/policies/paperwork-reduction-act
|
||
|
|
https://www.cancer.gov/policies/privacy-security
|
||
|
|
https://www.cancer.gov/precision-medicine-nctn-progress-and-lessons-learned-video
|
||
|
|
https://www.cancer.gov/pten.pdf
|
||
|
|
https://www.cancer.gov/publications
|
||
|
|
https://www.cancer.gov/publications/blogs-newsletters
|
||
|
|
https://www.cancer.gov/publications/blogs-newsletters/cancer-bulletin
|
||
|
|
https://www.cancer.gov/publications/dictionaries
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/18fl-fac
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/2-fluorofucose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/3d-expanded-placenta-derived-cells-plx-r18
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluoro-2-deoxycytidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/5-fluorouracil-salicylic-acid-topical-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/6-azauridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/7-hydroxystaurosporine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/710508
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/761606
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/782063
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788964
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/8-hydroxyquinoline-sulfate-ointment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abagovomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abemaciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abequolixron
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abexinostat-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abiraterone-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abivertinib-maleate-anhydrous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/absorbable-gelatin-sponge
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/abvd-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ac-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acai-berry-juice
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acalabrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetaminophen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acetylcysteine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acimtamig
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aclarubicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/actinium-ac-225-lintuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activated-marrow-infiltrating-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/activin-type-2b-receptor-fc-fusion-protein-stm-434
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/acyclovir-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad-isf35
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-adp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ad5-ycd-muttksr39rep-hil12
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adagloxad-simolenin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adakitug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adavosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenoviral-vector-ad5-cea6d-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-5-human-guanylyl-cyclase-c-padre-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adenovirus-vector
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-regenerative-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/adipose-derived-stromal-vascular-fraction-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ae37-peptide-gm-csf-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afatinib-dimaleate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/afuresertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agatolimod-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aglatimagene-besadenovec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/agonistic-anti-ox40-monoclonal-antibody-medi6469
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-1-2-inhibitor-bay1125976
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-ly2780301
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/akt-inhibitor-mk2206
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/albumin-binding-cisplatin-prodrug-btp-114
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aldesleukin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alectinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alemtuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alflutinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/algenpantucel-l
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alisertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-inhibitor-cep-37440
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-fak-pyk2-inhibitor-ct-707
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-inhibitor-asp3026
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alk-trk-inhibitor-tsr-011
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allodepleted-t-cell-immunotherapeutic-atir101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-dendritic-cell-vaccine-combig-dc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-mg4101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-natural-killer-cell-line-nk-92
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allogeneic-tumor-cell-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/allopurinol-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alobresib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aloe-vera-gel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpelisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-lipoic-acid-palladium-vitamin-mineral-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alpha-v-beta-1-inhibitor-atn-161
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alrizomadlin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvespimycin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alvocidib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amatuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amcasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amifostine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aminopterin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amivantamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amrubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amsacrine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/amuvatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anamorelin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anastrozole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/andecaliximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antagonist-trc253
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/androgen-receptor-antisense-oligonucleotide-azd5312
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anetumab-ravtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/angelica-sinensis-root-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annamycin-liposomal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/annonaceous-acetogenins
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anselamimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-5t4-antibody-drug-conjugate-pf-06263507
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ag7-antibody-drug-conjugate-abgn-107
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ags-16-monoclonal-antibody-ags-16m18
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ang2-monoclonal-antibody-medi-3617
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-asct2-antibody-drug-conjugate-medi7247
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-fms-monoclonal-antibody-amg-820
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-c-kit-antibody-drug-conjugate-lop628
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca19-9-monoclonal-antibody-5b1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ca6-dm4-immunoconjugate-sar566658
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-cd3-bispecific-antibody-jnj-63709178
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-monoclonal-antibody-khk2823
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd123-pyrrolobenzodiazepine-dimer-antibody-drug-conjugate-sgn-cd123a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd157-monoclonal-antibody-men1112
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-anti-cd22-bispecific-immunotoxin-dt2219arl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-antibody-drug-conjugate-sgn-cd19b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-cd3-tetravalent-antibody-afm11
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-di-b4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd19-monoclonal-antibody-mdx-1342
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd20-engineered-toxin-body-mt-3724
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd27l-antibody-drug-conjugate-amg-172
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-immunotoxin-a-dmdt390-bisfvucht1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd3-x-anti-cd20-bispecific-antibody-armed-activated-t-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-antibody-drug-conjugate-imgn779
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd33-monoclonal-antibody-bi-836858
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd352-antibody-drug-conjugate-sgn-cd352a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd37-monoclonal-antibody-bi-836826
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd40-monoclonal-antibody-chi-lob-7-4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd44-monoclonal-antibody-ro5429083
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd47-monoclonal-antibody-cc-90002
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-mdx-1203
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd70-antibody-drug-conjugate-sgn-cd70a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd73-monoclonal-antibody-bms-986179
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cd98-monoclonal-antibody-ign523
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cdh6-antibody-drug-conjugate-hkt288
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-anti-hsg-bispecific-monoclonal-antibody-tf2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cea-bite-monoclonal-antibody-amg211
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ceacam1-monoclonal-antibody-cm-24
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cldn6-monoclonal-antibody-asp1650
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf-1r-monoclonal-antibody-imc-cs4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1-monoclonal-antibody-pd-0360324
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-csf1r-monoclonal-antibody-imc-cs4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ctla4-monoclonal-antibody-bms-986218
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-cxcr4-monoclonal-antibody-pf-06747143
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-dkk1-monoclonal-antibody-bhq880
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-fluorescence-imaging-agent-aby-029
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfr-monoclonal-antibody-mixture-mm-151
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-egfrviii-antibody-drug-conjugate-amg-595
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-enpp3-antibody-drug-conjugate-ags-16c3f
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-epha2-monoclonal-antibody-ds-8895a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-erbb3-monoclonal-antibody-cdx-3379
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fgfr3-antibody-drug-conjugate-ly3076226
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-fucosyl-gm1-monoclonal-antibody-bms-986012
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd2-monoclonal-antibody-hu1418k322a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gd3-antibody-drug-conjugate-pf-06688992
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-agonistic-monoclonal-antibody-bms-986156
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-gwn-323
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gitr-monoclonal-antibody-mk-4166
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-gpa33-cd3-monoclonal-antibody-mgd007
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-antibody-drug-conjugate-medi4276
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her2-auristatin-payload-antibody-drug-conjugate-xmt-1522
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-her3-monoclonal-antibody-gsk2849330
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-hif-1alpha-lna-antisense-oligonucleotide-ezn-2968
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-human-gitr-monoclonal-antibody-trx518
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-icos-monoclonal-antibody-medi-570
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-1-alpha-monoclonal-antibody-mabp1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-il-4-il-13-combination-agent-qbx258
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-integrin-monoclonal-antibody-dm4-immunoconjugate-imgn388
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-kir-monoclonal-antibody-iph-2101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ksp-anti-vegf-sirnas-aln-vsp02
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lamp1-antibody-drug-conjugate-sar428926
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-lgr5-monoclonal-antibody-bnc101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ly6e-antibody-drug-conjugate-rg-7841
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-antibody-drug-conjugate-bms-986148
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-mesothelin-pseudomonas-exotoxin-24-cytolytic-fusion-protein-lmb-100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-met-monoclonal-antibody-mixture-sym015
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-nucleolin-aptamer-as1411
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-antibody-bms-986178
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-ox40-monoclonal-antibody
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-fusion-protein-amp-224
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-1-monoclonal-antibody-medi0680
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-faz053
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-pd-l1-monoclonal-antibody-mdx-1105
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-plgf-monoclonal-antibody-tb-403
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-prolactin-receptor-antibody-lfa102
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psca-monoclonal-antibody-ags-1c4d4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-psma-cd3-monoclonal-antibody-mor209-es414
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tgf-beta-rii-monoclonal-antibody-imc-tr1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-thymocyte-globulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tim3-monoclonal-antibody-ly3321367
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-tissue-factor-monoclonal-antibody-morab-066
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegf-ang2-nanobody-bi-836880
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-vegfc-monoclonal-antibody-vgx-100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-anti-tim-1-vcmmae-cdx-014
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-002
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-004
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antibody-drug-conjugate-sc-006
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antimetabolite-ff-10502
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antineoplaston-a10
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/antrodia-cinnamomea-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anvatabart-opadotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apalutamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apatorsen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apaziquone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apilimod-dimesylate-capsule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/apomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aprutumab-ixadotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/archexin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arginine-butyrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/arsenic-trioxide-capsule-formulation-orh-2014
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asciminib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ascrinvacumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ashwagandha-root-powder-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asp4132
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/asparaginase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atenolol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atezolizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-inhibitor-m-3541
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/atm-kinase-inhibitor-azd0156
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aumolertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-inhibitor-vic-1911
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-a-kinase-tyrosine-kinase-inhibitor-enmd-2076
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aurora-b-serine-threonine-kinase-inhibitor-tak-901
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19-28z-chimeric-antigen-receptor-expressing-t-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-cd19car-cd28-cd3zeta-egfrt-expressing-tcm-enriched-t-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-lung-cancer-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-gm-csf-secreting-lethally-irradiated-pancreatic-cancer-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-mage-a3-a6-specific-tcr-gene-engineered-lymphocytes-kite-718
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-prostate-stem-cell-antigen-specific-car-t-cells-bpx-601
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-cell-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/autologous-tumor-infiltrating-lymphocytes-ln-145
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avadomide-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avapritinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avelumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/avutometinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axalimogene-filolisbac
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axicabtagene-ciloleucel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/axl-receptor-tyrosine-kinase-cmet-inhibitor-bpi-9016m
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azacitidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azaserine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/aziridinylbenzoquinone-rh1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/azurin50-77-cell-penetrating-peptide-p28
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baclofen-amitriptyline-ketamine-gel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bafetinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balanced-crystalloid-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balixafortide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/balstilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baltaleucel-t
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/barasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/baricitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/batoprotafib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bavituximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bc-819-plasmid-polyethylenimine-complex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcg-tokyo-172-strain-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcl-2-inhibitor-bcl201
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bcr-abl-kinase-inhibitor-k0706
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beetroot-juice
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/begelomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belagenpumatucel-l
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belantamab-mafodotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belapectin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belumosudil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belvarafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/belzutifan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemarituzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemcentinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bendamustine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzoylphenylurea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/benzydamine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bep-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bersanlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/berzosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-bromodomain-inhibitor-zen-3694
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-bay1238097
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ft-1101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-gsk2820151
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-incb054329
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bet-inhibitor-ro6870810
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-elemene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-glucan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-hydroxy-beta-methylbutyrate-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/beta-lapachone-prodrug-arq-761
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betibeglogene-autotemcel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/betulinic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bevacizumab-irdye-800cw
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bezuclastinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bh3-mimetic-abt-737
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bicalutamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bimiralisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birabresib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birinapant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/biropepimut-s
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/birtamimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bisantrene-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bispecific-antibody-mdx447
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizalimogene-ralaplasmid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bizaxofusp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bl22-immunotoxin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blinatumomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/blue-citrus-based-herbal-capsule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bms-214662
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bomedemstat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bortezomib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bosutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/botanical-lotion-cg428
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bowman-birk-inhibitor-concentrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bp-cx1-platinum-complex-bp-c1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/braf-inhibitor-arq-736
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brafv600-pi3k-inhibitor-asn003
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/branched-chain-amino-acid-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brd4-inhibitor-plx51107
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brentuximab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/briciclib-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brigatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brilanestrant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brivanib-alaninate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/broccoli-sprout-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/brontictuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bryostatin-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-dtrmwxhs-12
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/btk-inhibitor-tl-895
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/budigalimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/buparlisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/burixafor-hydrobromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/butylscopolamine-bromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bxq-350-nanovesicle-formulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/c-met-inhibitor-amg-337
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabazitaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabiralizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cabozantinib-s-malate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caf-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/caix-inhibitor-dtp348
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calcium-release-activated-channels-inhibitor-rp4010
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calculus-bovis-moschus-olibanum-myrrha-capsule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camidanlumab-tesirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camrelizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/camsirubicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cancer-peptide-vaccine-s-588410
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/canertinib-dihydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cannabidiol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capecitabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capivasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capmatinib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/capox-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbogen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-choline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carbon-c-11-pbr-28
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboplatin-paclitaxel-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxyamidotriazole-orotate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carboxymethyl-starch-topical-powder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carfilzomib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carmustine-implant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/carotuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catequentinib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cathepsin-activatable-cy5-fluorescent-imaging-probe-lum015
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/catumaxomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-ccx872-b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-antagonist-pf-04136309
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ccr2-ccr5-antagonist-bms-813160
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cd40-agonist-monoclonal-antibody-cp-870893
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-at7519
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk-inhibitor-sns-032
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cdk4-inhibitor-p1446a-05
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cea-muc-1-tricom-vaccine-cv301
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cebpa-targeting-sarna-mtl-cebpa-liposome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cediranib-maleate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/celecoxib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cemiplimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cephalexin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceralasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceramide-nanoliposome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ceritinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetrelimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cetuximab-sarotalocan-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cevostamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cfms-tyrosine-kinase-inhibitor-arry-382
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/checkpoint-kinase-inhibitor-azd7762
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chinese-herbal-formulation-phy906
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chitin-oligosaccharides-supplement-t-chos
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-gdc-0575
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-pf-477736
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chk1-inhibitor-sra737
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorhexidine-gluconate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorogenic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chloroquine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chlorozotocin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cholecystokinin-b-receptor-antagonist-yf476
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/choline-kinase-alpha-inhibitor-tcd-717
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/chop-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cibisatamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciforadenant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cifurtilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cilengitide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cimetidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintirorgon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cintredekin-besudotox
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciprofloxacin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cisplatin-vinblastine-cell-penetration-enhancer-formulation-int230-6
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citarinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/citrulline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cixutumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cladribine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clindamycin-hydrocortisone-lotion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clino-san-vaginal-lubricant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clofarabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/clostridium-novyi-nt-spores
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cmf-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cngrc-peptide-tnf-alpha-conjugate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobimetinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cobomarsen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cofetuzumab-pelidotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colchicine-site-binding-agent-abt-751
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/collagen-aloe-vera-vitamin-e-lidocaine-topical-hydrogel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/colloidal-gold-bound-tumor-necrosis-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/compound-kushen-injection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conatumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/contusugene-ladenovec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copanlisib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copdac-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-61-atsm
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-atsm
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-dota-trastuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-cu-64-tp3805
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/copper-gluconate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cordycepin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cpg-oligodeoxynucleotide-gnkg168
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/creatine-monohydrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crenolanib-besylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cridanimod-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizanlizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crizotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crolibulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/crotoxin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/curcumin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cusatuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/custirsen-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxc-chemokine-receptor-2-antagonist-azd5069
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-antagonist-usl311
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cxcr4-peptide-antagonist-ly2510924
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclobenzaprine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclophosphamide-epirubicin-vincristine-prednisone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyclosporine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyl-02-plasmid-dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cyp17-lyase-inhibitor-asn001
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cysteine-rich-non-denatured-whey-protein-isolate-imn1207
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytarabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-based-biologic-agent-irx-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/cytokine-induced-killer-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dabrafenib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacarbazine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacetuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dach-platin-micelle-nc-4016
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dacomitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactinomycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dactolisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalantercept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalpiciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danusertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/danvatirsen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daporinad
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/daratumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darinaparsin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darleukin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darolutamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/darovasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dasatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/davamotecan-pegadexamer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/decitabine-and-cedazuridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/defactinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/degarelix
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-8-tetrahydrocannabinol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/delta-tocopherol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demcizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/demplatin-pegraglumer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dendritic-cell-targeting-lentiviral-vector-id-lv305
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denifanstat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denileukin-diftitox
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denintuzumab-mafodotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/denosumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/depatuxizumab-mafodotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derazantinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/derma-membrane-structure-topical-cream
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/devimistat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexamethasone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexanabinol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dexpanthenol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/di-leu16-il2-immunocytokine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diammonium-glycyrrhizinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dianhydrogalactitol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/didemnin-b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diindolylmethane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dilpacimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dimesna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinaciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dinutuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dioscorea-nipponica-makino-extract-dne3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphencyprone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphenhydramine-hydrochloride-dexamethasone-nystatin-magic-mouthwash
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxin-fragment-interleukin-2-fusion-protein-e7777
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/diphtheria-toxoid-tetanus-toxoid-vaccine-adsorbed
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disitamab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/disufenton-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ditiocarb
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-dependent-protein-kinase-inhibitor-vx-984
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-pk-tor-kinase-inhibitor-cc-115
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dna-vaccine-vb1016
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/docetaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dociparstat-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dolastatin-10
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/domatinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dordaviprone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dostarlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dovitinib-lactate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxorubicin-loaded-egfr-targeting-nanocells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/doxycycline-calcium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dpx-e7-hpv-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dronabinol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dta-h19-plasmid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dual-igf-1r-insr-inhibitor-bms-754807
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dubermatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dulanermin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duligotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/durvalumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dusigitumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dutpase-dpd-inhibitor-tas-114
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvelisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/duvortuxizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ebselen-containing-oral-capsule-spi-1005
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/echinomycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edatrexate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edicotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edodekin-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/edrecolomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eed-inhibitor-mak683
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efaproxiral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efatutazone-dihydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efbemalenograstim-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efgivanermin-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efizonerimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efprezimod-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/efs-ada-lentiviral-vector-transduced-cd34-positive-autologous-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eftilagimod-alpha
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eganelisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-antagonist-hemay022
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-her2-inhibitor-av-412
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-mutant-specific-inhibitor-ck-101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/egfr-t790m-antagonist-bpi-15086
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elgemtumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elisidepsin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltanexor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eltrombopag-olamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eluvixtamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emactuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emapalumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emibetuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/empesertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/emvododstat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enadenotucirev
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enapotamab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enasidenib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/encorafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/endoxifen-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enfortumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enoblituzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enobosarm
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensartinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ensituximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entospletinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/entrectinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/envafolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzalutamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/enzymatically-hydrolyzed-whey-protein-based-nutritional-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epacadostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epha2-targeting-dopc-encapsulated-sirna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epirubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-r-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epoch-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/epratuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eprenetapopt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eragidomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eramkafusp-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erastin-analogue-prlx-93936
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erdafitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/eribulin-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erk-inhibitor-cc-90003
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/erlotinib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ertumaxomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etaracizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethinyl-estradiol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ethiodized-oil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etirinotecan-pegol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/etoposide-toniribate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ets-family-transcription-factor-inhibitor-tk216
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/everolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evexomostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evofosfamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/evorpacept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ex-vivo-expanded-autologous-t-cells-ima101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exatecan-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/exemestane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezabenlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ezobresib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f-18-fluoroethyltyrosine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/f16-il2-fusion-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fact-complex-targeting-curaxin-cbl0137
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/factor-vii-targeting-immunoconjugate-protein-icon-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fadraciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-gsk2256098
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-pf-00562271
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fak-inhibitor-vs-4718
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/famotidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/farletuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fas-receptor-agonist-apo010
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/feladilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenebrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fenretinide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fentanyl-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-soybean-protein-beverage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fermented-wheat-germ-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferrous-sulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ferumoxtran-10
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fexagratinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgf-receptor-antagonist-hgs1036
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr-inhibitor-asp5878
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fgfr4-inhibitor-h3b-6527
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fianlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ficlatuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/figitumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filanesib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/filgrastim
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fimepinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/finasteride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fisogatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flotetuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/floxuridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/flt3-inhibitor-ff-10101-succinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluciclovine-f18
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fludarabine-phosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescence-imaging-agent-emi-137
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-imaging-ligand-otl38
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorescent-protease-activated-peptide-avb-620
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-fdht
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorine-f-18-piflufolastat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorothymidine-f-18
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fluorouracil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fms-trk-tyrosine-kinase-inhibitor-plx7486-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-fitc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folate-receptor-targeted-tubulysin-conjugate-ec1456
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfiri-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfirinox-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/folfox-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foretinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/forodesine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-disodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosbretabulin-tromethamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foscenvivint
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fosgemcitabine-palabenamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/foslinanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/french-maritime-pine-bark-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fresolimumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruit-and-vegetable-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fruquintinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fulvestrant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/furosemide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fursultiamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futibatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/futuximab-modotuximab-mixture
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/fuzuloparib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gadoxetate-disodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galectin-1-inhibitor-otx008
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotanoc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-dotatate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-edotreotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-gozetotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-aca-bbn7-14
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-ga-68-nota-ae105
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gallium-maltolate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/galunisertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamboge-resin-extract-tsb-9-w1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-delta-tocotrienol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gamma-secretase-inhibitor-ro4929097
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganciclovir
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganetespib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ganitumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gatipotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gebasaxturev
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gedatolisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gefitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemcitabine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemogenovatucel-t
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gemtuzumab-ozogamicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genetically-modified-mage-a3-expressing-mg1-maraba-virus-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/genistein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gi-4000-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/giloralimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gilteritinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/girentuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glasdegib-maleate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glembatumumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glesatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-cancer-vaccine-erc1671
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glioblastoma-multiforme-multipeptide-vaccine-ima950
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/globo-h-dt-vaccine-obi-833
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glucosamine-sulfate-chondroitin-sulfate-tablet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glutathione-disulfide-nov-002
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycerin-enema
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glycopeptide-antibiotic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/glyt2-5ht2a-antagonist-vvz-149
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gm-k562-cell-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gmcd40l-cell-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/golvatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gonadotropin-releasing-hormone-analog
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/goserelin-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp100280-288288v-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gp2-peptide-gm-csf-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gpi-0100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/grapiprant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/green-tea-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/gs-pan-notch-inhibitor-al102
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/guadecitabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/h33k27m-specific-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hafnium-oxide-containing-nanoparticles-nbtxr3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/halofuginone-hydrobromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-obp-801
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac-inhibitor-rec-2282
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdac6-inhibitor-ka2507
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hdm2-inhibitor-mk-8242
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hematoporphyrin-derivative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her-2-neu-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-ecdtm-virus-like-replicon-particles-vaccine-avx901
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2-targeted-liposomal-doxorubicin-hydrochloride-mm-302
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/her2bi-armed-activated-t-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/herba-scutellaria-barbata
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/heterodimeric-interleukin-15
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-1alpha-inhibitor-px-478
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hif-2alpha-inhibitor-pt2385
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/histone-lysine-n-methyltransferase-ezh2-inhibitor-gsk2816126
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hla-a2-restricted-melanoma-specific-peptides-vaccine-grn-1201
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpph
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hpv-e6-e7-dna-vaccine-gx-188e
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-snx-5422-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hsp90-inhibitor-xl888
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-encoding-dna-vaccine-invac-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/htert-vaccine-v934-v935
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/huaier-extract-granule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/human-mhc-non-restricted-cytotoxic-t-cell-line-tall-104
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydrated-sodium-calcium-aluminosilicate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxychloroquine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hydroxyurea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypercvad-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hyperimmune-bovine-colostrum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypertonic-saline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/hypoxia-activated-prodrug-th-4000
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iadademstat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ianalumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iap-inhibitor-hgs1029
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibcasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iberdomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ibrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ice-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icotinib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/icrucumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idasanutlin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idecabtagene-vicleucel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idelalisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idetrexed
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idh1r132-inhibitor-idh305
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-khk2455
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ido1-inhibitor-pf-06840003
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idronoxil-suppository-nox66
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idroxioleic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ieramilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifabotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ifosfamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-10-immunomodulator-mk-1966
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/il-2-recombinant-fusion-protein-alt-801
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ilorasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imalumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imatinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imetelstat-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imidazolyl-ethanamide-pentandioic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/imiquimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunocytokine-nhs-il12
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunomodulator-ohr-avr118
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapeutic-combination-product-cmb305
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotherapy-regimen-mkc-1106-mt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-cmd-193
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/immunotoxin-d2c7-scdsfv-pe38kdel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inavolisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indium-in-111-pentetreotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indocyanine-green-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indole-3-carbinol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoleamine-23-dioxygenase-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indomethacin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indoximod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/indusatumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inebilizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inecalcitol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infigratinib-phosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/infliximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/integrin-receptor-antagonist-glpg0187
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/interferon-gamma-1b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/internalized-arginylglycylaspartic-acid-cyclic-peptide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/intetumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-123-mip-1095
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-iopofosine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-mip-1095
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-omburtamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iodine-i-131-tm-601
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipafricept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipamorelin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipatasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ipilimumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/irinotecan-sucrosofate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iron-isomaltoside-1000
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isatuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isoquercetin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/isotretinoin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iss-1018-cpg-oligodeoxynucleotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/istiratumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/itacitinib-adipate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivac-mutanome-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivaltinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivosidenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ivuxolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ixazomib-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak1-inhibitor-incb052793
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-azd1480
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-bms-911543
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jeb-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jin-fu-kang
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/juven
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/kanglaite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ketorolac
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-arginine-korean-ginseng-ginkgo-biloba-damiana-based-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-carnitine-l-tartrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-lysine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/l-methylfolate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/labetuzumab-govitecan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lacnotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-acidophilus-estriol-vaginal-tablet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-fermented-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-plantarum-strain-299v
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-gg
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lactobacillus-rhamnosus-l-jensenii-l-crispatus-l-gasseri-oral-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ladiratuzumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/laetrile
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapachone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lapatinib-ditosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/larotrectinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lead-pb-212-tcmc-trastuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lefitolimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenalidomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenograstim
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenti-d-abcd1-transduced-autologous-hematopoietic-stem-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lenvatinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lestaurtinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letolizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/letrozole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leucovorin-calcium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/leuprolide-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levamisole-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/levodopa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lexatumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/licartin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifastuzumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lifileucel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linifanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linrodostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/linsitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-docetaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposomal-hpv-16-e6-e7-multipeptide-vaccine-pds0101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-daunorubicin-cytarabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/liposome-encapsulated-mir-34-mimic-mrx34
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirametostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lirilumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisavanbulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lisinopril
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/listeria-monocytogenes-llo-psa-vaccine-adxs31-142
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-attenuated-listeria-encoding-human-mesothelin-vaccine-crs-207
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/live-freeze-dried-lactic-acid-bacteria-probiotic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lmb-2-immunotoxin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lobaplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lometrexol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lomustine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lonafarnib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loncastuximab-tesirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lontucirev
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/loperamide-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lorlatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/losatuxizumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lsd1-inhibitor-gsk2879552
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucatumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lucitanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lugols-solution
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/luminespib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lumretuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lupartumab-amadotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lurbinectedin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-dotatate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lutetium-lu-177-satoreotide-tetraxetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lymphokine-activated-killer-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lysine-specific-demethylase-1-inhibitor-incb059872
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lyso-thermosensitive-liposome-doxorubicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ma-zi-ren-wan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macimorelin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/macrogol-3350-based-iso-osmotic-laxative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mafosfamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-3a1-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a1-mage-a3-ny-eso-1-peptides-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mage-a3-expressing-adenovirus-type-5-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-isoglycyrrhizinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-l-threonate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-oxide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magnesium-valproate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/magrolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mai-dong
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maltodextrin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mannitol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/manuka-honey
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mapatumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/margetuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/marizomib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mart-1-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masitinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/masoprocol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/matuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavelertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maveropepimut-s
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mavorixafor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/maytansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-azd5991
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mcl-1-inhibitor-mik665
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-fish-oil-omega-3-fatty-acid-lipid-emulsion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mct-lct-lipid-emulsion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdm2-antagonist-ro5045337
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mdr-modulator-cbt-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/megestrol-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-1-mekk-1-inhibitor-e6201
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-gdc-0623
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mek-inhibitor-rec-4881
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melitac-121-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melk-inhibitor-ots167
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/meloxicam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-flufenamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/melphalan-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mercaptopurine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/merestinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/met-tyrosine-kinase-inhibitor-bms-777607
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metformin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methotrexate-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methoxyamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylmercaptopurine-riboside
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/methylprednisolone-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoclopramide-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/metoprine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mevociclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/midostaurin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milademetan-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/milatuzumab-doxorubicin-antibody-drug-conjugate-immu-110
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mimotope-p10s-padre-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mipicoledine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mipsagargin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/miransertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirdametinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mirvetuximab-soravtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/misonidazole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitazalimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitochondrial-oxidative-phosphorylation-inhibitor-atr-101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitomycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mitoxantrone-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivavotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mivebresib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mknk1-inhibitor-bay-1143269
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mnsod-mimetic-bmx-001
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mobocertinib-succinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mocetinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modakafusp-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vaccinia-virus-ankara-vaccine-expressing-p53
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/modified-vitamin-d-binding-protein-macrophage-activator-ef-022
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/momelotinib-dihydrochloride-monohydrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monalizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monocarboxylate-transporter-1-inhibitor-azd3965
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/monosialotetrahexosylganglioside
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-51-vg
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/montanide-isa-720
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motesanib-diphosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motexafin-gadolinium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motixafortide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/motolimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/moxetumomab-pasudotox
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mps1-inhibitor-bay-1217389
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-lung-cancer-vaccine-bi-1361849
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mrna-derived-prostate-cancer-vaccine-cv9104
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtf-1-inhibitor-apto-253-hcl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-azd8055
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor-kinase-inhibitor-cerc-006
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mtor1-2-kinase-inhibitor-me-344
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muc1-targeted-peptide-go-203-2c
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mulnitorsen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-anti-folate-receptor-peptide-vaccine-tpiv-200
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-epitope-folate-receptor-alpha-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multi-neo-epitope-vaccine-ose-2101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-aee788
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/multikinase-inhibitor-at9283
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/muparfostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mutant-p53-activator-coti-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mvx-1-loaded-macrocapsule-autologous-tumor-cell-vaccine-mvx-onco-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/myc-targeting-sirna-dcr-myc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mycophenolate-mofetil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nab-paclitaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nabiximols
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nadofaragene-firadenovec-syn3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/namodenoson
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nandrolone-decanoate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanoparticle-albumin-bound-docetaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nanosomal-docetaxel-lipid-suspension
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/napabucasin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naporafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naquotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naratuximab-emtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/narsoplimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navicixizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navitoclax
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navoximod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navtemadlin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/navy-bean-powder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/naxitamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nazartinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/necitumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedaplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nedd8-activating-enzyme-e1-inhibitor-tas4464
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neihulizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelfinavir-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nelipepimut-s-plus-gm-csf-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nemvaleukin-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nendratareotide-uzatansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-glioblastoma-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neoantigen-based-melanoma-poly-iclc-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/neratinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nesvacumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niacinamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nibrozetone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nilotinib-hydrochloride-monohydrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nimustine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nintedanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/niraparib-tosylate-monohydrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nirogacestat-hydrobromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nisevokitug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nitrogen-mustard-prodrug-pr-104
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nivolumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/noscapine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/notch-signaling-pathway-inhibitor-mk0752
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/nutraceutical-tbl-12
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-gla-se-vaccine-id-g305
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-reactive-tcr-retroviral-vector-transduced-autologous-pbl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ny-eso-1-specific-tcr-gene-transduced-t-lymphocytes-tbi-1301
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o-chloroacetylcarbamoylfumagillol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/o6-benzylguanine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obatoclax-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obinutuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oblimersen-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/obrindatamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ocifisertib-fumarate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/octreotide-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odetiglucan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/odronextamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ofatumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olanzapine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaratumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oleclumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olinvacimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olmutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olvimulogene-nanivacirepvec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omaveloxolone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/omeprazole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onalespib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onartuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onatasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-g207
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv1716
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-measles-virus-encoding-thyroidal-sodium-iodide-symporter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ontorpacept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvatilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/onvitrelin-ucalontide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/opaganib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oportuzumab-monatox
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oprozomib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-azacitidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oral-sodium-phenylbutyrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orantinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oraxol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orilanolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/orteronel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osimertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/osugacestat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxaliplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxidative-phosphorylation-inhibitor-iacs-010759
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxitriptan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oxphos-inhibitor-vlx600
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-inhibitor-pca062
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-cadherin-targeting-agent-pf-06671008
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p-p68-inhibitor-rx-5902
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-cgm097
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-hdm2-interaction-inhibitor-mi-773
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p53-peptide-vaccine-mps-128
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-akt-inhibitor-m-2698
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p70s6k-inhibitor-ly2584702
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/p97-inhibitor-cb-5083
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-poliglumex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-polymeric-micelle-formulation-nant-008
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paclitaxel-trevatide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacmilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pacritinib-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padeliporfin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padnarsertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/padre-cmv-fusion-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pak4-inhibitor-pf-03758309
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palbociclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/palladium-pd-103
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pamiparib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-inhibitor-arq751
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-akt-kinase-inhibitor-gsk690693
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-her-kinase-inhibitor-ac480
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-mutant-idh1-inhibitor-bay-1436032
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-inhibitor-clr457
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pi3k-mtor-inhibitor-sf1126
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-pim-kinase-inhibitor-azd1208
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-inhibitor-ly3009120
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-raf-kinase-inhibitor-cct3833
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-trk-inhibitor-ono-7579
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pan-vegfr-tie2-tyrosine-kinase-inhibitor-cep-11981
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/panobinostat-lactate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parp-inhibitor-cep-9722
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/parsaclisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patidegib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patisiran
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patritumab-deruxtecan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/patupilone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/paxalisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pazopanib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pd-l1-pd-l2-vista-antagonist-ca-170
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pdcd-1-knockout-autologous-t-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pe-hpv16-e7-kdel-fusion-protein-gpi-0100-tvgv-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peb-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peg-pei-cholesterol-lipopolymer-encased-il-12-dna-plasmid-vector-imnn-001
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegargiminase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegaspargase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegcetacoplan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegilodecakin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegvorhyaluronidase-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-interferon-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-liposomal-doxorubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegylated-recombinant-human-arginase-i-bct-100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pegzilarginase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pelabresib-anhydrous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pembrolizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemetrexed-disodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemigatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pemlimogene-merolisbac
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pentostatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-3-klh-conjugate-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pep-cmv-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pepinemab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peposertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/peretinoin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/perifosine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/personalized-genomic-vaccine-001
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pertuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/petrolatum-mineral-oil-lanolin-ceresin-ointment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pevonedistat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexastimogene-devacirepvec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pexidartinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/phytochemical
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-alpha-beta-inhibitor-bay1082439
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-beta-inhibitor-gsk2636771
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-delta-inhibitor-amg-319
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-acp-319
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-inhibitor-zstk474
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3k-p110beta-delta-inhibitor-cvl237
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pi3kbeta-inhibitor-azd8186
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/picropodophyllin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pictilisib-bismesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pidilizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pilaralisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-flt3-kinase-inhibitor-sel24
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pim-kinase-inhibitor-lgh447
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimitespib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pimonidazole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pinometostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pirotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pixantrone-dimaleate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pladienolide-derivative-e7107
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plamotamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plerixafor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plicamycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plinabulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plixorafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plk1-inhibitor-bi-2536
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/plozalizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polatuzumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-ic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poly-iclc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polyethylene-glycol-3350-containing-enema-ner1008
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pomalidomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ponatinib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-etc-1922159
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/porcupine-inhibitor-wnt974
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/povidone-iodine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/poziotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pralsetinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/praluzatamab-ravtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prame-targeting-t-cell-receptor-inducible-caspase-9-bpx-701
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisolone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prednisone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/preimplantation-factor-pif-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/prexigebersen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/proflavine-hemisulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/promethazine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/protein-phosphatase-2a-inhibitor-lb-100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-docetaxel-nanoparticles-bind-014
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/psma-targeted-tubulysin-b-containing-conjugate-ec1169
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ptvg-hp-plasmid-dna-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pulrodemstat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrazofurin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyridoxine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyrotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/pyruvate-kinase-inhibitor-tln-232
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quaratusugene-ozeplasmid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quercetin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinacrine-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quinine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/quisinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r---gossypol-acetic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/r-chop-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rabusertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racemetyrosine-methoxsalen-phenytoin-sirolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/racotumomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radium-ra-223-dichloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radix-angelicae-sinensis-radix-astragali-herbal-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/radotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raf-kinase-inhibitor-xl281
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ragifilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralaniten-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ralimetinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/raloxifene-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramosetron-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ramucirumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rasdegafusp-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravoxertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ravulizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/razoxane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/realgar-indigo-naturalis-formulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rebastinib-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-adenovirus-encoding-p53
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-ephb4-hsa-fusion-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-globulin-component-macrophage-activating-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-adenovirus-type-5-h101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-albumin-human-granulocyte-colony-stimulating-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-egf-rp64k-montanide-isa-51-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-endostatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-human-papillomavirus-nonavalent-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-alfa-2b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-interferon-beta
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-oncolytic-poliovirus-pvs-ripo
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/recombinant-super-compound-interferon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/refametinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/regorafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relacorilant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/relatlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/remetinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/renal-cell-carcinoma-peptides-vaccine-ima901
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/renvistobart
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/reparixin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/repotrectinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/resveratrol-formulation-srt501
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rezvilutamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ribociclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ricolinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ridaforolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rigosertib-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilimogene-galvacirepvec-rilimogene-glafolivec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rilotumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rimiducid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rindopepimut
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rineterkib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rintatolimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ripretinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rituximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/riviciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivoceranib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rivogenlecleucel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rnr-inhibitor-coh29
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roblitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rocakinogene-sifuplasmid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roducitabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rogaratinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolapitant-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rolinsatamab-talirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/romidepsin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/roniciclib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropeginterferon-alfa-2b
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ropidoxuridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rose-bengal-solution-pv-10
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rosmantuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rovalpituzumab-tesirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-camsylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rucaparib-phosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruthenium-ru-106
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxolitinib-phosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ruxotemitide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/s-adenosyl-l-methionine-disulfate-p-toluene-sulfonate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saccharomyces-boulardii-probiotic-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sacituzumab-govitecan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/safingol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sagopilone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salirasib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salmonella-vnp20009
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/salvia-officinalis-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sam68-modulator-cwp232291
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samalizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samarium-sm-153-lexidronam-pentasodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samotolisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/samrotamab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapanisertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sapitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saponin-based-immunoadjuvant-obi-821
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/saracatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sargramostim
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sasanlimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/savolitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sb-as15-adjuvant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-androgen-receptor-modulator-ly2452473
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-azd9496
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selective-estrogen-receptor-degrader-lsz102
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selicrelumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selinexor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selonsertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selpercatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/selumetinib-sulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/semustine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seneca-valley-virus-001
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/senna-fruit
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sepantronium-bromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serabelisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serdemetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seribantumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serine-threonine-kinase-inhibitor-cbp501
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sertraline-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/serum-derived-bovine-immunoglobulin-protein-isolate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/seviteronel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/shark-cartilage-extract-ae-941
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sheddase-inhibitor-incb007839
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sig12d-loder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/silmitasertib-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simlukafusp-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simo-decoction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/simurosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sinecatechins
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sintilimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sipuleucel-t
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/siremadlin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirolimus-albumin-bound-nanoparticles
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sirtratumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sitravatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smac-mimetic-lcl161
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/smoothened-antagonist-bms-833923
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-dichloroacetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-hyaluronate-topical-hydrogel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-metaarsenite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sodium-phosphate-sodium-biphosphate-laxative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sofituzumab-vedotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/solitomab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonepcizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonidegib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sonolisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sorafenib-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotatercept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotigalimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sotuletinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sovleplenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-isoflavones
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/soy-protein-isolate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spartalizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spebrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/spherical-nucleic-acid-nanoparticle-nu-0129
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/splicing-inhibitor-h3b-8800
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sr-t100-gel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ss1dsfv-pe38-immunotoxin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat-inhibitor-opb-111077
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-31121
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-opb-51602
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/stat3-inhibitor-wp1066
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sterile-distilled-water
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-activating-cyclic-dinucleotide-agonist-miw815
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/streptozocin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulanemadlin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulfatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sulforaphane-cyclodextrin-complex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sumatriptan-succinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sunitinib-malate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/supersaturated-calcium-phosphate-rinse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suramin-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/suratadenoturev
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/svn53-67-m57-klh-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/synthetic-htert-dna-vaccine-ino-1400
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/t1e28z-car-expressing-autologous-cd4-positive-t-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tac-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tacrolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tagraxofusp-erzs
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talacotuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talactoferrin-alfa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taladegib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talazoparib-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taletrectinib-adipate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/talimogene-laherparepvec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamibarotene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taminadenant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamnorzatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamoxifen-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tamrintamab-pamozirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanespimycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tanezumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tapotoclax
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarextumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tarp-27-35-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tasadenoturev
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taselisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taurolidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tavolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/taxane-analogue-tpi-287
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tazemetostat-hydrobromide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tebentafusp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-albumin-aggregated
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-dtpa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-human-serum-albumin-colloid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-hydroxydiphosphonate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-mebrofenin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-medronate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/technetium-tc-99m-sulfur-colloid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teclistamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-gimeracil-oteracil-potassium-leucovorin-calcium-oral-formulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telaglenastat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telapristone-acetate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telotristat-etiprate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/telratolimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temozolomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temsirolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/temuterkib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tenalisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tepotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/teprotumumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tertomotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesetaxel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tesevatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetrahydrouridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tetravalent-rna-lipoplex-cancer-vaccine-bnt111
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tgfbeta-inhibitor-ly3200882
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thalidomide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-allogeneic-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-autologous-dendritic-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/therapeutic-tumor-infiltrating-lymphocytes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioguanine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioredoxin-1-inhibitor-px-12
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thiotepa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thioureidobutyronitrile
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thl-p
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/thymopentin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tigatuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/til-1383i-t-cell-receptor-transduced-autologous-t-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilsotolimod-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/timonacic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinidazole
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tinostamustine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-choline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tiomolibdate-diammonium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tipifarnib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirabrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirapazamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tirbanibulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tisagenlecleucel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tislelizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivantinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tivozanib-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-g100
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr4-agonist-gsk1795091
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr7-agonist-852a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-imo-2055
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tlr9-agonist-sd-101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocilizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tocotrienol-rich-fraction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tolinapant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomaralimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tomivosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-keratin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-myristyl-nicotinate-cream
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topical-wound-spray-hp802-247
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-1-inhibitor-lmp744
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topoisomerase-i-ii-inhibitor-nev-801
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/topsalysin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/torc1-2-kinase-inhibitor-ds-3078a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tosedostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tovorafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozasertib-lactate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tozuleristide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabectedin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trabedersen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trametinib-dimethyl-sulfoxide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trans-sodium-crocetinate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-crm107
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-anti-rrm2-sirna-calaa-01
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/transferrin-receptor-targeted-liposomal-p53-cdna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-deruxtecan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-duocarmazine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trastuzumab-emtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trebananib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tremelimumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tretinoin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triamcinolone-acetonide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triapine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/triciribine-phosphate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trifluridine-and-tipiracil-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tris-acryl-gelatin-microspheres
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trivalent-influenza-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trodusquemine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/trofosfamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tsp-1-mimetic-abt-510
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucatinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucidinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tucotuzumab-celmoleukin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tusamitamab-ravtansine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tyrosine-kinase-inhibitor-xl228
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uae-inhibitor-tak-243
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ublituximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulevostinag
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulixertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ulocuplumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/umbralisib-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uncaria-tomentosa-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/unesbulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uniformly-labeled-13cglucose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uproleselan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uprosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uracil-ointment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/urelumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ursodiol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/usp14-uchl5-inhibitor-vlx1570
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/utatrectinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uv1-telomerase-peptide-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/uzansertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vac-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vaccinia-virus-dd-cdsr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vactosertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vadastuximab-talirine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valacyclovir-hydrochloride
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valemetostat-tosylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/valproic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vamotinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vamp-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vandetanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vantictumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varicella-zoster-virus-strain-oka-merck-live-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlilumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/varlitinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vatalanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vecabrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegf-hgf-targeting-darpin-mp0250
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-2-dna-vaccine-vxm01
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vegfr-fgfr-inhibitor-odm-203
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veliparib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/veltuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vemurafenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venetoclax
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/venlafaxine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vepoloxamer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/viagenpumatucel-l
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vibecotamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vibostolimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vidutolimod
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vimseltinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vincristine-sulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vindesine-sulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vinorelbine-tartrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vismodegib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vistusertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitamin-k1-containing-urea-skin-cream
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vitespen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vixtimotamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vocimagene-amiretrorepvec
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vofatamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volasertib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/volociximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vopratelimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorasidenib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/vorolanib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/voxtalisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/water-o-15
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wheatgrass-juice
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/white-button-mushroom-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wnt-5a-mimic-hexapeptide-foxy-5
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-a10-as01b-immunotherapeutic-gsk2130579a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-ocv-501
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-peptide-vaccine-wt2725
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wt1-protein-derived-peptide-vaccine-dsp-7888
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/wu-ling-san
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xbp1-us-xbp1-sp-cd138-cs1-multipeptide-vaccine-pvx-410
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xeliri-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xelox-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xentuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xevinapant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/xianling-gubao
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-anti-cdh3-monoclonal-antibody-ff-21101
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-clivatuzumab-tetraxetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-ibritumomab-tiuxetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/yttrium-y-90-tabituximab-barzuxetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zabadinostat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zalifrelimab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zandelisib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanidatamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zanubrutinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zelavespib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zilovertamab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinc-gluconate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zinostatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zirconium-zr-89-trastuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ziv-aflibercept
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoledronic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zorifertinib
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zoster-vaccine-recombinant-adjuvanted
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zotiraciclib-citrate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/131i-mibg
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/18f-fes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/18f-naf-pet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/21-gene-signature
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/34-benzpyrene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/3d-crt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/3t-mri
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/5-fluorouracil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/5q-minus-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/70-gene-signature
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abcd-rating
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abdominal-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abdominoperineal-resection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aberrant-crypt-foci
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abi-007
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abo-blood-group-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/absolute-neutrophil-count
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/absolute-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abve-pc-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ac-t-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ac-taxol-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ac-th-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/accelerated-fraction-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/accelerated-partial-breast-irradiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/accelerated-phase-chronic-myelogenous-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/accelerated-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acetyl-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acetyl-l-carnitine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/active-surveillance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/activities-of-daily-living
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acute-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acute-lymphoblastic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acute-myeloid-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acute-nonlymphocytic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/acute-promyelocytic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adcc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenocarcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenoid-cystic-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenopathy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenosquamous-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adi-peg-20
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjunct-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjunct-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjunctive-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adjuvant-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adnexal-mass
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adoptive-cell-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adrenal-gland
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/advanced-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adverse-effect
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adverse-event
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aerobic-metabolism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aerodigestive-tract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/agc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aggressive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aggressive-fibromatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/agnogenic-myeloid-metaplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/agus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ais
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/akt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alk-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alkylating-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/all
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/all-trans-retinoic-acid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allogeneic-bone-marrow-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allogeneic-stem-cell-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allopathic-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alopecia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alpha-emitter-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alternative-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/alveoli
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/amelanotic-melanoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/amg-162
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aml
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ammonium-tetrathiomolybdate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/amoxicillin-clavulanate-potassium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ampullary-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/amputation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/amyloidosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anaplastic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anaplastic-large-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anaplastic-lymphoma-kinase-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ancillary-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/androblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/androgen-deprivation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/androgen-independent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/androgen-receptor-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiofibroma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiofollicular-lymph-node-hyperplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiogenesis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiogenesis-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiomyolipoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/angiosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/animal-model
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/animal-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anll
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ans
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antagonist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anterior-mediastinotomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anterior-pelvic-exenteration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anthracenedione
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anthracycline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anti-ccr2-monoclonal-antibody-mln1202
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anti-idiotype-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anti-inflammatory-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antiandrogen-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antiangiogenesis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antiapoptotic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antibody-drug-conjugate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antibody-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anticancer-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anticarcinogenic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antiemetic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antiestrogen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antifolate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antimetabolite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antimicrotubule-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antimitotic-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antineoplastic-antibiotic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antioncogene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antisense-oligonucleotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/antitumor-antibiotic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anxiolysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aplastic-anemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/apocrine-gland
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/apoptosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/areola
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/argon-beam-coagulator-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aromatase-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/arrhenoblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/arterial-embolization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/asc-h
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ascites
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ascus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aspirate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/assay
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/asthenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/astrocytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/asymptomatic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/athymic-nude-mouse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atra
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atypia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atypical-glandular-cells
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atypical-glandular-cells-of-undetermined-significance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atypical-squamous-cells-cannot-exclude-a-high-grade-lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/atypical-squamous-cells-of-undetermined-significance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/aurimmune
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/autoimmune-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/autologous-stem-cell-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/autologous-tumor-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/autophagy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/avastin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/axillary-lymph-node
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/azq
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-cell-acute-lymphoblastic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/b-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/balloon-catheter-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/barium-swallow
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/basal-cell-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/basal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/baseline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/basophil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bbbd
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bcl2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bcr-abl-fusion-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bellini-duct-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bence-jones-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bench-to-bedside
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-breast-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-proliferative-breast-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-prostatic-hyperplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-prostatic-hypertrophy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benign-vascular-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/benzoapyrene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/beta-cell-tumor-of-the-pancreas
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/beta-hcg
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/betel-quid-with-tobacco
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bevacizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bi-rads
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biafine-cream
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bilateral-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bilateral-nephrectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bilateral-salpingo-oophorectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biliary-bypass
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biliary-tract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/binding-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bioactive-compound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biochemical-reactions
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biochemical-recurrence
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biochemical-relapse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biologic-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biological-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biological-drug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biological-response-modifier-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biological-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomedicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biopsy-specimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biorepository
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biospecimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biotin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bivalent-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bladder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bladder-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blast-crisis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blastic-phase-chronic-myelogenous-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blinded-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-brain-barrier
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-cell-count
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-chemistry-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-chemistry-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-stasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-stem-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/blood-transfusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bolus-dose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-aspiration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-aspiration-and-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-marrow-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-mass
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-mineral-density
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bone-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/boron-neutron-capture-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brachytherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/braf-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/braf-v600-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brain-metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brain-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brca1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brca2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brcapro
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breakthrough-pain
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-conserving-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-density
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-duct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-lobe
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-lobule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-self-exam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breast-sparing-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/breslow-thickness
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/brm-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bronchial-brush-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bronchial-washing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bronchogenic-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bronchoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/buccal-mucosa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/burkitt-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/burkitt-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/butane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/c-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/c-erbb-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/c-erbb-2-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/c-kit
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ca-125
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ca-19-9
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ca-19-9-assay
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ca-2729
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cachexia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cad
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/calcification
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/calcium-infusion-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cancer-antigen-125
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cancer-cell-line
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cancer-subtype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cannabinoid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/capecitabine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/capillary
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/capillary-leak-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/capiri-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/capsule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/car-t-cell-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carbo-tax-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carbon-c-11-choline-pet-ct-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinoembryonic-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinogenesis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinoid-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinomatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinomatous-meningitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carcinosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cardiotoxicity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carina-of-trachea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/carney-stratakis-dyad
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/case-control-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/case-report
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/case-series
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/castrate-resistant-prostate-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/catecholamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cause-specific-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cbc-with-differential
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ccsg
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cd20-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cd34-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cd4-positive-t-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cea-assay
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cecum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cediranib-maleate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-culture
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-cycle-regulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-differentiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-motility
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-proliferation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cell-to-cell-signaling
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cellular-metabolism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/centers-for-disease-control-and-prevention
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/central-venous-access-catheter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cerebral-hemisphere
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cerebrospinal-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cerebrospinal-fluid-diversion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cervical-adenocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cervical-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cervical-dysplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cervical-squamous-intraepithelial-neoplasia-2-3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cervix
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chamberlain-procedure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemical-imbalance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoembolization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoimmunotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoprevention
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoprotective-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoradiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoradiotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemoreduction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemosensitivity-assay
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemotherapeutic-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chest-x-ray
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/childhood-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chimeric
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chimeric-antigen-receptor-t-cell-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chinese-meridian-theory
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chloroma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cholangiocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cholangiosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chondrosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chope-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chorioadenoma-destruens
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/choriocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chorioepithelioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chorionic-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chromogranin-a
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chromosome-17
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-granulocytic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-idiopathic-myelofibrosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-myeloid-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-phase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cin-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cin-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cin-2-3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cin-3
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cisplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clark-level-iii-skin-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clark-level-iv-skin-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clark-level-v-skin-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clear-cell-adenocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clear-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clear-cell-sarcoma-of-the-kidney
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-breast-exam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-resistance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-stage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-staging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/clinical-trial-sponsor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cll
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cll-sll
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cml
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cns-prophylaxis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cohort-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cold-ischemia-time
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cold-nodule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/collecting-duct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/collective-patient-perspective
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/coloanal-anastomosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/coloanal-pull-through
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colon-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colon-crypt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colon-polyp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colonoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colorectal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/colposcopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/combination-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/combined-androgen-blockade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/comedo-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/common-bile-duct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/common-hepatic-duct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/comorbidity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/compassionate-use
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complementary-and-alternative-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complementary-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complete-blood-count
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complete-hysterectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complete-remission
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/complete-response
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/composite-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/compound-nevus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/comprehensive-cancer-center
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/concomitant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/concurrent-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conditioning-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cone-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/consecutive-case-series
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/consolidation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/constitutional-dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/contiguous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/continuous-infusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/continuum-of-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/contralateral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/contrast-esophagram
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/contrast-material
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/control-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/controlled-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/controlled-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conventional-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conventional-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/conventional-treatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/coping-skills
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/core-needle-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/coronary-artery-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cp-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/craniotomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/crpc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cryosurgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cryotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/csf
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/css
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ct-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ctla-4
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ctx
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cumulative-dose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cumulative-exposure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cumulative-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/curative-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cutaneous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cutaneous-t-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cva
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cyclophosphamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cyst
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cystoprostatectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytochrome-p450-enzyme-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytogenetics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytokeratin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytokine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytoplasm
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytostatic-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytotoxic-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytotoxic-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytotoxic-t-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/cytotoxic-t-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dark-field-microscope
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dcis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/de-gramont-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/de-novo
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/de-qi-sensation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/death-rattle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/debulking
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/deferred-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/definitive-diagnosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/definitive-treatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/degenerative-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/delayed-type-hypersensitivity-response
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dendritic-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dendritic-cell-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/desmoid-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/desmoid-type-fibromatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/developmental-stage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dexa-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dfs
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dhl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diagnosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diagnostic-procedure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diagnostic-technique
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diagnostic-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dietary-counseling
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/differentiating-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/differentiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diffuse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diffuse-hyperplastic-perilobar-nephroblastomatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diffuse-intrinsic-pontine-glioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/diffuse-large-b-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/digital-rectal-examination
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dilation-and-curettage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/disease-free-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/disease-progression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/disease-specific-survival-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/disseminate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distal-colon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distal-urethra
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distant-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distant-metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/distress
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dna-cross-linking-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dna-intercalating-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/donor-lymphocyte-infusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dose-dense-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dose-dependent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dose-limiting
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/double-blind-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/double-contrast-barium-enema
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/doubling-time
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-accountability-record
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-resistance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/drug-tolerance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ductal-carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ductal-intraepithelial-neoplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dukes-c-colorectal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/duodenum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dysgerminoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dysgeusia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dysphagia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dysplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dysplastic-nevus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/dyspnea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/e-cigarette
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/early-stage-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/early-stage-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ectocervix
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/edta
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/efs
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egfr-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/egg-freezing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/eklund-displacement-views
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/electrodiathermy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/electrofulguration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/electronic-medical-record
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/eligibility-criteria
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/embolization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/embryonal-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/encapsulated
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/end-of-life-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/end-stage-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endocervical-curettage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endocervix
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endocrine-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endocrine-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endometrial-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endometrial-hyperplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endorectal-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endorphin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endoscopic-ultrasound-guided-fine-needle-aspiration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endothelial-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/endpoint
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/energy-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ent-doctor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/enveloped-virus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/environmental-tobacco-smoke
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ephedra
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epidemiology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epidermal-growth-factor-receptor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epidermoid-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epigenetic-alteration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epigenetics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epimutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epithelial-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epithelial-ovarian-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/epstein-barr-virus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/erus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/erythroid-dysplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/erythroleukoplakia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/esophageal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/esophageal-stent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/esophagogastroduodenoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/esophagoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/estrogen-blocker
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/estrogen-receptor-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/estrogen-receptor-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ethanol-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/etiology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/euphoria
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/eus-fna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/evaluable-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/evaluable-patients
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/event-free-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/everolimus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ex-vivo
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/excisional-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/expectant-management
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/experimental-drug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/exploratory-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extensive-stage-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/external-beam-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/external-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extrahepatic-bile-duct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extranodal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extraosseous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extraosseous-osteosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extravasation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extremely-dense-breast-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/eye-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/false-negative-test-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/false-positive-test-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/familial-atypical-multiple-mole-melanoma-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/familial-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fammm-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fat-necrosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fat-soluble-vitamin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fatty-breast-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/febrile-neutropenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fecal-occult-blood-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fertility-preservation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fibroadenoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fibrocystic-breast-changes
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fight-or-flight-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-burden
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-stress
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/financial-toxicity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fine-needle-aspiration-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/first-degree-relative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/first-line-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fish
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/five-year-survival-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/flow-cytometry
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fluorescence-in-situ-hybridization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fluoropyrimidine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fluorouracil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/focal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folate-antagonist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfiri-avastin-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfox
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfox-4-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfox-6-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfox-7-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folfox-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folic-acid-antagonist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/follicular-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/follow-up
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/follow-up-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/follow-up-care-plan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/form-fda-1572-statement-of-investigator
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fosaprepitant-dimeglumine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/free-radical
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/free-radical-scavenger
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/frontal-sinus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ftorafur
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fulguration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fungating-lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fusion-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/fusion-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gallbladder-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gamma-knife-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gardasil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gastric-acid-secretion-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gastric-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gastric-mucosal-hypertrophy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gastric-scirrhous-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene-amplification
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene-deletion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene-expression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene-expression-profile
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gene-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genetic-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genetic-marker
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genetic-profile
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genetic-susceptibility
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genetic-testing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genitourinary-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genome-wide-association-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genomic-characterization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genomic-profiling
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/genomics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/germ-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/germ-cell-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/germline-dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/germline-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gerotas-fascia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gfobt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/giant-cell-fibroblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/giant-cell-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gleason-score
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/glial-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/glioblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/glioblastoma-multiforme
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/glioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gold-fiducial-markers
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gold-seed-fiducial-markers
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gold-seeds
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/golgi-complex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gonadotropin-releasing-hormone-agonist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/grade-1-follicular-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/grading
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/graft-versus-host-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/graft-versus-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/granulocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/green-tea-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/growth-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gut-flora
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/gynecologic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/halsted-radical-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hamartoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hand-foot-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hard-palate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hazard-ratio
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hboc-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hca
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/head-and-neck-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/healthy-control
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heart-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heart-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heat-shock-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/helical-computed-tomography
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/helical-tomotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hemangiosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematologic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematopoiesis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematopoietic-stem-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hematopoietic-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heme
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hemoglobin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hemorrhagic-cystitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heparin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hepatic-arterial-occlusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hepatic-veno-occlusive-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hepatocellular-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/her1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/her2-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/her2-neu
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/her2-neu-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/her2-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/herceptin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hereditary-cancer-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heterocyclic-amine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heterogeneous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/heterogeneously-dense-breast-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-dose-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-dose-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-grade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-grade-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-grade-squamous-intraepithelial-lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-risk-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/high-risk-hpv
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/highly-active-antiretroviral-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/histologic-examination
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/histologic-grade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/histology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/histopathology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/historical-control-subject
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hiv-rna-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hiv-window-period
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hodgkin-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/homeostasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormonal-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormone-receptor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormone-refractory
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormone-replacement-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hormone-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/host-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hotspot
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hpv
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hpv-pap-cotest
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hpv-rna-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hpv-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hsil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/htlv-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-epidermal-growth-factor-receptor-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-epidermal-growth-factor-receptor-2-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-epidermal-growth-factor-receptor-2-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-herpesvirus-8
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-leukocyte-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-lymphocyte-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-papillomavirus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/human-t-cell-leukemia-virus-type-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/humanized-monoclonal-antibody
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/humor-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hydroureter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hydroxydaunorubicin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperalimentation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperbaric-oxygen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypercalcemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperfractionated-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperfractionation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperkeratosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypernephroma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hyperthermia-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypervascular
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypofractionated-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypofractionation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hypogammaglobulinemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/hysterectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/idiopathic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/idiopathic-pneumonia-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ifobt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/igfr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ih636-grape-seed-extract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ileum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/imaging-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/imatinib-mesylate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immature-teratoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immune-checkpoint-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immune-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunoassay-fecal-occult-blood-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunochemical-fecal-occult-blood-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunocompetent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunocompromised
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunocytochemistry
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunoglobulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunohistochemistry
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunologic-fecal-occult-blood-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunomodulating-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunomodulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunophenotyping
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunosuppression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunosuppressive-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/imodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/implant-displacement-views
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/implant-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/in-transit-metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/in-vitro
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/in-vivo
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/incidence
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/indication
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/indolent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/indolent-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/induction-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/infiltrating-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/infiltrating-ductal-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/inflammatory-myofibroblastic-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/informed-consent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/infusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/inoperable
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/institutional-review-board
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/insulin-like-growth-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/integrative-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intensification-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intensity-modulated-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intercellular-communication
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interferon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interleukin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interleukin-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interleukin-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interleukin-6
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intermediate-grade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/internal-exam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/internal-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interstitial-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/interstitial-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intervention-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intestinal-microflora
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intestinal-obstruction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intra-arterial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intracavitary-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intraductal-breast-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intrahepatic-bile-duct-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intralesional
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intraoperative-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intrathecal-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intratumoral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intravasation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intravenous-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intravenous-infusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intravenous-injection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/intraventricular-infusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/invasive-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/invasive-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/invasive-cervical-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/invasive-ductal-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/invasive-procedure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/inverted-papilloma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/investigational-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/investigational-drug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/involuntary-nervous-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ipilimumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ipsilateral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/irb
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ischemic-necrosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/isointense
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/j-pouch-coloanal-anastomosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/jamshidi-needle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/jejunum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/junctional-nevus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kahler-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/karnofsky-performance-status
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/keratin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ketogenic-diet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/keytruda
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kidney-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/killer-t-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kinaret
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kinase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kinase-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/klatskin-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kps
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kras-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/krukenberg-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/kymriah
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laboratory-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laboratory-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lactoferrin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lamina-propria
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laparoscopic-assisted-colectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/large-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/large-granular-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/large-intestine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laryngeal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laser-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/late-effect
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/late-stage-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/latency-period
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/latent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/laughter-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lcis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lead-compound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/led-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leep
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leiomyoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leiomyosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leptomeningeal-metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leukapheresis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leukemic-meningitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leukocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/leukopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lh-rh
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lifetime-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/limb-salvage-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/limb-sparing-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/linitis-plastica
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lipoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liquid-based-pap-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liquid-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/liver-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lobectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lobular-capillary-hemangioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lobular-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lobular-intraepithelial-neoplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/local-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/localized
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/localized-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/locally-advanced-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/locally-recurrent-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/long-term-side-effect
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/low-grade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/low-grade-fibromyxoid-sarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/low-grade-squamous-intraepithelial-lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/low-risk-human-papillomavirus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/low-tar-cigarette
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lphl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lsil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lumen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lumpectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lung-function
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/luteinizing-hormone-releasing-hormone-agonist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-node
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-node-dissection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymph-vessel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphadenectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphadenopathy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphangiosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphangitic-carcinomatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphatic-basin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphatic-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphatic-mapping
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphatic-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphedema
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphocytic-leukopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphoepithelioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphomatous-meningitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphoplasmacytic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphoproliferative-disorder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphoscintigraphy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphostatic-elephantiasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lynch-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lyrica
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lytic-lesion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/macrocalcification
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/macrophage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/magnetic-resonance-imaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/magnetic-resonance-spectroscopic-imaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mainstream-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mainstream-smoke
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/maintenance-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/male-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignancy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-ascites
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-ectomesenchymoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-fibrous-cytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-fibrous-histiocytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-pericardial-effusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-peripheral-nerve-sheath-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-peritoneal-effusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-pleural-effusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malignant-triton-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/malondialdehyde
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mammalian-target-of-rapamycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mammary-dysplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mammogram
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mammosite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/manipulative-and-body-based-practice
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mannitol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mantle-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/manual-healing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/margin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/marginal-zone-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mass
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mast-cell-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/matrix-metalloproteinase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mature-t-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mature-teratoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/maxillary-sinus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/maximum-tolerated-dose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mayo-clinic-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mbl
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mds
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mdx-010
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mean-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/measurable-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/medial-supraclavicular-lymph-node
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/median-overall-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/median-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mediastinal-pleura
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/medical-history
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/medical-nutrition-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/medical-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/medulloblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melan-a-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melanocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melanoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/melanoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/men2b-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/meningeal-carcinomatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/meningeal-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/meningeal-metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/meningeal-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/meningioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/menthol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/merkel-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mesenchymal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mesothelin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mesothelioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metabolic-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metabolite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metaplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metastasectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metastasize
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metastatic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metasynchronous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/methotrexate-sodium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/methyl-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/metronomic-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microcalcification
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microfluidic-device
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/micrometastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microsatellite-instability
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microsatellite-instability-high-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/microwave-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/millimeter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mind-body-exercise
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mind-body-modality
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/minimally-invasive-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mismatch-repair-deficiency
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mithramycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mitosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mitotic-activity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mitotic-index
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mitotic-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mitotic-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mmmt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modality
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modified-folfox-6
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modified-folfox-6-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modified-radical-hysterectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modified-radical-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/modified-radical-vulvectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mohs-micrographic-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mohs-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molar-pregnancy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecular-diagnosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecular-marker
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecular-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecular-pathway
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecular-testing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/molecularly-targeted-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monks-pepper
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monoclonal-antibody
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monoclonal-b-cell-lymphocytosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monoclonal-gammopathy-of-undetermined-significance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monoclonal-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/monotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/montanide-isa-51
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/morbidity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/morphine-sulfate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/morphology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mortality
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mouse-model
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mpl-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mri
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mrna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mtd
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mtor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mucinous-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mucositis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mucous-membrane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mullerian-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multicenter-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multicentric-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multifocal-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multimodality-treatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multiple-myeloma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/multiplicity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/muscle-wasting
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mutagen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mutation-carrier
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mycn-amplification-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myeloablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myeloablative-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelodysplastic-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myeloid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelomatosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelosclerosis-with-myeloid-metaplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelosuppression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelosuppressive-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myopericytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nanoprobe
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/naproxen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nasoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/national-clinical-trials-network
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/natural-history-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/natural-killer-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nci-clinical-trials-cooperative-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/necrosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/negative-axillary-lymph-node
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/negative-test-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neoadjuvant-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neoplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neoplasm
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neoplastic-meningitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nephrectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nerve-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuro-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroendocrine-carcinoma-of-the-skin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroendocrine-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuroma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuromuscular-electrical-stimulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neuropathy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neutropenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/neutrophil
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/niacinamide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nicotine-replacement-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nitrosamine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nitrosourea
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nivolumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nk-lgl-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nk-lgll
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nmri
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/node-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/node-positive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nodular-lymphocyte-predominant-hodgkin-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nodular-parenchyma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nodule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/non-hodgkin-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonavalent-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonconsecutive-case-series
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/noncontiguous-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonfunctioning-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonhematologic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/noninvasive
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonlytic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonmalignant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonmalignant-hematologic-disorder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonmelanoma-skin-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonmetastatic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonrandomized-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nonseminoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nrf2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nuclear-grade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nuclear-magnetic-resonance-imaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nut-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nutrient-dense-food
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nutritional-status
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/nutritional-supplement
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/objective-response
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/observational-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/obstetrics-and-gynecology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/obtundation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/occult-primary-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/occult-stage-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/octreotide-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oculodermal-melanocytosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/odds-ratio
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oligodendroglioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oligofructose-enriched-inulin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oligometastasis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncogene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncology-nurse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncology-pharmacy-specialist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncolysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncolytic-virotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncolytic-virus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncolytic-virus-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oncotype-dx-breast-cancer-assay
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oophoropexy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/opdivo
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/open-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/open-label-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/optical-spectroscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oral-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oral-cavity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oral-cavity-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oropharyngeal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oropharynx
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/orphan-drug-designation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/orthodox-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/orthotopic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/os
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/osteomyelitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/osteopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/osteosarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ovarian-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ovarian-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ovarian-transposition
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overall-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overall-survival-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overdiagnosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overexpress
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/overtreatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oxaliplatin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oxidative-metabolism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/oxygen-saturation-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/p-value
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/p30-cancer-center-support-grant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/p53-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pack-year
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pain-flare
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palliation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palliative-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palliative-sedation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palliative-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palmar-plantar-erythrodysesthesia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/palpable-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancreatic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancreatic-polypeptide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/panhypopituitarism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pap-smear
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pap-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papanicolaou-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papillary-dermis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papillary-serous-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papillary-thyroid-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papillary-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/papilledema
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paraganglia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paraganglioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parageusia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paralytic-ileus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parametrium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paranasal-sinus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paranasal-sinus-and-nasal-cavity-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paraneoplastic-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parathormone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parenchyma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parietal-cell-vagotomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parotid-gland-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/parp-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/partial-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/partial-nephrectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/partial-radical-vulvectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/partial-remission
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/partial-response
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/paterson-kelly-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pathologic-complete-response
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pathological-stage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pathological-staging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pathologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pathology-report
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/patient-advocate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pbsct
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pcr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pd-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pdx
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peak-exposure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peau-dorange
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pecoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pediasure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pediatric-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pedicle-flap
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pedunculated
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peer-reviewed-scientific-journal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peg-asparaginase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peitc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pelvic-exam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pelvic-lymphadenectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pelvic-wall
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pembrolizumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/penile-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/percutaneous-ethanol-injection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/percutaneous-transhepatic-biliary-drainage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/performance-status
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/periampullary-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/perineal-colostomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/perineum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peripheral-blood
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peripheral-blood-smear
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peripheral-blood-stem-cell-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peripheral-neuropathy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peripheral-venous-catheter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peritoneal-cavity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peritoneal-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peritoneal-washing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peritoneum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/personal-history
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/personal-medical-history
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pet-ct-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pet-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/petroleum-jelly
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pfs
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phagocytosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pharmacokinetics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pharyngeal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pharynx
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-i-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-i-ii-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-ii-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-ii-iii-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-iii-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phase-iv-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pheochromocytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/philadelphia-chromosome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phlebotomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/phospholipid-complex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/photon-beam-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/photosensitizing-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pi
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pi3k
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/picc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pilocytic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pinealoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/placebo-controlled
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plaque-radiotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plasma-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plasmacyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/plasmacytic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/platelet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/platelet-derived-growth-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/platinum
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pleomorphic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pleural-effusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pmn
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pnet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pneumonectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pneumonitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polycythemia-vera
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polymerase-chain-reaction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polymeric-enteral-nutrition-formula
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polymorphism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/polymorphonuclear-leukocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/population-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/port-a-cath
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/positive-test-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/positron-emission-tomography-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/posterior-pelvic-exenteration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/postmenopausal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ppnet
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pr-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precancerous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precision-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/preclinical-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precursor-b-lymphoblastic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/predictive-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/premalignant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/premature-death
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pretracheal-space
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prevascular-space
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prevention
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-endpoint
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-peritoneal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-treatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primary-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/primitive-neuroectodermal-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/principal-investigator
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proctosigmoidoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/progesterone-receptor-negative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prognosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prognostic-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/programmed-cell-death
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/progression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/progression-free-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/progressive-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proliferating
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proliferative-index
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prophylactic-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prospective-cohort-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/prostate-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proteasome-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/protein-expression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/protein-signature
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proteomic-profile
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proto-oncogene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/protocol
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proton-beam-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proton-magnetic-resonance-spectroscopic-imaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proximal-colon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/proximal-urethra
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/psa-bounce
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/psa-failure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/psa-velocity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/psammoma-body
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pseudomyxoma-peritonei
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/psychosocial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/punch-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/quadrantectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/quadrivalent-vaccine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/quality-of-life
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/quinone-reductase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/r-chop
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiation-necrosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiation-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiation-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-cervicectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-hysterectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-local-excision
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-lymph-node-dissection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-nephrectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-prostatectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-retropubic-prostatectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radical-vulvectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioactive-drug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioactive-glucose
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioactive-iodine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiofrequency-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioimmunoconjugate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioimmunotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioisotope
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiologic-exam
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiopharmaceutical
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radioprotective-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiosensitization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiosensitizer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiosensitizing-agent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/raftilose-synergy-1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/randomization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/randomized-clinical-trial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rapamycin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rapid-onset-opioid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ras-gene-family
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rbc
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reactive-oxygen-species
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reagent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/recist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/recombinant-human-interleukin-2
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/recombinant-tissue-plasminogen-activator
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rectal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rectal-reconstruction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/recurrence
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/recurrent-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/red-blood-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reed-sternberg-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/refractory-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/regional-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/regional-enteritis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/regional-lymph-node
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/regional-lymph-node-dissection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/regression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rehabilitation-services
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relapse
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relapse-free-survival
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relative-odds
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relative-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relative-survival-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relaxation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/remission
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/remission-induction-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/renal-cell-adenocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/renal-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/renal-function-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reproductive-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reproductive-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/research-base
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/research-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/resectable
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/resection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/resectoscope
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/residual-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/resistant-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/respiratory-tract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/response-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/restaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/reticular-dermis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/retromolar-trigone
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/retroperitoneal
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/retrospective-cohort-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/retrospective-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rfs
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rhabdoid-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/richter-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/richter-transformation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/risk-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/risk-group
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/risk-ratio
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ros1-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/roswell-park-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rotationplasty
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/s-phase-fraction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/salvage-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sarcomatoid-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/satellite-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/saturated-fat
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scar-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scatter-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scattered-fibroglandular-breast-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scf
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/schiller-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/schwannoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scientific-review-committee
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/scintigraphy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sclerosing-adenosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/screening-mammogram
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/second-degree-relative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/second-line-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/second-look-surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/second-primary-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/secondary-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/secondary-ovarian-failure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/secondary-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/segmental-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/segmental-resection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/segmentectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/selection-bias
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/seminal-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/seminoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/senile-keratosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sensitivity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sentinel-lymph-node-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sentinel-lymph-node-mapping
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sequential-treatment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/seroma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/serosa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/serotonin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/serum-glutamic-oxaloacetic-transaminase
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/severe-myelosuppression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sex-cord-gonadal-stromal-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sex-cord-stromal-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sham-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/short-term-side-effect
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/shunt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/side-effect
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sideropenic-dysphagia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sidestream-smoke
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sigmoid-colon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sigmoidoscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/signal-transduction-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/signaling-pathway
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/signature-molecule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/signet-ring-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/simple-vulvectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/single-blind-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/single-nucleotide-polymorphism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/single-photon-emission-computed-tomography
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sinusoidal-obstruction-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sipple-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/skin-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/skin-stimulation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/skin-vesicle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sleeve-lobectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sleeve-resection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/small-lymphocytic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/small-molecule-drug
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/smoking-cessation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/smoldering-myeloma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/snp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/social-support
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/soft-tissue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/solid-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/somatic-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/somatomedin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/somatostatin-receptor-scintigraphy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/somnolence-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/specificity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sphenoid-sinus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spiculated-mass
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spindle-cell-hemangioma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spindle-cell-sarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spindle-cell-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spiral-ct-scan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/spleen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sporadic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/squamous-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/squamous-cell-carcinoma-of-the-head-and-neck
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stable-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-0-colorectal-carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-0-esophageal-carcinoma-in-situ
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-0-transitional-cell-carcinoma-in-situ-of-the-renal-pelvis-and-ureter
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-4-neuroblastoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-ib-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-ii-esophageal-squamous-cell-carcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-ii-prostate-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iia-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iib-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iii-endometrial-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iiia-colorectal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iiia-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iiib-non-small-cell-lung-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iv-cervical-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iv-colorectal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iva-laryngeal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-ivb-laryngeal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-ivc-lip-and-oral-cavity-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/standard-of-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/standard-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stem-cell-engraftment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stem-cell-mobilization
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stem-cell-rescue
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stem-cell-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stereotactic-body-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stereotactic-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stereotactic-radiosurgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sterile-talc-powder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stomach-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stomatitis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stool-guaiac-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/straight-colorectal-anastomosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stress-protein
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stromal-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/subcutaneous-port
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/subependymal-giant-cell-astrocytoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/subglottis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/subset-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/superficial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/supplemental-oxygen-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/supportive-care
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/suppressor-t-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/supraglottis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/surface-electrode
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/surgery
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/surgical-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/surgical-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/surrogate-endpoint
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survival-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship-care-plan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/symptom-management
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/synergistic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/syngeneic-bone-marrow-transplant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/syngeneic-stem-cell-transplantation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/systemic-chemotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/systemic-disease
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/systemic-inflammatory-response-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/systemic-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/systemic-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-cell-acute-lymphoblastic-leukemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-cell-depletion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-cell-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-cell-receptor-gene-rearrangement-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-dm1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-lymphoblastic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/t-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tae
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tailored-intervention
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/targeted-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/taxane
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/technetium-tc-99m-sulfur-colloid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/telangiectasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/teratocarcinoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/teratoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/terminal-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/testicular-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/testicular-intratubular-germ-cell-neoplasia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/testosterone-flare
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tetrahydrouridine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/therapeutic-medical-play
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thermal-ablation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/third-line-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thoracic-surgeon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/throat-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thrombocytopenia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thrombohemorrhagic-event
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thymine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thymoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thymus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thyroid-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/thyroxin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/time-to-progression
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tissue-fluid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tnm-staging-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tobacco-tar
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tomotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/topoisomerase-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/total-androgen-blockade
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/total-hysterectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/total-mastectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/total-nodal-irradiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/total-skin-electron-beam-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/toxicant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/toxicity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tpf-regimen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/trabecular-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tracer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/traditional-chinese-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transabdominal-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transformation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transfusion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transgenic-mice
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/translational-research
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/translocation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transperineal-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transrectal-biopsy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transrectal-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transurethral-electrovaporization-of-the-prostate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/transvaginal-ultrasound
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/trastuzumab
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-cycle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-plan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-schedule
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/treatment-summary
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/triple-negative-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/true-histiocytic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tubulovillous-adenoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-board-review
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-burden
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-debulking
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-infiltrating-lymphocyte
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-initiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-load
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-lysis-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-marker
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-microenvironment
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-model
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-necrosis-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-promotion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-specific-antigen
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-suppressor-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tumor-volume
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/tyrosine-kinase-inhibitor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ulceration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ultrasound-transducer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ultraviolet-a-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ultraviolet-b-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ultraviolet-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/umbilical-cord-blood-transplantation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/uncontrolled-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/undifferentiated
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/undifferentiated-pleomorphic-sarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/undifferentiated-sarcoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/unilateral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/unresectable
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/unresected
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/unsealed-internal-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/upstaging
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ureteronephrectomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ureteroscopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/urinary-tract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/urologic-oncologist
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/urothelial-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/uterine-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/uterus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/uvb-radiation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/uveal-tract
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vaccine-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vaginal-stenosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vascular-endothelial-growth-factor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vascular-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vegf-trap
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ventricle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/verum-acupuncture
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vesicant-extravasation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/villous-adenoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vinca-alkaloid
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/viral-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/viral-vector
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/virulent
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/virus-like-particle
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/visceral
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/visual-analog-scale
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vitamin-b-complex
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vitamin-b1
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/vitamin-b5
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/voltaren-gel
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/waldenstrom-macroglobulinemia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/waldeyers-ring
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/warm-ischemia-time
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/watchful-waiting
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/water-deprivation-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/water-soluble-vitamin
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wbrt
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wedge-resection
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/well-differentiated
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/well-differentiated-lymphocytic-lymphoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wermer-syndrome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/western-medicine
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/whey-protein-powder
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/whipple-procedure
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/white-blood-cell
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/whitmore-jewett-staging-system
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/whole-brain-radiation-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/whole-brain-radiotherapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wide-local-excision
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wild-type-kras-gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wilms-tumor
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/wobe-mugos-e
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/x-ray-therapy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/xenograft
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/xerostomia
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/yin-and-yang
|
||
|
|
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/yttrium-y-90-ibritumomab-tiuxetan
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/acrochordon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/affected-individual
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/allele
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/allelic-heterogeneity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/aneuploidy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/art
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/ashkenazi-jews
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/assisted-reproductive-technology
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/attributable-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/autosomal-recessive-inheritance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/band
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/base-pair
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/biallelic
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/carrier
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/carrier-frequency
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/carrier-rate
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cascade-screening
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/chromosome
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cnv
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/codon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/compound-heterozygosity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/consanguinity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/constitutional-dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/consultand
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/copy-number-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cosegregation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cutaneous-leiomyoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cutaneous-lichen-amyloidosis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/cytogenetics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/damico-criteria
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/deleterious-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/deletion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/depth-of-coverage
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/disease-causing-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/domain
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/double-heterozygosity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/epigenetic-alteration
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/epigenetics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/epimutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/er-negative-pr-negative-her2-neu-negative-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/exon
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/false-positive-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/familial
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/family-history
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/fdr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/fibrofolliculoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/first-degree-relative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/fish
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/founder-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/founder-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/frameshift-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/frameshift-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/gene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-anticipation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-counseling
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-heterogeneity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-predisposition
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-screening
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genetic-susceptibility
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genome-wide-association-study
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genomic-imprinting
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/genotype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/germline
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/germline-dna
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/germline-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/gwas
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/haploinsufficiency
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/haplotype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/hemizygous
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/heritability
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/heteroduplex-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/heterogeneity-logarithm-of-the-odds-score
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/heterozygous-genotype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/hlod-score
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/homozygous-genotype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/indeterminate-result
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/informative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/insertion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/intron
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/inversion
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/kindred
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/late-or-variable-onset
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/linkage-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/linkage-disequilibrium
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/locus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/locus-heterogeneity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/lod-score
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/logarithm-of-the-odds-score
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/loh
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/loss-of-heterozygosity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/massively-parallel-sequencing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/microsatellite
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/missense-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/missense-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/mlpa
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/mode-of-inheritance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/mosaicism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/msi
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/multigene-panel-test
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/mutation-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/negative-predictive-value
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/new-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/next-generation-sequencing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/nonpenetrance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/nonsense-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/nonsense-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/novel-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/novel-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/npv
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/nucleotide
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/null-allele
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/nutrigenomics
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/pathogenic-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/pedigree
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/penetrance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/phenocopy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/phenotype
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/point-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/polymerase-chain-reaction
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/polymorphism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/positive-predictive-value
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/ppv
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/predisposing-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/presymptomatic-testing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/proband
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/pseudogene
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/recurrence-risk
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/rna-splicing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/sanger-sequencing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/sdr
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/second-degree-relative
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/segregation-analysis
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/single-nucleotide-polymorphism
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/snp
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/somatic-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/southern-blot
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/specificity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/splice-site-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/sporadic-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/susceptibility-gene-mutation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/transcription
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/translocation
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/trichilemmoma
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/triple-negative-breast-cancer
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/trisomy
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/unclassified-variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/variable-expressivity
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/variant
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/variant-of-uncertain-significance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/variant-of-unknown-significance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/vus
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/whole-exome-sequencing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/whole-genome-sequencing
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-dominant-inheritance
|
||
|
|
https://www.cancer.gov/publications/dictionaries/genetics-dictionary/def/x-linked-recessive-inheritance
|
||
|
|
https://www.cancer.gov/publications/fact-sheets
|
||
|
|
https://www.cancer.gov/publications/health-communication
|
||
|
|
https://www.cancer.gov/publications/health-communication/making-data-talk.pdf
|
||
|
|
https://www.cancer.gov/publications/health-communication/pink-book.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education
|
||
|
|
https://www.cancer.gov/publications/patient-education/advanced-cancer
|
||
|
|
https://www.cancer.gov/publications/patient-education/advancedcancer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/cancer-treatment-research-studies
|
||
|
|
https://www.cancer.gov/publications/patient-education/caring-for-the-caregiver
|
||
|
|
https://www.cancer.gov/publications/patient-education/caring-for-the-caregiver-epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/caring-for-the-caregiver-mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/caring-for-the-caregiver.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/caring-for-the-caregiver2024.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/cervix.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/cervix.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/chemo-and-you
|
||
|
|
https://www.cancer.gov/publications/patient-education/chemotherapy-and-you.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/children-with-cancer-2015.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/children-with-cancer-2015.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/children-with-cancer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/clearing-the-air
|
||
|
|
https://www.cancer.gov/publications/patient-education/clearing-the-air-epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/clearing-the-air-mobile
|
||
|
|
https://www.cancer.gov/publications/patient-education/clearing-the-air-pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/coping-with-advance-cancer.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/coping-with-advance-cancer.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/covers-eating-hints.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/covers-life-after-treatment.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/crs.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/ctes-prevbrochenglishapp1.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/eating-hints
|
||
|
|
https://www.cancer.gov/publications/patient-education/eatinghints.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/facing-forward
|
||
|
|
https://www.cancer.gov/publications/patient-education/facing-forward.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/facing-forward.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/facing-forward.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/guide-for-parents
|
||
|
|
https://www.cancer.gov/publications/patient-education/help-research-donate-tissue
|
||
|
|
https://www.cancer.gov/publications/patient-education/insides-eating-hints.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/insides-life-after-treatment.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/life-after-treatment.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/life-after-treatment.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/life-after-treatment.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/make-a-difference
|
||
|
|
https://www.cancer.gov/publications/patient-education/ncieatinghintsbooklet.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/ncieatinghintsbooklet.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/ncitakingtimebooklet.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/ncitakingtimebooklet.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/pain-control
|
||
|
|
https://www.cancer.gov/publications/patient-education/paincontrol.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/paincontrol.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/paincontrol.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/parents-guide-hp-flyer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/providing-tissue.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/qr-code-sheet.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/radiation-therapy-and-you
|
||
|
|
https://www.cancer.gov/publications/patient-education/radiation-therapy-and-you.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/ray-e.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/ray-e.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/sibling-has-cancer
|
||
|
|
https://www.cancer.gov/publications/patient-education/someone-you-love-completed-cancer-treatment
|
||
|
|
https://www.cancer.gov/publications/patient-education/someone-you-love-completed-cancer-treatment.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/someone-you-love-completed-cancer-treatment.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/someone-you-love-completed-cancer-treatment.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/taking-time
|
||
|
|
https://www.cancer.gov/publications/patient-education/takingpartbooklet.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/takingpartbooklet.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/takingtime.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/teenguide-sibs-2013.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/teenguide-sibs.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/thyroid.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/thyroid.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/ucc-hp-flyer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/understanding-breast-changes
|
||
|
|
https://www.cancer.gov/publications/patient-education/understanding-breast-changes-and-conditions-promo-flyer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/understanding-cervical-changes
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-cancer-returns
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-cancer-returns.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-cancer-returns.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-cancer-returns.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-has-advanced-cancer
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-has-advanced-cancer.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-has-advanced-cancer.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-has-advanced-cancer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-is-being-treated
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-is-being-treated-for-cancer.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-is-being-treated-for-cancer.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-someone-you-love-is-treated.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-your-parent-has-cancer
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-your-parent-has-cancer.epub
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-your-parent-has-cancer.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-your-parent-has-cancer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/when-your-sibling-has-cancer.pdf
|
||
|
|
https://www.cancer.gov/publications/patient-education/wyntkesophagus-2013.mobi
|
||
|
|
https://www.cancer.gov/publications/patient-education/wyntkesophagus.epub
|
||
|
|
https://www.cancer.gov/publications/pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/adult-treatment
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/cam
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/genetics
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/members
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/pediatric-treatment
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/screening-prevention
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-boards/supportive-care
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-processes
|
||
|
|
https://www.cancer.gov/publications/pdq/editorial-processes/editorial-process-infographic
|
||
|
|
https://www.cancer.gov/publications/pdq/evidence-assessment
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/adult-treatment
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/cam
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/bhd-syndrome-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/brca-genes-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/cebpa-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/ddx41-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/gapps-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/gata2
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/hereditary-diffuse-gastric-cancer-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/hereditary-hematologic-malignancies
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/hlrcc-syndrome-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/hprc-syndrome-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/mbd4-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/overview-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/palb2-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/risk-assessment-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/rtps1-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/runx1-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/genetics/vhl-syndrome-hp-pdq
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/pediatric-treatment
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/prevention
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/screening
|
||
|
|
https://www.cancer.gov/publications/pdq/information-summaries/supportive-care
|
||
|
|
https://www.cancer.gov/publications/pdq/levels-evidence/cam
|
||
|
|
https://www.cancer.gov/publications/pdq/levels-evidence/genetics
|
||
|
|
https://www.cancer.gov/publications/pdq/levels-evidence/screening-prevention
|
||
|
|
https://www.cancer.gov/publications/pdq/levels-evidence/supportive-care
|
||
|
|
https://www.cancer.gov/publications/pdq/levels-evidence/treatment
|
||
|
|
https://www.cancer.gov/publications/pdq/other-languages
|
||
|
|
https://www.cancer.gov/publications/reports
|
||
|
|
https://www.cancer.gov/questions-to-ask-cancer-treatment-ct.pdf
|
||
|
|
https://www.cancer.gov/ralc.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/about
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/about/connect-overview-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/about/contact-us
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/about/meetings
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/about/staff
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog-0
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/2019/clinical-trial-development-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/2019/did-you-know
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/2024-brain-other-nervous-system-cancers
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/brain-tumor-patient-advocates-share-messages-of-hope-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/celebration-of-hope-for-brain-tumor-community
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/clinical-trial-tests-nivolumab-for-patients-with-rare-cns-cancers-audio-described-transcript
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/forming-connections-to-address-rare-brain-tumor-treatment-audio-described-transcript
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/global-collaboration-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/going-home-checklist-and-breathing-techniques
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/medulloblastoma-survivor-journey-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/nob-shapes-next-generation-of-researchers-clinicians-audio-described-transcript
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/synapses-2023-btam-art-exhibition
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/telehealth-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/test
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/blog/tips-to-cope-with-cancer-during-the-winter-season
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/consulta/clinica/clinica.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/consulta
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/consulta/clinica
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/consulta/consultas
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/mapa-sitio
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/anatomia
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/anatomia/anatomia-funciones-cerebro
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/anatomia/anatomia-funciones-medula-espinal
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/ependimoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/gliomas-difuso-linea-media
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/gliomatosis-cerebral
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/gliosarcoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/meduloblastoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/meningioma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/oligodendroglioma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/tnep
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/ttra
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/tumores-plexo-coroideo
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/tumores-region-pineal
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/tumores-sobre-snc
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/espanol/tumores/xantoastrocitoma-pleomorfico
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/coping/find-support-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/finished-treatment
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/finished-treatment/brain-spine-tumor-impact-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/in-treatment
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/in-treatment/determine-treatment-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/newly-diagnosed
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/newly-diagnosed/ependymoma-survivor-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/newly-diagnosed/manage-common-brain-tumor-symptoms-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/clinical-trials
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/clinical-trials/clinical-trials-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/diagnosis
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/doctor-experience
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/doctor-experience/center-of-excellence-treatment-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/neurosurgeon
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/neurosurgeon/find-expert-neurosurgeon-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/recurrence
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/support
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/survivorship
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/questions/treatment
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/recurrence
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/recurrence/patient-tips-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/related-organizations
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/emotions
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/emotions/labeling-psychological-distress-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/mental-health
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/mental-health/accepting-new-normal-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/mental-health/everyday-moments-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/mental-health/goal-planner.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/physical-health
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/physical-health/benefits-of-exercise-cancer-infographic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/physical-health/tracking-symptoms-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/relationships
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/relationships/building-relationships-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/spirituality
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/spirituality/yoga-poses-cancer-infographic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/work
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/self-care/work/to-do-list.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/stories
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/android-video-instructions
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/android-video-promo
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/mystori-application-instruction-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/mystori-application-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/privacy-policy
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/app/privacy-policy-android
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/cognitive
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/cognitive/ways-to-manage-your-cognitive-symptoms.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/difficulty-walking
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/fatigue
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/gastrointestinal
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/headache
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/mood-disturbance
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/pain
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/seizure
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/seizure/seizure-response-infographic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/sleep-disturbance
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/sleep-disturbance/ways-to-improve-sleep-infographic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/weakness
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/living/symptoms/weakness/ways-to-make-your-home-safe.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/calm-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/ependymoma-clinical-trial-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/gliosarcoma-clinical-trial
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/immune-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/immunotherapy-clinical-trial-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/marizomib-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/natural-history-study-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/natural-history-study.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/nivolumab-idh-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/nivolumab-study.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/outcomes-risk-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/outcomes-risk-study-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/plx038-cnstumors-study
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/risk-study
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/sleep-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/sunitinib-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/clinical-studies/virtual-reality-study-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/partnerships
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/partnerships/be-our-partner/connect-partner.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/appointment-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/cares-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic/cares-group-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic/genetic-counseling-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic/healthcare-meeting-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic/pathology-review-clinic-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/clinic/what-to-expect-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/genetic-counseling.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/referral-flyer.pdf
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/referrals/referrals-appointments-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/refer-participate/why-participate-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/site-map
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/about-cns-tumors
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/about-cns-tumors/treatment-advances-video
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/anatomy
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/anatomy/brain-anatomy-functions
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/anatomy/spine-functions-infographic
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/atrt
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/choroid-plexus-tumors
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/diffuse-midline-gliomas
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/ependymoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/gliomatosis-cerebri
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/gliosarcoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/medulloblastoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/meningioma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/oligodendroglioma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/pineal-region-tumors
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/pleomorphic-xanthroastrocytoma
|
||
|
|
https://www.cancer.gov/rare-brain-spine-tumor/tumors/pnet
|
||
|
|
https://www.cancer.gov/research
|
||
|
|
https://www.cancer.gov/research-funding-information.pdf
|
||
|
|
https://www.cancer.gov/research/areas
|
||
|
|
https://www.cancer.gov/research/areas/biology
|
||
|
|
https://www.cancer.gov/research/areas/biology/david-lyden-exosomes-metastasis
|
||
|
|
https://www.cancer.gov/research/areas/biology/human-tumor-atlas-network-infographic
|
||
|
|
https://www.cancer.gov/research/areas/biology/proteogenomics-research
|
||
|
|
https://www.cancer.gov/research/areas/causes
|
||
|
|
https://www.cancer.gov/research/areas/causes/breast-cancer-and-the-environment-controversial-and-emerging-exposures.pdf
|
||
|
|
https://www.cancer.gov/research/areas/causes/breast-cancer-environment
|
||
|
|
https://www.cancer.gov/research/areas/childhood
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-basic-cancer-research
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative-0
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/about
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/about/toolkit
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/about/toolkit/ccdi-overview-flyer.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/about/toolkit/data-ecosystem-faq.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/ccdi-poster-abstracts.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/ccdi-symposium-agenda-2019.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/childhood-cancer-data-initiative-infographic
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/childhood-cancer-data-initiative-video
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/data-ecosystem
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/data-ecosystem/ccdi-data-ecosystem-infographic
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/data-ecosystem/platforms-tools
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars-0
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-automated-extraction-of-ehr-data.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-feb.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-hub-ccdc.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-march.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-mtp.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-nccr-leveraging-data-standards-for-improving-interoperability.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-nccr.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-sept-cf.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/ccdi-webinar-stjudedatasharingtools.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/electronic-health-record.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/2019
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/2021
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/collaborations-transformative-research-opportunities.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/electronic-health-record-data-extraction.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/external-controls-for-pediatric-cancer-clinical-trials.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/molecular-characterization-initiative-potential-for-future-cohort-studies.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/observational-studies-novel-approaches-for-rare-pediatric-cancers.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-symposiums/patient-family-perspectives-on-computable-consent.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/2023
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/ccdi-impact-of-mci.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/ccdi-proton-photon-therapy.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/ccdi-webinar-dataaccess.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/ccdi-webinar-federated-data.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-webinars/nccr-data-platform.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/past-workshops
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/events-webinars/symposium-0
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/ideas-summary.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/learning-from-every-child-video
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/overview-and-progress-webinar
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs/molecular-characterization
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs/molecular-characterization/mci-infographic
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/programs/rare-cancers
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/progress
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/progress-0
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/progress/nci-advisory-board-presentation.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/progress/projects
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/abby
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/alice
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/aubrey
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/bonnie
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/brigitte
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/callan
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/cameron
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/charlie
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/corinne
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/deepa
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/elana
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/emily
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/ethel
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/faithanne
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/fernanda
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/grace
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/gregory
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/hailey
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/jace
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/jason
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/javed
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/joe
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/juanita
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/kamalani
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/lauren
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/lisa
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/lisa-mirabello
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/lynne
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/maryfrances
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/matt
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/michael
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/mignon
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/nilsa
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/olivia
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/pamela
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/paula
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/payal
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/robin
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/sarah
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/sharon
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/smita
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/sophie
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/subhashini
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/thalia
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/troy
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/stories/xiao-nan
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/symposium-agenda.pdf
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/symposium-preview
|
||
|
|
https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative/webinar
|
||
|
|
https://www.cancer.gov/research/areas/childhood/gregory-aune-less-toxic-cancer-treatments-kids
|
||
|
|
https://www.cancer.gov/research/areas/childhood/julie-park-tandem-transplants-treat-neuroblastoma
|
||
|
|
https://www.cancer.gov/research/areas/childhood/philip-moss-improving-outcomes-nf1-neurofibromas
|
||
|
|
https://www.cancer.gov/research/areas/childhood/shrinking-fibrosarcoma-tumor
|
||
|
|
https://www.cancer.gov/research/areas/childhood/widemann-special-advisor
|
||
|
|
https://www.cancer.gov/research/areas/diagnosis
|
||
|
|
https://www.cancer.gov/research/areas/diagnosis/prevent-cervical-cancer
|
||
|
|
https://www.cancer.gov/research/areas/disparities
|
||
|
|
https://www.cancer.gov/research/areas/disparities/chanita-hughes-halbert-clinical-trials-community-access
|
||
|
|
https://www.cancer.gov/research/areas/disparities/charting-future-position-statement.pdf
|
||
|
|
https://www.cancer.gov/research/areas/disparities/electra-paskett-addressing-cancer-disparities-appalachia
|
||
|
|
https://www.cancer.gov/research/areas/disparities/eliminate-ovarian-cancer-disparities
|
||
|
|
https://www.cancer.gov/research/areas/genomics
|
||
|
|
https://www.cancer.gov/research/areas/global-health
|
||
|
|
https://www.cancer.gov/research/areas/prevention
|
||
|
|
https://www.cancer.gov/research/areas/prevention/balloon-detect-barrett-esophagus-infographic
|
||
|
|
https://www.cancer.gov/research/areas/prevention/olivera-finn-prevention-vaccine
|
||
|
|
https://www.cancer.gov/research/areas/prevention/science-of-cancer-prevention-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health
|
||
|
|
https://www.cancer.gov/research/areas/public-health/25-years-survivorship-science-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health/cancer-center-cessation-initiative-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health/cancer-survivorship-research-vision-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health/deaf-health-info-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health/immune-system-microbiome
|
||
|
|
https://www.cancer.gov/research/areas/public-health/michael-fiore-reducing-tobacco-cancer-burden
|
||
|
|
https://www.cancer.gov/research/areas/public-health/reducing-cancer-risk
|
||
|
|
https://www.cancer.gov/research/areas/public-health/seer-intro-video
|
||
|
|
https://www.cancer.gov/research/areas/public-health/sue-wharfe-lifestyle-exercise-nutrition-study
|
||
|
|
https://www.cancer.gov/research/areas/public-health/what-is-seer-infographic
|
||
|
|
https://www.cancer.gov/research/areas/screening
|
||
|
|
https://www.cancer.gov/research/areas/screening/avrum-spira-early-detection-lung-cancer
|
||
|
|
https://www.cancer.gov/research/areas/treatment
|
||
|
|
https://www.cancer.gov/research/areas/treatment/enhancing-drug-discovery
|
||
|
|
https://www.cancer.gov/research/areas/treatment/immunotherapy-research-steven-rosenberg-video
|
||
|
|
https://www.cancer.gov/research/areas/treatment/implementation-science
|
||
|
|
https://www.cancer.gov/research/areas/treatment/kevan-shokat-targeted-drug-discovery
|
||
|
|
https://www.cancer.gov/research/areas/treatment/nci-formulary-infographic
|
||
|
|
https://www.cancer.gov/research/areas/treatment/nci-precision-medicine-infographic
|
||
|
|
https://www.cancer.gov/research/areas/treatment/survivor-immunotherapy-drug
|
||
|
|
https://www.cancer.gov/research/areas/treatment/treat-prostate-cancer
|
||
|
|
https://www.cancer.gov/research/areas/treatment/vonderheide-minn-twyman-saint-victor-radiation-checkpoint-inhibitors
|
||
|
|
https://www.cancer.gov/research/ashg-video
|
||
|
|
https://www.cancer.gov/research/finding-hope-ending-cancer-as-we-know-it-video
|
||
|
|
https://www.cancer.gov/research/grants-after-jan-25-2010.pdf
|
||
|
|
https://www.cancer.gov/research/help-immune-system-fight-cancer-infographic
|
||
|
|
https://www.cancer.gov/research/implementation-science-infographic
|
||
|
|
https://www.cancer.gov/research/improve-detection-of-cervical-precancer-leveraging-ai-infographic
|
||
|
|
https://www.cancer.gov/research/infrastructure
|
||
|
|
https://www.cancer.gov/research/infrastructure/artificial-intelligence
|
||
|
|
https://www.cancer.gov/research/infrastructure/artificial-intelligence/cancer-research-ai-careers-podcast
|
||
|
|
https://www.cancer.gov/research/infrastructure/bioinformatics
|
||
|
|
https://www.cancer.gov/research/infrastructure/bioinformatics/bringing-data-to-life-video
|
||
|
|
https://www.cancer.gov/research/infrastructure/bioinformatics/cancer-research-data-ecosystem-infographic
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/arizonacc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/baylorduncan
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/beckmancityofhope
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/casewestern
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/cinj
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/coldspringharbor
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/dartmouthnorriscotton
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/dfharvard
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/dukeci
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/emorywinship
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/foxchase
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/fredhutchcrc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/georgetownlombardi
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/hopkinskimmel
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/indianasimon
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/iowaholden
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/irvingcolumbia
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/jacksonlab
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/jeffersonkimmel
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/kucc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/marker.kml
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/mayoclinic
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/meccc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/memorialsloankettering
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/minnesotamasonic
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/mitkoch
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/moffitt
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/muschollings
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/nebraska
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/newmexicocrtc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/northwesternlurie
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/nyuci
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ohsuknight
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/osujames
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/purdueccr
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/roswellpark
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/salk
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/sanfordburnham
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/stanfordci
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/stephenson
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/stjude
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/sylvester-miami
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/tischmountsinai
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uabccc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ucdaviscc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uchicagoccc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ucirvinechao
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uclajonsson
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ucolorado
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ucsdmoores
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ucsfhelendiller
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ufhealth
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uhawaiicc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/ukmarkey
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/umdgreenebaum
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/umichiganccc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/unclineberger
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/upci
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/upennabramson
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uscnorris
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/utahhuntsman
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/utsanantonio
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/utswsimmons
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uvacc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/uwcarbone
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/vanderbiltingram
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/vcumassey
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/wakeforest
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/washingtonsiteman
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/waynestatekarmanos
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/wistar
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/find/yalecc
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/history
|
||
|
|
https://www.cancer.gov/research/infrastructure/cancer-centers/history/1971
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/betsy-brauser-combining-drugs-treat-ovarian-cancer
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/ctiu
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/combomatch
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/nci-match
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/pediatric-match
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nci-supported/pediatric-match/pediatric-match-infographic
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/ncorp
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/ncorp/cancer-care-delivery-research-video
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/ncorp/clinical-trials-in-your-community-video
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/ncorp/fears-cancer-clinical-research-video
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nctn
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nctn/funding-nctn-program-funding
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nctn/nctn-clinical-trials-network
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nctn/precision-medicine-lung-cancer-video
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/nctn/structure-nctn-cooperative-groups
|
||
|
|
https://www.cancer.gov/research/infrastructure/clinical-trials/valerie-winston-clinical-trial-multiple-myeloma
|
||
|
|
https://www.cancer.gov/research/infrastructure/fnlcr
|
||
|
|
https://www.cancer.gov/research/infrastructure/fnlcr/shared-national-resource-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/funding
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/nccaps
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/capacity-building-centers
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/faqs
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/launch-media-briefing-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/resources
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/seronet-pre-application-webinar-slides.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/seronet-webinar-funding-opportunities-questions-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/seronet-webinar-funding-opportunities-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/u01-research-projects
|
||
|
|
https://www.cancer.gov/research/key-initiatives/covid-19/serological-sciences-network/u54-centers-of-excellence
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/about
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/all-working-group-reports.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/blue-ribbon-panel-report-summary.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-cancer-atlas-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-cancer-data-ecosystem-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-cancer-research-ideas-summary.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-develop-cancer-technologies-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-immunotherapy-clinical-trials-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-mine-patient-data-predict-future-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-minimize-side-effects-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-oncoproteins-pediatric-cancer-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-patient-network-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-prevention-strategies-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-summary-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/brp-therapeutic-targets-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/cancer-immunology-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/clinical-trials-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/enhanced-data-sharing-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/implementation-science-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/pediatric-cancer-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/prevention-screening-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/tumor-evolution-working-group-report.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/closed
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/public-access-policy
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/accsis-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/accsis-pre-application-webinar
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/childhood-fusion-oncoproteins-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/ctcae-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/hta-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/htan-faqs
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/htan-webinar-rfa-ca-17-36
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/human-tumor-atlas-network-webina-rfa-ca-17-035.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/human-tumor-atlas-network-webinar-rfa-ca-17-034.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/immunotherapy-network-webinar.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/impact-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/inherited-syndromes-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/iotn-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/iotn-pre-application-webinar.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/oncoproteins-consortium-webinar.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/piddn-foa-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/pro-ctcae-rfa-ca-17-052-faqs.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding/upcoming/pro-ctcae-webinar-rfa-ca-17-052.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/history
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/history/blue-ribbon-panel-report-2016.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/history/panel-members
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation-cancer-moonshot.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/adult-immunotherapy-network
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/adult-immunotherapy-network/fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/adult-immunotherapy-network/iotn-webinar.pptx
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/childhood-cancer-research
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/data-ecosystem
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/drug-resistance
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/hereditary-cancers
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/human-tumor-atlas
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/human-tumor-atlas/fact-sheet.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/mine-patient-data
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/new-technologies
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/patient-engagement
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/patient-engagement/nci-consortia-initiative
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/patient-engagement/social-media-clinical-trials-workshop-executive-summary.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/patient-engagement/social-media-clinical-trials-workshop-workshop-summary.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/pediatric-immunotherapy-network
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/prevention-early-detection
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/symptom-management
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/telehealth-cancer-care-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/moonshot-cancer-research-ideas-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/progress
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/progress/charting-new-courses-cancer-moonshot
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/progress/discovering-drivers-of-childhood-cancer-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/progress/moonshot-progress-unleashing-comparative-oncology-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series-0
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/advancing-cancer-outcomes-through-implementation-science-and-participant-engagement-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/apr-2024-detection-and-treatment-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/aug-2023-spatial-data-analyses-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/blue-ribbon-panel
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/car-t-cell-therapies-updates
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-april-2023-cell-death-mechanisms-therapy-resistance
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-dec-2021-new-technologies-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-feb-2022-hereditary-cancers-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-jan-2022-adult-immunotherapy-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-june-2022-patient-derived-xenografts
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-june-2023-fusion-oncoproteins
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-mar-2022-nci-connect-patient-advocacy
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-march-2023-multiplexed-tissue-spatial-biology
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-martha-shrubsole
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-may-2022-patient-engagement-implementation-science
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-may-2023-count-me-in-sarcomas
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-nov-2021-pediatric-immunotherapy-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-november-2022-cancer-omics-datasets
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-november-2022-molecular-dissection-tumor-biology
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-november-2023-surveillance-data-aritificial-intelligence-cancer
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/cmss-september-2022-breast-cancer-immunoprevention
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/feb-2024-cancer-biology-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/imaging-data-commons
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/jan-2024-telemedicine-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/july-2023-improving-immunotherapy-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/lineage-plasticity-and-drug-resistance-in-cancer-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/mar-2024-immunotherapies-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/may-2024-data-cancer-moonshot-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/projection-electrophoresis
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/sept-2023-tobacco-treatment-cancer-care-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/southwestern-tribal-nations-cancer-genome-sequencing-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/structure-function-mammalian-complexes-in-synovial-sarcoma-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/supporting-innovative-cancer-research-through-data-privacy
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/towards-spatially-resolved-single-cell-atlases-of-tumor-initiation-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/seminar-series/understanding-treatment-tolerability-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program/about
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program/about/leadership-messages/black-history-month
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program/equity-council
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program/funding
|
||
|
|
https://www.cancer.gov/research/key-initiatives/nci-equity-inclusion-program/presentations-articles
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/about
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/about/collaborations
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/about/leadership-advisory-groups
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/dialogue-blog/gene-names-proteins-aliases-in-the-ras-pathway.xlsx
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/dialogue-blog/kras-data-2020.xlsx
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/dialogue-blog/kras-graphics
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/dialogue-blog/ras-pathway-gene-names
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/events
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/lab-discussion-forum
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/webinar-videos
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/news-events/webinar-videos/2nd-ras-symposium-program.pdf
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/publications
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/ras-video
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/biochemistry-biophysics
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/bioinformatics
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/chemistry
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/computational-chemistry
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/drug-screening
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/imaging
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/mass-spectrometry
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/reagents
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/research-teams/structural-biology
|
||
|
|
https://www.cancer.gov/research/key-initiatives/ras/tools-resources
|
||
|
|
https://www.cancer.gov/research/leading-progress
|
||
|
|
https://www.cancer.gov/research/leading-progress/2022-annual-plan-budget-proposal-aag.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2023-annual-plan-budget-proposal-aag.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2023-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2024-annual-plan-budget-proposal-aag.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2024-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2025-annual-plan-budget-proposal.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2025-professional-judgment-budget-proposal-aag.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/2026-professional-judgment-budget-proposal-aag.pdf
|
||
|
|
https://www.cancer.gov/research/leading-progress/budget-proposal
|
||
|
|
https://www.cancer.gov/research/leading-progress/budget-proposal/fy24-budget-infographic
|
||
|
|
https://www.cancer.gov/research/leading-progress/directors-message
|
||
|
|
https://www.cancer.gov/research/leading-progress/research-portfolio
|
||
|
|
https://www.cancer.gov/research/leading-progress/scientific-opportunities
|
||
|
|
https://www.cancer.gov/research/leading-progress/scientific-topics/cell-therapy/car-t-cell-therapy-infographic
|
||
|
|
https://www.cancer.gov/research/leading-progress/scientific-topics/how-adaptive-cancer-therapy-works-infographic
|
||
|
|
https://www.cancer.gov/research/leading-progress/scientific-topics/protac-infographic
|
||
|
|
https://www.cancer.gov/research/leading-progress/scientific-topics/what-is-drug-resistance-infographic
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/cytalux
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/erin
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/jennifer
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/justin
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/justin-pa
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/kellie
|
||
|
|
https://www.cancer.gov/research/leading-progress/stories/leeya
|
||
|
|
https://www.cancer.gov/research/nci-role
|
||
|
|
https://www.cancer.gov/research/nci-role/cancer-research-types-infographic
|
||
|
|
https://www.cancer.gov/research/nci-role/cancer-research-workforce
|
||
|
|
https://www.cancer.gov/research/nci-role/driving-discovery-video
|
||
|
|
https://www.cancer.gov/research/nci-role/extramural
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural/brain-tumor-metabolism-video
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural/cpfp-catalog.pdf
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural/scientists-spotlight-apolo-video
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural/scientists-spotlight-cherry-video
|
||
|
|
https://www.cancer.gov/research/nci-role/intramural/scientists-spotlight-draper-video
|
||
|
|
https://www.cancer.gov/research/nci-role/partners-collaborators
|
||
|
|
https://www.cancer.gov/research/nci-role/partners-collaborators/tech-transfer-video
|
||
|
|
https://www.cancer.gov/research/nci-sbir-sttr-program-garners-strong-roi-infographic
|
||
|
|
https://www.cancer.gov/research/participate
|
||
|
|
https://www.cancer.gov/research/participate/about-cancer-clinical-research
|
||
|
|
https://www.cancer.gov/research/participate/articles/sample-informed-consent-form
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/help
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/steps
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/steps/detailschecklist.pdf
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2009-00470
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2009-00603
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2010-01242
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2010-02069
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2011-02037
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2011-03000
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-00357
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-00535
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-00634
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-01142
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-01257
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-01337
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-01541
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-02045
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-02202
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2012-02775
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00286
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00370
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00581
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00610
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00818
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00826
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00875
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-00995
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01144
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01275
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01496
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01588
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01642
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01702
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01799
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01814
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-01850
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-02240
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-02245
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-02281
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2013-02402
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00012
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00137
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00315
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00338
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00461
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00495
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00677
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00784
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00860
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00883
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00926
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-00983
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01301
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01499
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01507
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01508
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01770
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01811
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-01952
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02013
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02058
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02168
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02176
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02183
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02339
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02379
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02463
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02583
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2014-02674
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00014
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00054
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00089
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00128
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00136
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00172
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00239
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00275
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00324
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00337
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00498
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00546
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00547
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00560
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00593
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00611
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00648
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00651
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00693
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00708
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00730
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00835
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00854
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00858
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-00919
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01018
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01097
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01139
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01146
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01349
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01478
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01495
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01524
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01529
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01536
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01552
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01556
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01557
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01628
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01642
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01643
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01683
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01694
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01707
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01728
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01750
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01768
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01783
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01822
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01835
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01849
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01906
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01913
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01915
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01918
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01919
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01947
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01954
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-01955
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02027
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02093
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02155
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02256
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02263
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2015-02285
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00007
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00064
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00110
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00116
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00132
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00153
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00158
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00199
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00207
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00221
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00222
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00227
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00233
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00242
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00260
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00265
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00267
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00326
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00329
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00337
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00393
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00409
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00420
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00422
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00447
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00449
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00545
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00581
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00586
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00594
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00596
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00611
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00679
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00684
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00692
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00717
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00731
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00772
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00793
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00817
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00836
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00849
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00884
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00900
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00922
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00923
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00957
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00963
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-00986
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01004
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01032
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01040
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01041
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01050
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01052
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01077
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01081
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01092
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01112
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01113
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01146
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01162
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01179
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01186
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01205
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01211
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01225
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01233
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01254
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01301
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01304
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01307
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01356
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01363
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01364
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01369
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01417
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01433
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01458
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01467
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01473
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01486
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01494
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01503
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01513
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01563
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01564
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01565
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01567
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01578
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01581
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01591
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01595
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01598
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01672
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01716
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01720
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01723
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01733
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01795
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01799
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01800
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01820
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01843
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01878
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01891
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01892
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01910
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01966
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01980
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01981
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-02016
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-02036
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-02057
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00009
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00027
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00041
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00071
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00093
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00094
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00101
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00128
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00133
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00141
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00161
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00172
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00178
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00200
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00204
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00206
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00223
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00230
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00234
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00236
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00241
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00247
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00256
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00261
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00278
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00280
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00285
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00365
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00377
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00378
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00404
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00433
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00441
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00448
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00491
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00501
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00510
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00534
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00550
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00563
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00579
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00590
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00635
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00640
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00722
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00733
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00738
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00741
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00748
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00753
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00766
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00796
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00826
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00831
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00851
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00887
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00897
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00905
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00906
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00923
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00929
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00931
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00934
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00937
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00945
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00970
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00990
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00998
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01017
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01027
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01030
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01066
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01069
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01073
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01119
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01125
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01129
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01130
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01132
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01150
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01155
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01157
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01181
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01197
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01215
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01240
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01245
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01247
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01261
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01264
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01275
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01293
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01295
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01296
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01299
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01320
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01337
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01347
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01348
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01360
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01369
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01377
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01387
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01388
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01428
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01432
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01462
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01488
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01495
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01498
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01501
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01503
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01505
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01522
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01523
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01528
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01535
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01545
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01564
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01568
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01573
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01579
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01587
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01629
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01633
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01645
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01650
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01652
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01660
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01662
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01671
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01674
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01688
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01691
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01693
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01703
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01707
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01712
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01723
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01724
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01726
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01727
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01728
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01735
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01737
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01741
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01762
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01775
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01826
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01829
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01830
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01851
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01866
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01868
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01870
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01874
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01876
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01882
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01899
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01902
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01923
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01929
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01942
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01945
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01969
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01985
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C114812/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C2910/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C2910/screening
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C2910/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3168/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3174/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3247/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3270/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3330,C4348,C8388/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C3997/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C4967/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C5816,C8550,C3813/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C7709/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C7884/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C8578/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9145/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9154/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9160/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9242/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9242/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/C9306/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/anal-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/bladder-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/c7251,c9063/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/cervical-cancer/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/cervical-cancer/screening
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/cervical-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/clear-cell-renal-cell
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/cll/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/colorectal-cancer/screening
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/esophageal-cancer/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/esophageal-cancer/screening
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/esophageal-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/extragonadal-germ-cell-tumors/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/gallbladder-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/hairy-cell-leukemia/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/kaposi-sarcoma/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/merkel-cell/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/mesothelioma/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/multiple-myeloma/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/myelodysplastic-myeloproliferative/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/myeloproliferative-neoplasm/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/non-small-cell-lung/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/non-small-cell-lung/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/pancreatic-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/pancreatic-islet-cell/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/parathyroid-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/penile-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/prostate-cancer/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/prostate-cancer/screening
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/prostate-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/rectal-cancer/prevention
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/rectal-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/skin-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/small-cell-lung-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/stomach-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/disease/thyroid-cancer/treatment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/facts
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/how-trials-work
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/how-trials-work/randomization-in-clinical-trials-video
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/8-hydroxyquinoline-sulfate-ointment
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/abemaciclib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/abiraterone-acetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/acalabrutinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/actinium-ac-225-lintuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ad5cmv-p53-gene
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/adenosine-a2a-receptor-antagonist-cpi-444
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/adenosine-a2a-receptor-antagonist-pbf-509
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/afatinib-dimaleate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/akt-inhibitor-azd5363
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/akt-inhibitor-mk2206
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/akterk-inhibitor-onc201
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/aldesleukin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/alectinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/alisertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/allogeneic-natural-killer-cell-line-nk-92
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/alpelisib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/alpha-folate-receptor-targeting-thymidylate-synthase-inhibitor-onx-0801
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/amifostine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/aminolevulinic-acid-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anastrozole
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anetumab-ravtansine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/annonaceous-acetogenins
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-bcma-antibody-drug-conjugate-gsk2857916
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-c-fms-monoclonal-antibody-amg-820
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-cd33cd3-bite-antibody-amg-330
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-cd40-monoclonal-antibody-sea-cd40
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-cd47-monoclonal-antibody-hu5f9-g4
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-cd73-monoclonal-antibody-bms-986179
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-cd73-monoclonal-antibody-medi9447
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-ceacd3-bispecific-antibody-ro6958688
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-ctla-4-monoclonal-antibody-agen1884
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-fapinterleukin-2-fusion-protein-ro6874281
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-gitr-agonistic-monoclonal-antibody-incagn01876
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-her2-antibody-drug-conjugate-medi4276
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-icos-agonist-antibody-gsk3359609
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-icos-monoclonal-antibody-medi-570
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-il-8-monoclonal-antibody-humax-il8
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-lag-3-monoclonal-antibody-bms-986016
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-lag-3-monoclonal-antibody-lag525
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-lag-3-monoclonal-antibody-regn3767
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-mmp-9-monoclonal-antibody-gs-5745
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-nectin-4-antibody-drug-conjugate-asg-22ce
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-nucleolin-aptamer-as1411
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-ox40-antibody-bms-986178
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-ox40-monoclonal-antibody
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-pd-1-monoclonal-antibody-jnj-63723283
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-pd-1-monoclonal-antibody-regn2810
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-pd-1-monoclonal-antibody-tsr-042
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-pd-l1-monoclonal-antibody-mdx-1105
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-tigit-monoclonal-antibody-bms-986207
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-tim-3-monoclonal-antibody-tsr-022
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/anti-vista-monoclonal-antibody-jnj-61610588
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/antibody-drug-conjugate-sc16ld65
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/antineoplastic-agent-combination-sm-88
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/apalutamide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/arsenic-trioxide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ashwagandha-root-powder-extract
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/aspirin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/atezolizumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/atr-kinase-inhibitor-vx-970
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/autologous-tumor-cell-vaccine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/avelumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/axitinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/axl-inhibitor-bgb324
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/azacitidine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bcl-2-inhibitor-bcl201
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bcr-abl-kinase-inhibitor-k0706
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/beetroot-juice
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bendamustine-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bet-bromodomain-inhibitor-zen-3694
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bet-inhibitor-bms-986158
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bet-inhibitor-gs-5829
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bet-inhibitor-ro6870810
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/beta-glucan
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/betulinic-acid
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bevacizumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bh3-mimetic-abt-737
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bi-functional-alkylating-agent-val-083
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bicalutamide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/birinapant
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bleomycin-sulfate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/blinatumomab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bortezomib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/boswellia-serrata-extract
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/braf-inhibitor-plx8394
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/brd4-inhibitor-plx51107
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/brentuximab-vedotin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/btk-inhibitor-bgb-3111
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/buparlisib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/bxq-350-nanovesicle-formulation
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/c-kit-inhibitor-plx9486
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cabazitaxel
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cabozantinib-s-malate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/capecitabine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/capmatinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/carboplatin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/carfilzomib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/carmustine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cbpbeta-catenin-antagonist-pri-724
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cd40-agonist-monoclonal-antibody-cp-870893
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cd40-agonist-monoclonal-antibody-ro7009789
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cdc7-inhibitor-tak-931
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cdk259-inhibitor-cyc065
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ceritinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cetuximab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/chitin-oligosaccharides-supplement-t-chos
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cisplatin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/clarithromycin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cobimetinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/compound-kushen-injection
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cordycepin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/crizotinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/csf-1r-inhibitor-blz945
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/curcumin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cxcr4-antagonist-bl-8040
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cyclophosphamide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/cytarabine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/daratumumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dasatinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/decitabine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/defactinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/delta-8-tetrahydrocannabinol
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/denosumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dexamethasone
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/diindolylmethane
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dinutuximab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/disulfiram
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dna-pk-inhibitor-msc2490484a
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dna-pktor-kinase-inhibitor-cc-115
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/docetaxel
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dot1l-inhibitor-epz-5676
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dovitinib-lactate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/doxorubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/dual-alkegfr-inhibitor-ap26113
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/durvalumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/egfr-inhibitor-abt-414
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/egfr-inhibitor-egf816
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/egfrher2-inhibitor-ap32788
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ellagic-acidannona-muricata-supplement
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/enasidenib-mesylate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/enobosarm
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ensartinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/entinostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/enzalutamide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/epacadostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/epirubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/eribulin-mesylate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/erk-inhibitor-ltt462
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/erlotinib-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/etoposide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/everolimus
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/exemestane
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fak-inhibitor-gsk2256098
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fasn-inhibitor-tvb-2640
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fermented-wheat-germ-extract
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fgfr-inhibitor-azd4547
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fgfr-inhibitor-incb054828
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fgfr-inhibitor-tas-120
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/filgrastim
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fimepinostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fluorescent-imaging-ligand-otl38
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fluorouracil
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/fulvestrant
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gallium-ga-68-labeled-psma-11
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/galunisertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ganetespib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ganitumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gedatolisib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gefitinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gemcitabine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gemcitabine-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/genistein
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gilteritinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gitr-agonist-medi1873
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/glutaminase-inhibitor-cb-839
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/goserelin-acetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/guadecitabine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/gvax-pancreatic-cancer-vaccine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/hdm2-inhibitor-hdm201
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/hif-2alpha-inhibitor-pt2385
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/hyperimmune-bovine-colostrum
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ibrutinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/idasanutlin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/idelalisib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/idh1-inhibitor-ag-120
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ido1-inhibitor-khk2455
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/imatinib-mesylate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/imetelstat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/imiquimod
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/indoximod
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ipamorelin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ipilimumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/irinotecan-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ixazomib-citrate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/jak1-inhibitor-incb039110
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/kitpdgfr-inhibitor-dcc-2618
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/l-carnitine-l-tartrate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lanreotide-acetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/larotrectinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lenalidomide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lenvatinib-mesylate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/letrozole
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/leucovorin-calcium
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/leuprolide-acetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/liposomal-cytarabine-daunorubicin-cpx-351
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lomustine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lsd1-inhibitor-gsk2879552
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lurbinectedin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/lutetium-lu-177-dota-tate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/magnesium-l-threonate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/manuka-honey
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mavelertinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mcl-1-inhibitor-amg-176
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mcl-1-inhibitor-mik665
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mdm2-inhibitor-amg-232
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mdm2-inhibitor-ds-3032b
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mdr-modulator-cbt-1
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/megestrol-acetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/melk-inhibitor-ots167
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/melphalan
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/metformin-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/methotrexate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mifepristone
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mitomycin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mogamulizumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/monoclonal-antibody-mga271
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/montanide-isa-51-vg
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/multitargeted-tyrosine-kinase-inhibitor-plx3397
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/mutant-p53-activator-coti-2
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/nabiximols
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/napabucasin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/navitoclax
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/navoximod
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/neratinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/niclosamide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/nimotuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/niraparib-tosylate-monohydrate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/nitazoxanide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/nivolumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/notch-signaling-pathway-inhibitor-mk0752
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/nrf2-activator-rta-408
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ny-eso-1-peptide-vaccine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/obinutuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/olaparib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/olaratumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/onalespib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/osimertinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/oxaliplatin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/oxidative-phosphorylation-inhibitor-iacs-010759
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/p97-inhibitor-cb-5083
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/paclitaxel
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/paclitaxel-albumin-stabilized-nanoparticle-formulation
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/palbociclib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-fgfr-kinase-inhibitor-bgj398
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-fgfr-tyrosine-kinase-inhibitor-bay1163877
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-mutant-idh1-inhibitor-bay-1436032
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-raf-inhibitor-lxh254
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-raf-inhibitor-ly3009120
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pan-raf-kinase-inhibitor-tak-580
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/panobinostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/parp-inhibitor-bgb-290
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pazopanib-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pd-l1pd-l2vista-antagonist-ca-170
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pd0325901
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pegfilgrastim
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pegylated-liposomal-doxorubicin-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pegylated-recombinant-human-arginase-i-bct-100
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pegylated-recombinant-human-hyaluronidase-ph20
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pembrolizumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pemetrexed-disodium
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pertuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pevonedistat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pgg-beta-glucan
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3k-beta-inhibitor-gsk2636771
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3k-delta-inhibitor-incb050465
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3k-delta-inhibitor-tgr-1202
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3k-gamma-inhibitor-ipi-549
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3k-inhibitor-gdc0077
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pi3kmtor-inhibitor-bez235
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pladienolide-derivative-e7107
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/poly-iclc
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pomalidomide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/porcupine-inhibitor-wnt974
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/poziotinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/prednisone
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/prexasertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/prima-1-analog-apr-246
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/pv-10
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/radium-ra-223-dichloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/raloxifene-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ramucirumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/recombinant-ephb4-hsa-fusion-protein
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/regorafenib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ribociclib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/rimiducid
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/rituximab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/romidepsin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ruthenium-ru-106
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ruxolitinib-phosphate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sacituzumab-govitecan
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sapanisertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/selinexor
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/selumetinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sepantronium-bromide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/seviteronel
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sipuleucel-t
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sirolimus
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/smac-mimetic-lcl161
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sodium-dichloroacetate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sonolisib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sorafenib-tosylate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/spartalizumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sting-activating-cyclic-dinucleotide-agonist-miw815
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sting-agonist-mk-1454
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/sunitinib-malate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/talazoparib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/talimogene-laherparepvec
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tamoxifen-citrate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tazemetostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/temozolomide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/temsirolimus
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tesevatinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/thalidomide
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tisagenlecleucel
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/topical-fluorouracil
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/topotecan-hydrochloride
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trabectedin
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trametinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trastuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trastuzumab-emtansine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trebananib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tremelimumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/triapine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trifluridinetipiracil-hydrochloride-combination-agent-tas-102
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/trodusquemine
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/tumor-infiltrating-lymphocyte-therapy
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ulixertinib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/ulocuplumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/urelumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/vactosertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/veliparib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/vemurafenib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/venetoclax
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/vinorelbine-tartrate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/vistusertib
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/vorinostat
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/wee1-inhibitor-azd1775
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/wild-type-reovirus
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/wt1-protein-derived-peptide-vaccine-dsp-7888
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/xentuzumab
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/intervention/zoledronic-acid
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/paying
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/safety
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/safety/patient-safety-video
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/what-are-clinical-trials
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/what-to-expect
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/why-participate
|
||
|
|
https://www.cancer.gov/research/participate/clinical-trials/why-participate/should-you-join-a-clinical-trial-video
|
||
|
|
https://www.cancer.gov/research/participate/diversity-in-cancer-research
|
||
|
|
https://www.cancer.gov/research/participate/how
|
||
|
|
https://www.cancer.gov/research/participate/how/donate-medical-data-health-samples
|
||
|
|
https://www.cancer.gov/research/participate/how/observational-studies
|
||
|
|
https://www.cancer.gov/research/participate/how/observational-studies/selected
|
||
|
|
https://www.cancer.gov/research/participate/how/prevention-trials
|
||
|
|
https://www.cancer.gov/research/participate/how/screening-trials
|
||
|
|
https://www.cancer.gov/research/participate/how/supportive-care-trials
|
||
|
|
https://www.cancer.gov/research/participate/how/treatment-trials
|
||
|
|
https://www.cancer.gov/research/participate/plan
|
||
|
|
https://www.cancer.gov/research/participate/plan/informed-consent
|
||
|
|
https://www.cancer.gov/research/participate/plan/results-from-cancer-research-study
|
||
|
|
https://www.cancer.gov/research/participate/stories
|
||
|
|
https://www.cancer.gov/research/participate/stories/adine
|
||
|
|
https://www.cancer.gov/research/participate/stories/mel
|
||
|
|
https://www.cancer.gov/research/participate/stories/raymond-osarogiagbon
|
||
|
|
https://www.cancer.gov/research/participate/stories/vivian
|
||
|
|
https://www.cancer.gov/research/participate/what-are-research-studies/why-is-cancer-research-important-infographic
|
||
|
|
https://www.cancer.gov/research/progress
|
||
|
|
https://www.cancer.gov/research/progress/250-years-milestones
|
||
|
|
https://www.cancer.gov/research/progress/annual-report-nation
|
||
|
|
https://www.cancer.gov/research/progress/annual-report-nation/breast-cancer-in-women-infographic
|
||
|
|
https://www.cancer.gov/research/progress/annual-report-nation/did-you-know-status-of-cancer-2015-video
|
||
|
|
https://www.cancer.gov/research/progress/cancer-types-research-advances
|
||
|
|
https://www.cancer.gov/research/progress/discovery
|
||
|
|
https://www.cancer.gov/research/progress/discovery/adam-improve-car-t-cell-therapies
|
||
|
|
https://www.cancer.gov/research/progress/discovery/biology-cancer-health-disparities
|
||
|
|
https://www.cancer.gov/research/progress/discovery/blood-cancer
|
||
|
|
https://www.cancer.gov/research/progress/discovery/brca
|
||
|
|
https://www.cancer.gov/research/progress/discovery/cisplatin
|
||
|
|
https://www.cancer.gov/research/progress/discovery/edith-mitchell-reduce-cancer-disparities
|
||
|
|
https://www.cancer.gov/research/progress/discovery/gleevec
|
||
|
|
https://www.cancer.gov/research/progress/discovery/gregg-prevent-familial-colon-cancer
|
||
|
|
https://www.cancer.gov/research/progress/discovery/gutcheck-intro-video
|
||
|
|
https://www.cancer.gov/research/progress/discovery/her2
|
||
|
|
https://www.cancer.gov/research/progress/discovery/hpv-vaccines
|
||
|
|
https://www.cancer.gov/research/progress/discovery/kristin-detecting-cancer-in-dense-breasts
|
||
|
|
https://www.cancer.gov/research/progress/discovery/methotrexate
|
||
|
|
https://www.cancer.gov/research/progress/discovery/mtor-inhibitors
|
||
|
|
https://www.cancer.gov/research/progress/discovery/neuroblastoma
|
||
|
|
https://www.cancer.gov/research/progress/discovery/nlst
|
||
|
|
https://www.cancer.gov/research/progress/discovery/oral-mucositis
|
||
|
|
https://www.cancer.gov/research/progress/discovery/selumetinib-plexiform-neurofibromas
|
||
|
|
https://www.cancer.gov/research/progress/discovery/selumetinib-plexiform-neurofibromas-infographic
|
||
|
|
https://www.cancer.gov/research/progress/discovery/stomach-cancer
|
||
|
|
https://www.cancer.gov/research/progress/discovery/strategies-prevention-early-detection
|
||
|
|
https://www.cancer.gov/research/progress/discovery/target-initiative
|
||
|
|
https://www.cancer.gov/research/progress/discovery/taxol
|
||
|
|
https://www.cancer.gov/research/progress/discovery/tony-quitting-smoking-after-diagnosis
|
||
|
|
https://www.cancer.gov/research/progress/discovery/velcade
|
||
|
|
https://www.cancer.gov/research/progress/discovery/victoria-support-early-stage-investigators
|
||
|
|
https://www.cancer.gov/research/progress/discovery/zach-investigational-drug-home-run
|
||
|
|
https://www.cancer.gov/research/progress/pancreatic-action-plan.pdf
|
||
|
|
https://www.cancer.gov/research/resources/about
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/events
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/events/cancer-ai-accelerator-visioning-summary-2023-01.pdf
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/events/computational-approaches-addressing-imperfect-data-2023-04.pdf
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/funding
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/research-highlights
|
||
|
|
https://www.cancer.gov/research/resources/ai-cancer-research/resources-tools
|
||
|
|
https://www.cancer.gov/research/resources/citizen-science
|
||
|
|
https://www.cancer.gov/research/resources/citizen-science/partnering-with-public-seminar-series
|
||
|
|
https://www.cancer.gov/research/resources/citizen-science/resources
|
||
|
|
https://www.cancer.gov/research/resources/citizen-science/working-group
|
||
|
|
https://www.cancer.gov/research/resources/community-hub
|
||
|
|
https://www.cancer.gov/research/resources/cryoem
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/access
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/faqs
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/publications/ncef-publications
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/sif.pdf
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/team-members
|
||
|
|
https://www.cancer.gov/research/resources/cryoem/titan-krios-build-video
|
||
|
|
https://www.cancer.gov/research/supporting-cancer-research-workforce-infographic
|
||
|
|
https://www.cancer.gov/research/training-career-development.pdf
|
||
|
|
https://www.cancer.gov/research/why-invest-in-basic-science-infographic
|
||
|
|
https://www.cancer.gov/resources-for
|
||
|
|
https://www.cancer.gov/resources-for/advocates
|
||
|
|
https://www.cancer.gov/resources-for/caregivers
|
||
|
|
https://www.cancer.gov/resources-for/hp
|
||
|
|
https://www.cancer.gov/resources-for/hp/education
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-classroom-cancer-control-video
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-classroom-clinical-trials-101-video
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-classroom-clinical-trials-102-video
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-classroom-screening-video
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-classroom-treatment-video
|
||
|
|
https://www.cancer.gov/resources-for/hp/education/cancer-patient-education-resource
|
||
|
|
https://www.cancer.gov/resources-for/industry
|
||
|
|
https://www.cancer.gov/resources-for/international-partners
|
||
|
|
https://www.cancer.gov/resources-for/patients
|
||
|
|
https://www.cancer.gov/resources-for/researchers
|
||
|
|
https://www.cancer.gov/resources-for/researchers/certificates-confidentiality
|
||
|
|
https://www.cancer.gov/social-media
|
||
|
|
https://www.cancer.gov/syndication
|
||
|
|
https://www.cancer.gov/syndication/api
|
||
|
|
https://www.cancer.gov/syndication/rss
|
||
|
|
https://www.cancer.gov/syndication/widgets
|
||
|
|
https://www.cancer.gov/tj-sharpe-biomarkers-immunotherapy-melanoma
|
||
|
|
https://www.cancer.gov/tp53.pdf
|
||
|
|
https://www.cancer.gov/trial-resources-video
|
||
|
|
https://www.cancer.gov/types
|
||
|
|
https://www.cancer.gov/types/adrenocortical
|
||
|
|
https://www.cancer.gov/types/adrenocortical/hp
|
||
|
|
https://www.cancer.gov/types/adrenocortical/hp/adrenocortical-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/adrenocortical/hp/child-adrenocortical-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/adrenocortical/patient/adrenocortical-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/adrenocortical/patient/child-adrenocortical-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/adrenocortical/research
|
||
|
|
https://www.cancer.gov/types/anal
|
||
|
|
https://www.cancer.gov/types/anal/hp
|
||
|
|
https://www.cancer.gov/types/anal/hp/anal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/anal/hp/anal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/anal/patient/anal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/anal/patient/anal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/anal/research
|
||
|
|
https://www.cancer.gov/types/anal/research/electrocautery
|
||
|
|
https://www.cancer.gov/types/anal/research/quad-hpv-vaccine-men
|
||
|
|
https://www.cancer.gov/types/aya
|
||
|
|
https://www.cancer.gov/types/aya/after-diagnosis
|
||
|
|
https://www.cancer.gov/types/aya/aya-fertility
|
||
|
|
https://www.cancer.gov/types/aya/end-of-life
|
||
|
|
https://www.cancer.gov/types/aya/overview-video
|
||
|
|
https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf
|
||
|
|
https://www.cancer.gov/types/aya/support
|
||
|
|
https://www.cancer.gov/types/bladder
|
||
|
|
https://www.cancer.gov/types/bladder/causes-risk-factors
|
||
|
|
https://www.cancer.gov/types/bladder/childhood
|
||
|
|
https://www.cancer.gov/types/bladder/coping
|
||
|
|
https://www.cancer.gov/types/bladder/diagnosis
|
||
|
|
https://www.cancer.gov/types/bladder/did-you-know-bladder-cancer-video
|
||
|
|
https://www.cancer.gov/types/bladder/hp
|
||
|
|
https://www.cancer.gov/types/bladder/hp/bladder-screening-pdq
|
||
|
|
https://www.cancer.gov/types/bladder/hp/bladder-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bladder/hp/child-bladder-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bladder/research
|
||
|
|
https://www.cancer.gov/types/bladder/research/articles
|
||
|
|
https://www.cancer.gov/types/bladder/research/chemoradiation
|
||
|
|
https://www.cancer.gov/types/bladder/screening
|
||
|
|
https://www.cancer.gov/types/bladder/stages
|
||
|
|
https://www.cancer.gov/types/bladder/survival
|
||
|
|
https://www.cancer.gov/types/bladder/symptoms
|
||
|
|
https://www.cancer.gov/types/bladder/treatment
|
||
|
|
https://www.cancer.gov/types/bladder/treatment/by-stage
|
||
|
|
https://www.cancer.gov/types/bone
|
||
|
|
https://www.cancer.gov/types/bone/bone-fact-sheet
|
||
|
|
https://www.cancer.gov/types/bone/hp
|
||
|
|
https://www.cancer.gov/types/bone/hp/child-chordoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/patient/child-chordoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/patient/ewing-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/patient/osteosarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/bone/research
|
||
|
|
https://www.cancer.gov/types/brain
|
||
|
|
https://www.cancer.gov/types/brain/addressing-brain-tumor-treatment-video
|
||
|
|
https://www.cancer.gov/types/brain/adult-astrocytoma-survivor-video
|
||
|
|
https://www.cancer.gov/types/brain/adult-brain-tumor-research-fb-live-video
|
||
|
|
https://www.cancer.gov/types/brain/connect-overview-video
|
||
|
|
https://www.cancer.gov/types/brain/dyk-brain-cancer
|
||
|
|
https://www.cancer.gov/types/brain/hp
|
||
|
|
https://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-astrocytoma-glioma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-brain-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-cns-embryonal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-cns-germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-cranio-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/adult-brain-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/child-cns-atrt-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/child-cns-embryonal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/child-cns-germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/child-cranio-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/brain/patient/childhood-ependymoma
|
||
|
|
https://www.cancer.gov/types/brain/patient/childhood-glioma-astrocytoma
|
||
|
|
https://www.cancer.gov/types/brain/patient/diffuse-intrinsic-pontine-glioma
|
||
|
|
https://www.cancer.gov/types/brain/patient/glioblastoma-caregiver-video
|
||
|
|
https://www.cancer.gov/types/brain/research
|
||
|
|
https://www.cancer.gov/types/brain/research/articles
|
||
|
|
https://www.cancer.gov/types/brain/research/chemotherapy-improves-survival
|
||
|
|
https://www.cancer.gov/types/brain/research/video-helps-end-of-life-discussions
|
||
|
|
https://www.cancer.gov/types/breast
|
||
|
|
https://www.cancer.gov/types/breast/abortion-miscarriage-risk
|
||
|
|
https://www.cancer.gov/types/breast/breast-cancer-disparities-video
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/breast-biopsy.pdf
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/dense-breasts
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/talk-about-breast-changes.pdf
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/understanding-breast-changes.epub
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/understanding-breast-changes.mobi
|
||
|
|
https://www.cancer.gov/types/breast/breast-changes/understanding-breast-changes.pdf
|
||
|
|
https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/did-you-know-breast-2014-video
|
||
|
|
https://www.cancer.gov/types/breast/ere-workshop-statement
|
||
|
|
https://www.cancer.gov/types/breast/hp
|
||
|
|
https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/breast-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/breast-screening-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/child-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/male-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/hp/pregnancy-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/ibc-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/mammograms-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/paget-breast-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/patient/breast-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/breast/patient/breast-screening-pdq
|
||
|
|
https://www.cancer.gov/types/breast/patient/breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/patient/child-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/patient/male-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/patient/pregnancy-breast-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/breast/reconstruction-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/research
|
||
|
|
https://www.cancer.gov/types/breast/research/10-years-tamoxifen
|
||
|
|
https://www.cancer.gov/types/breast/research/additional-surgery-variation
|
||
|
|
https://www.cancer.gov/types/breast/research/adjuvant-bisphosphonates-meta-analysis
|
||
|
|
https://www.cancer.gov/types/breast/research/advanced-cancer-research-fb-live-video
|
||
|
|
https://www.cancer.gov/types/breast/research/altto
|
||
|
|
https://www.cancer.gov/types/breast/research/altto-qa
|
||
|
|
https://www.cancer.gov/types/breast/research/articles
|
||
|
|
https://www.cancer.gov/types/breast/research/benefit-risk-tool
|
||
|
|
https://www.cancer.gov/types/breast/research/cisnet-interview-modeling-cronin-video
|
||
|
|
https://www.cancer.gov/types/breast/research/eribulin-improves-survival
|
||
|
|
https://www.cancer.gov/types/breast/research/ert-benefits-risks-age
|
||
|
|
https://www.cancer.gov/types/breast/research/everolimus-plus-exemestane
|
||
|
|
https://www.cancer.gov/types/breast/research/exemestane-prolongs-survival
|
||
|
|
https://www.cancer.gov/types/breast/research/exemestane-reduces-risk
|
||
|
|
https://www.cancer.gov/types/breast/research/experts-discuss-challenges-breast-cancer-research-video
|
||
|
|
https://www.cancer.gov/types/breast/research/interval-breast-cancer
|
||
|
|
https://www.cancer.gov/types/breast/research/less-heart-toxic-regimen
|
||
|
|
https://www.cancer.gov/types/breast/research/letrozole-prevents-recurrence
|
||
|
|
https://www.cancer.gov/types/breast/research/menopausal-ht-risk
|
||
|
|
https://www.cancer.gov/types/breast/research/occult-mets
|
||
|
|
https://www.cancer.gov/types/breast/research/palbociclib-hormone-receptor-positive
|
||
|
|
https://www.cancer.gov/types/breast/research/radiation-improves-survival
|
||
|
|
https://www.cancer.gov/types/breast/research/ribociclib-metastatic-breast
|
||
|
|
https://www.cancer.gov/types/breast/research/star-trial-results-qa
|
||
|
|
https://www.cancer.gov/types/breast/research/t-dm1
|
||
|
|
https://www.cancer.gov/types/breast/research/tailorx
|
||
|
|
https://www.cancer.gov/types/breast/research/tailorx-low-risk
|
||
|
|
https://www.cancer.gov/types/breast/research/tamoxifen-15-year-benefits
|
||
|
|
https://www.cancer.gov/types/breast/research/tamoxifen-long-lasting-benefit
|
||
|
|
https://www.cancer.gov/types/breast/research/tmist-trial
|
||
|
|
https://www.cancer.gov/types/breast/research/trastuzumab-after-chemo
|
||
|
|
https://www.cancer.gov/types/breast/research/trastuzumab-locally-advanced-inflammatory
|
||
|
|
https://www.cancer.gov/types/breast/research/two-drugs-one-target
|
||
|
|
https://www.cancer.gov/types/breast/risk-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/risk-reducing-surgery-fact-sheet
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/lymphedema
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/surgery-choices-learn-about-video
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/surgery-choices-talk-with-doc-video
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/surgery-choices-think-about-video
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/surgery-choices.epub
|
||
|
|
https://www.cancer.gov/types/breast/surgery-choices/surgery-choices.mobi
|
||
|
|
https://www.cancer.gov/types/by-body-location
|
||
|
|
https://www.cancer.gov/types/cardiac/hp-child-cardiac-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/cardiac/patient-child-cardiac-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/cervical
|
||
|
|
https://www.cancer.gov/types/cervical/causes-risk-prevention
|
||
|
|
https://www.cancer.gov/types/cervical/childhood-cervical-vaginal-cancer
|
||
|
|
https://www.cancer.gov/types/cervical/coping
|
||
|
|
https://www.cancer.gov/types/cervical/diagnosis
|
||
|
|
https://www.cancer.gov/types/cervical/did-you-know-cervical-cancer-video
|
||
|
|
https://www.cancer.gov/types/cervical/did-you-know-hpv-video
|
||
|
|
https://www.cancer.gov/types/cervical/facebook-live-cervical-treatments-video
|
||
|
|
https://www.cancer.gov/types/cervical/hp
|
||
|
|
https://www.cancer.gov/types/cervical/hp/cervical-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/cervical/hp/cervical-screening-pdq
|
||
|
|
https://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/cervical/hp/child-cervical-vaginal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/cervical/research
|
||
|
|
https://www.cancer.gov/types/cervical/research/cervarix-prevents-hpv
|
||
|
|
https://www.cancer.gov/types/cervical/research/gardasil9-prevents-more-hpv-types
|
||
|
|
https://www.cancer.gov/types/cervical/research/gemcitabine-improves-survival
|
||
|
|
https://www.cancer.gov/types/cervical/screening
|
||
|
|
https://www.cancer.gov/types/cervical/screening/abnormal-hpv-pap-test-results
|
||
|
|
https://www.cancer.gov/types/cervical/screening/abnormal-hpv-pap-test-results/understanding-cervical-changes.pdf
|
||
|
|
https://www.cancer.gov/types/cervical/stages
|
||
|
|
https://www.cancer.gov/types/cervical/survival
|
||
|
|
https://www.cancer.gov/types/cervical/symptoms
|
||
|
|
https://www.cancer.gov/types/cervical/treatment
|
||
|
|
https://www.cancer.gov/types/cervical/treatment/by-stage
|
||
|
|
https://www.cancer.gov/types/cervical/treatment/cancer-treatment-during-pregnancy
|
||
|
|
https://www.cancer.gov/types/childhood-cancers
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/caring-for-children-with-cancer-video
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/ccss
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/childhood-cancer-awareness-facebook-live
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/allogeneic
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/autologous
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/car-t-cell-therapy
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp-stem-cell-transplant/gvhd
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/hp/rare-childhood-cancers-pdq
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/immunotherapy-pediatric-treatment-facebook-live-video
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/late-effects-hp-pdq
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/late-effects-pdq
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/patient/rare-childhood-cancers-pdq
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/pediatric-genomics-hp-pdq
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research/aprepitant-side-effects
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research/childhood-genomics-workshop-summary
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research/childhood-genomics-workshop-summary.pdf
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research/ct-scans-risk
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/research/pediatric-analysis.pdf
|
||
|
|
https://www.cancer.gov/types/childhood-cancers/treatment-considerations-video
|
||
|
|
https://www.cancer.gov/types/colorectal
|
||
|
|
https://www.cancer.gov/types/colorectal/colorectal-cancer-prevention-screening-video
|
||
|
|
https://www.cancer.gov/types/colorectal/colorectal-screening-cdc-psa
|
||
|
|
https://www.cancer.gov/types/colorectal/did-you-know-colorectal-cancer-video
|
||
|
|
https://www.cancer.gov/types/colorectal/hp
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/child-colorectal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/colon-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/colorectal-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/colorectal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/colorectal-screening-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/hp/rectal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/patient/child-colorectal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/patient/colon-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/patient/colorectal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/patient/colorectal-screening-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/patient/rectal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/colorectal/rectal-cancer-facebook-live-video
|
||
|
|
https://www.cancer.gov/types/colorectal/research
|
||
|
|
https://www.cancer.gov/types/colorectal/research/articles
|
||
|
|
https://www.cancer.gov/types/colorectal/research/aspirin-reduces-risk
|
||
|
|
https://www.cancer.gov/types/colorectal/research/bevacizumab-severe-side-effects
|
||
|
|
https://www.cancer.gov/types/colorectal/research/cetuximab-chemo-no-benefit
|
||
|
|
https://www.cancer.gov/types/colorectal/research/colonoscopy-reduces-deaths
|
||
|
|
https://www.cancer.gov/types/colorectal/research/forte-colorectal-cancer-prevention
|
||
|
|
https://www.cancer.gov/types/colorectal/research/screening-sigmoidoscopy
|
||
|
|
https://www.cancer.gov/types/colorectal/research/tas-102-overall-survival
|
||
|
|
https://www.cancer.gov/types/colorectal/research/virtual-colonoscopy-results-qa
|
||
|
|
https://www.cancer.gov/types/colorectal/screening-fact-sheet
|
||
|
|
https://www.cancer.gov/types/common-cancers
|
||
|
|
https://www.cancer.gov/types/esophageal
|
||
|
|
https://www.cancer.gov/types/esophageal/did-you-know-esophageal-cancer-video
|
||
|
|
https://www.cancer.gov/types/esophageal/hp
|
||
|
|
https://www.cancer.gov/types/esophageal/hp/child-esophageal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/hp/esophageal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/hp/esophageal-screening-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/hp/esophageal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/patient/child-esophageal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/patient/esophageal-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/patient/esophageal-screening-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/patient/esophageal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/esophageal/research
|
||
|
|
https://www.cancer.gov/types/esophageal/research/preop-treatment-improves-survival
|
||
|
|
https://www.cancer.gov/types/extracranial-germ-cell
|
||
|
|
https://www.cancer.gov/types/extracranial-germ-cell/hp
|
||
|
|
https://www.cancer.gov/types/extracranial-germ-cell/hp/germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/extracranial-germ-cell/patient/germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/extragonadal-germ-cell
|
||
|
|
https://www.cancer.gov/types/extragonadal-germ-cell/hp
|
||
|
|
https://www.cancer.gov/types/extragonadal-germ-cell/hp/extragonadal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/extragonadal-germ-cell/patient/extragonadal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/eye
|
||
|
|
https://www.cancer.gov/types/eye/hp
|
||
|
|
https://www.cancer.gov/types/eye/hp/child-intraocular-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/eye/patient/child-intraocular-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/eye/patient/intraocular-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/eye/research
|
||
|
|
https://www.cancer.gov/types/gallbladder
|
||
|
|
https://www.cancer.gov/types/gallbladder/hp
|
||
|
|
https://www.cancer.gov/types/gallbladder/hp/gallbladder-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gallbladder/patient/gallbladder-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gestational-trophoblastic
|
||
|
|
https://www.cancer.gov/types/gestational-trophoblastic/hp
|
||
|
|
https://www.cancer.gov/types/gestational-trophoblastic/hp/gtd-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gestational-trophoblastic/patient/gtd-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/hp
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/hp/gi-neuroendocrine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/hp/pediatric-gi-neuroendocrine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/patient/child-gi-neuroendocrine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/patient/gi-neuroendocrine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/gi-neuroendocrine-tumors/research
|
||
|
|
https://www.cancer.gov/types/head-and-neck
|
||
|
|
https://www.cancer.gov/types/head-and-neck/did-you-know-oral-cancer-video
|
||
|
|
https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/hypopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/laryngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/lip-mouth-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/metastatic-squamous-neck-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/nasopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/oropharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/paranasal-sinus-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/adult/salivary-gland-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child/esthesioneuroblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child/laryngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child/nasopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child/oral-cavity-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/child/salivary-gland-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/oral-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/hp/oral-screening-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/hypopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/laryngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/lip-mouth-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/metastatic-squamous-neck-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/nasopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/oropharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/paranasal-sinus-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/adult/salivary-gland-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child/esthesioneuroblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child/laryngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child/nasopharyngeal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child/oral-cavity-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/child/salivary-gland-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/oral-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/patient/oral-screening-pdq
|
||
|
|
https://www.cancer.gov/types/head-and-neck/research
|
||
|
|
https://www.cancer.gov/types/head-and-neck/research/nivolumab-hnscc
|
||
|
|
https://www.cancer.gov/types/head-and-neck/research/pet-ct-surveillance
|
||
|
|
https://www.cancer.gov/types/kidney
|
||
|
|
https://www.cancer.gov/types/kidney/did-you-know-kidney-cancer-2016-video
|
||
|
|
https://www.cancer.gov/types/kidney/hp
|
||
|
|
https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics
|
||
|
|
https://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/patient/kidney-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/patient/transitional-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/patient/wilms-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/kidney/research
|
||
|
|
https://www.cancer.gov/types/kidney/research/articles
|
||
|
|
https://www.cancer.gov/types/langerhans
|
||
|
|
https://www.cancer.gov/types/langerhans/hp
|
||
|
|
https://www.cancer.gov/types/langerhans/hp/langerhans-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/langerhans/patient/langerhans-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia
|
||
|
|
https://www.cancer.gov/types/leukemia/dyk-leukemia-video
|
||
|
|
https://www.cancer.gov/types/leukemia/hp
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-apl-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-cml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/childhood-jmml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/myeloid-dysplastic-neoplasms-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq/myeloid-proliferations-down-syndrome-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/cml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/hp/hairy-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/adult-all-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/child-all-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/child-aml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/patient/hairy-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/leukemia/research
|
||
|
|
https://www.cancer.gov/types/leukemia/research/articles
|
||
|
|
https://www.cancer.gov/types/leukemia/research/cladribine-hairy-cell
|
||
|
|
https://www.cancer.gov/types/leukemia/research/ibrutinib-cll
|
||
|
|
https://www.cancer.gov/types/leukemia/research/idelalisib-rituximab-cll
|
||
|
|
https://www.cancer.gov/types/leukemia/research/more-chemo-helps-all
|
||
|
|
https://www.cancer.gov/types/leukemia/research/myelomatch-trials
|
||
|
|
https://www.cancer.gov/types/leukemia/research/obinutuzumab-chlorambucil-cll
|
||
|
|
https://www.cancer.gov/types/leukemia/research/ponatinib-cml
|
||
|
|
https://www.cancer.gov/types/liver
|
||
|
|
https://www.cancer.gov/types/liver/bile-duct-cancer
|
||
|
|
https://www.cancer.gov/types/liver/bile-duct-cancer/causes-risk-factors
|
||
|
|
https://www.cancer.gov/types/liver/bile-duct-cancer/diagnosis
|
||
|
|
https://www.cancer.gov/types/liver/bile-duct-cancer/stages
|
||
|
|
https://www.cancer.gov/types/liver/bile-duct-cancer/treatment
|
||
|
|
https://www.cancer.gov/types/liver/ccr-liver-cancer-clinical-trials-video
|
||
|
|
https://www.cancer.gov/types/liver/childhood-liver-cancer
|
||
|
|
https://www.cancer.gov/types/liver/childhood-liver-cancer/hepatoblastoma
|
||
|
|
https://www.cancer.gov/types/liver/childhood-liver-cancer/hepatocellular-carcinoma
|
||
|
|
https://www.cancer.gov/types/liver/childhood-liver-cancer/infantile-choriocarcinoma
|
||
|
|
https://www.cancer.gov/types/liver/childhood-liver-cancer/undifferentiated-embryonal-sarcoma
|
||
|
|
https://www.cancer.gov/types/liver/did-you-know-liver-cancer-2014-video
|
||
|
|
https://www.cancer.gov/types/liver/dyk-hepatitis-liver-cancer-video
|
||
|
|
https://www.cancer.gov/types/liver/hp
|
||
|
|
https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/liver/hp/liver-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/liver/hp/liver-screening-pdq
|
||
|
|
https://www.cancer.gov/types/liver/liver-cancer-research-twitter-video
|
||
|
|
https://www.cancer.gov/types/liver/research
|
||
|
|
https://www.cancer.gov/types/liver/research/articles
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer/causes-risk-factors
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer/diagnosis
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer/screening
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer/stages
|
||
|
|
https://www.cancer.gov/types/liver/what-is-liver-cancer/treatment
|
||
|
|
https://www.cancer.gov/types/lung
|
||
|
|
https://www.cancer.gov/types/lung/changing-landscape-lung-cancer-research-google-hangout-video
|
||
|
|
https://www.cancer.gov/types/lung/did-you-know-lung-cancer-video
|
||
|
|
https://www.cancer.gov/types/lung/hp
|
||
|
|
https://www.cancer.gov/types/lung/hp/child-pleuropulmonary-blastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/child-pulmonary-inflammatory-myofibroblastic-tumor-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/child-tracheobronchial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/lung-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/lung-screening-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/hp/small-cell-lung-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/child-pleuropulmonary-blastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/child-tracheobronchial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/lung-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/lung-screening-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lung/research
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemist
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemist-a081105.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemist-a151216.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemist-e4512.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemist-ea5142.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/alchemistinto.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/alechmist-launch-qa
|
||
|
|
https://www.cancer.gov/types/lung/research/articles
|
||
|
|
https://www.cancer.gov/types/lung/research/crizotinib
|
||
|
|
https://www.cancer.gov/types/lung/research/dr-david-gandara-lung-map-trial
|
||
|
|
https://www.cancer.gov/types/lung/research/lung-map
|
||
|
|
https://www.cancer.gov/types/lung/research/nlst
|
||
|
|
https://www.cancer.gov/types/lung/research/nlst-qa
|
||
|
|
https://www.cancer.gov/types/lung/research/nlststudyguidepatientsphysicians.pdf
|
||
|
|
https://www.cancer.gov/types/lung/research/pd-1-immunotherapy
|
||
|
|
https://www.cancer.gov/types/lung/research/pembrolizumab-nsclc-keynote-024
|
||
|
|
https://www.cancer.gov/types/lung/research/pragmatica-lung-cancer-trial
|
||
|
|
https://www.cancer.gov/types/lymphoma
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/aids-related-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/b-cell-lymphoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/child-hodgkin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/child-nhl-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/mycosis-fungoides-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/non-hodgkin-lymphoma-treatment-during-pregnancy-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/peripheral-t-cell-lymphoma-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/hp/primary-cns-lymphoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/aids-related-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/child-hodgkin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/child-nhl-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/mycosis-fungoides-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/patient/primary-cns-lymphoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/lymphoma/research
|
||
|
|
https://www.cancer.gov/types/lymphoma/research/articles
|
||
|
|
https://www.cancer.gov/types/lymphoma/research/bendamustine-rituximab
|
||
|
|
https://www.cancer.gov/types/lymphoma/research/rituximab-retreatment-follicular
|
||
|
|
https://www.cancer.gov/types/mesothelioma
|
||
|
|
https://www.cancer.gov/types/mesothelioma/hp
|
||
|
|
https://www.cancer.gov/types/mesothelioma/hp/child-mesothelioma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/mesothelioma/hp/mesothelioma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/mesothelioma/patient/child-mesothelioma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/metastatic-cancer
|
||
|
|
https://www.cancer.gov/types/metastatic-cancer/how-cancer-spreads-video
|
||
|
|
https://www.cancer.gov/types/metastatic-cancer/research
|
||
|
|
https://www.cancer.gov/types/metastatic-cancer/research/cardiac-tumors
|
||
|
|
https://www.cancer.gov/types/metastatic-cancer/research/oxygen-metastasis-video
|
||
|
|
https://www.cancer.gov/types/midline/hp-child-midline-tract-carcinoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/midline/patient-child-midline-tract-carcinoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/multiple-endocrine-neoplasia/hp-child-men-syndromes-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/multiple-endocrine-neoplasia/patient-child-men-syndromes-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloma
|
||
|
|
https://www.cancer.gov/types/myeloma/hp
|
||
|
|
https://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloma/patient/myeloma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloma/research
|
||
|
|
https://www.cancer.gov/types/myeloma/research/carfilzomib-lenalidomide-dexamethasone
|
||
|
|
https://www.cancer.gov/types/myeloma/research/daratumumab-castor-pollux
|
||
|
|
https://www.cancer.gov/types/myeloma/research/pomalidomide-dexamethasone
|
||
|
|
https://www.cancer.gov/types/myeloproliferative
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/hp
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/hp/mds-mpd-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/hp/myeloproliferative-neoplasms-treatment
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/patient/chronic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/patient/mds-mpd-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/neuroblastoma
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/hp
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-screening-pdq
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/patient/neuroblastoma-screening-pdq
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/patient/neuroblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/neuroblastoma/research
|
||
|
|
https://www.cancer.gov/types/ovarian
|
||
|
|
https://www.cancer.gov/types/ovarian/did-you-know-ovarian-cancer-video
|
||
|
|
https://www.cancer.gov/types/ovarian/hp
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/child-ovarian-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/ovarian-borderline-tumors-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/ovarian-epithelial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/ovarian-germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/ovarian-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/hp/ovarian-screening-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/child-ovarian-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/ovarian-germ-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/ovarian-low-malignant-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/ovarian-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/patient/ovarian-screening-pdq
|
||
|
|
https://www.cancer.gov/types/ovarian/research
|
||
|
|
https://www.cancer.gov/types/ovarian/research/articles
|
||
|
|
https://www.cancer.gov/types/ovarian/research/bevacizumab-combo-chemo
|
||
|
|
https://www.cancer.gov/types/ovarian/research/hrt-survival
|
||
|
|
https://www.cancer.gov/types/pancreatic
|
||
|
|
https://www.cancer.gov/types/pancreatic/did-you-know-pancreatic-cancer-video
|
||
|
|
https://www.cancer.gov/types/pancreatic/future-of-pancreatic-cancer-research-and-treatment-video
|
||
|
|
https://www.cancer.gov/types/pancreatic/hp
|
||
|
|
https://www.cancer.gov/types/pancreatic/hp/child-pancreatic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/patient/child-pancreatic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/patient/pancreatic-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pancreatic/research
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/advances-video
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/articles
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/folfirinox
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/nab-paclitaxel-gemcitabine
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/neuroendocrine-sunitinib-everolimus
|
||
|
|
https://www.cancer.gov/types/pancreatic/research/pancreatic-research-progress-2012.pdf
|
||
|
|
https://www.cancer.gov/types/parathyroid
|
||
|
|
https://www.cancer.gov/types/parathyroid/hp
|
||
|
|
https://www.cancer.gov/types/parathyroid/hp/parathyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/parathyroid/patient/parathyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/penile
|
||
|
|
https://www.cancer.gov/types/penile/hp
|
||
|
|
https://www.cancer.gov/types/penile/hp/penile-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/penile/patient/penile-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/penile/research
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma/hp
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma/hp/child-pheochromocytoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma/patient/child-pheochromocytoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pheochromocytoma/patient/pheochromocytoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pituitary
|
||
|
|
https://www.cancer.gov/types/pituitary/hp
|
||
|
|
https://www.cancer.gov/types/pituitary/hp/pituitary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/pituitary/patient/pituitary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/prostate
|
||
|
|
https://www.cancer.gov/types/prostate/did-you-know-prostate-cancer-video
|
||
|
|
https://www.cancer.gov/types/prostate/hp
|
||
|
|
https://www.cancer.gov/types/prostate/hp/prostate-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/hp/prostate-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/hp/prostate-screening-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/hp/prostate-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/patient/prostate-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/prostate/prostate-cancer-youtube-live-video
|
||
|
|
https://www.cancer.gov/types/prostate/prostate-hormone-therapy-fact-sheet
|
||
|
|
https://www.cancer.gov/types/prostate/psa-fact-sheet
|
||
|
|
https://www.cancer.gov/types/prostate/research
|
||
|
|
https://www.cancer.gov/types/prostate/research/abiraterone
|
||
|
|
https://www.cancer.gov/types/prostate/research/articles
|
||
|
|
https://www.cancer.gov/types/prostate/research/chemohormonal-treatment-extends-survival
|
||
|
|
https://www.cancer.gov/types/prostate/research/denosumab-bone-fractures
|
||
|
|
https://www.cancer.gov/types/prostate/research/enzalutamide-metastatic
|
||
|
|
https://www.cancer.gov/types/prostate/research/finasteride-reduces-low-grade
|
||
|
|
https://www.cancer.gov/types/prostate/research/plco-screening-results-qa
|
||
|
|
https://www.cancer.gov/types/prostate/research/prostate-cancer-prevention-trial-qa
|
||
|
|
https://www.cancer.gov/types/prostate/research/psa-velocity-detection
|
||
|
|
https://www.cancer.gov/types/prostate/research/radium-223-improves-survival
|
||
|
|
https://www.cancer.gov/types/prostate/research/screening-psa-dre
|
||
|
|
https://www.cancer.gov/types/prostate/research/select-trial-results-qa
|
||
|
|
https://www.cancer.gov/types/prostate/understanding-prostate-changes
|
||
|
|
https://www.cancer.gov/types/recurrent-cancer
|
||
|
|
https://www.cancer.gov/types/retinoblastoma
|
||
|
|
https://www.cancer.gov/types/retinoblastoma/hp
|
||
|
|
https://www.cancer.gov/types/retinoblastoma/hp/retinoblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/retinoblastoma/patient/retinoblastoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/retinoblastoma/research
|
||
|
|
https://www.cancer.gov/types/skin
|
||
|
|
https://www.cancer.gov/types/skin/did-you-know-melanoma-cancer-2014-video
|
||
|
|
https://www.cancer.gov/types/skin/hp
|
||
|
|
https://www.cancer.gov/types/skin/hp/child-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/child-skin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/merkel-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/skin-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/skin-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/skin-screening-pdq
|
||
|
|
https://www.cancer.gov/types/skin/hp/skin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/melanoma-facebook-live
|
||
|
|
https://www.cancer.gov/types/skin/melanoma-photos
|
||
|
|
https://www.cancer.gov/types/skin/mole-photos
|
||
|
|
https://www.cancer.gov/types/skin/moles-fact-sheet
|
||
|
|
https://www.cancer.gov/types/skin/patient/child-melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/child-skin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/merkel-cell-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/skin-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/skin-screening-pdq
|
||
|
|
https://www.cancer.gov/types/skin/patient/skin-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/skin/research
|
||
|
|
https://www.cancer.gov/types/skin/research/advanced-melanoma-therapies
|
||
|
|
https://www.cancer.gov/types/skin/research/articles
|
||
|
|
https://www.cancer.gov/types/skin/research/dabrafenib-trametinib
|
||
|
|
https://www.cancer.gov/types/skin/research/nivolumab
|
||
|
|
https://www.cancer.gov/types/skin/research/nivolumab-checkmate067
|
||
|
|
https://www.cancer.gov/types/skin/research/pembrolizumab
|
||
|
|
https://www.cancer.gov/types/skin/research/pembrolizumab-ipilimumab-resistance
|
||
|
|
https://www.cancer.gov/types/skin/research/smaller-margins
|
||
|
|
https://www.cancer.gov/types/skin/research/vemurafenib-ipilimumab
|
||
|
|
https://www.cancer.gov/types/skin/research/vismodegib-basal-cell
|
||
|
|
https://www.cancer.gov/types/skin/skin-cancer-in-black-or-brown-skin
|
||
|
|
https://www.cancer.gov/types/small-intestine
|
||
|
|
https://www.cancer.gov/types/small-intestine/hp
|
||
|
|
https://www.cancer.gov/types/small-intestine/hp/small-intestine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/small-intestine/patient/small-intestine-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/small-intestine/research
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/gist-facebook-live-video
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/adult-soft-tissue-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-gist-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-soft-tissue-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/child-vascular-tumors-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/gist-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/kaposi-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/hp/rhabdomyosarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/child-gist-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/child-soft-tissue-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/child-vascular-tumors-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/gist-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/kaposi-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/patient/rhabdomyosarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/research
|
||
|
|
https://www.cancer.gov/types/soft-tissue-sarcoma/research/regorafenib-gist
|
||
|
|
https://www.cancer.gov/types/stomach
|
||
|
|
https://www.cancer.gov/types/stomach/causes-risk-factors
|
||
|
|
https://www.cancer.gov/types/stomach/childhood
|
||
|
|
https://www.cancer.gov/types/stomach/coping
|
||
|
|
https://www.cancer.gov/types/stomach/diagnosis
|
||
|
|
https://www.cancer.gov/types/stomach/hp
|
||
|
|
https://www.cancer.gov/types/stomach/hp/gastric-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/stomach/hp/pediatric-gastric-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/stomach/hp/stomach-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/stomach/hp/stomach-screening-pdq
|
||
|
|
https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/stomach/research
|
||
|
|
https://www.cancer.gov/types/stomach/research/preop-chemo
|
||
|
|
https://www.cancer.gov/types/stomach/screening
|
||
|
|
https://www.cancer.gov/types/stomach/stages
|
||
|
|
https://www.cancer.gov/types/stomach/survival
|
||
|
|
https://www.cancer.gov/types/stomach/symptoms
|
||
|
|
https://www.cancer.gov/types/stomach/treatment
|
||
|
|
https://www.cancer.gov/types/stomach/treatment/by-stage
|
||
|
|
https://www.cancer.gov/types/testicular
|
||
|
|
https://www.cancer.gov/types/testicular/did-you-know-video
|
||
|
|
https://www.cancer.gov/types/testicular/hp
|
||
|
|
https://www.cancer.gov/types/testicular/hp/child-testicular-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/hp/testicular-screening-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/hp/testicular-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/patient/child-testicular-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/patient/testicular-screening-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/testicular/research
|
||
|
|
https://www.cancer.gov/types/thymoma
|
||
|
|
https://www.cancer.gov/types/thymoma/hp
|
||
|
|
https://www.cancer.gov/types/thymoma/hp/child-thymoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thymoma/patient/child-thymoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thymoma/patient/thymoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid
|
||
|
|
https://www.cancer.gov/types/thyroid/did-you-know-thyroid-cancer-2015-video
|
||
|
|
https://www.cancer.gov/types/thyroid/hp
|
||
|
|
https://www.cancer.gov/types/thyroid/hp/child-thyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/hp/medullary-thyroid-genetics-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/hp/thryoid-screening-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/patient/child-thyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/patient/thyroid-screening-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/patient/thyroid-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/thyroid/research
|
||
|
|
https://www.cancer.gov/types/thyroid/research/articles
|
||
|
|
https://www.cancer.gov/types/thyroid/research/low-dose-radiation
|
||
|
|
https://www.cancer.gov/types/thyroid/research/sorafenib
|
||
|
|
https://www.cancer.gov/types/thyroid/research/vandetanib
|
||
|
|
https://www.cancer.gov/types/unknown-primary
|
||
|
|
https://www.cancer.gov/types/unknown-primary/hp
|
||
|
|
https://www.cancer.gov/types/unknown-primary/hp/child-unknown-primary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/unknown-primary/hp/unknown-primary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/unknown-primary/patient/child-unknown-primary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/unknown-primary/patient/unknown-primary-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/urethral
|
||
|
|
https://www.cancer.gov/types/urethral/hp
|
||
|
|
https://www.cancer.gov/types/urethral/hp/urethral-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/urethral/patient/urethral-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/uterine
|
||
|
|
https://www.cancer.gov/types/uterine/2012-endometrial-508.pdf
|
||
|
|
https://www.cancer.gov/types/uterine/did-you-know-endometrial-cancer-2016-video
|
||
|
|
https://www.cancer.gov/types/uterine/hp
|
||
|
|
https://www.cancer.gov/types/uterine/hp/endometrial-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/hp/endometrial-screening-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/hp/endometrial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/hp/uterine-sarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/patient/endometrial-prevention-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/patient/endometrial-screening-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/patient/uterine-sarcoma-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/uterine/research
|
||
|
|
https://www.cancer.gov/types/uterine/research/articles
|
||
|
|
https://www.cancer.gov/types/vaginal
|
||
|
|
https://www.cancer.gov/types/vaginal/hp
|
||
|
|
https://www.cancer.gov/types/vaginal/hp/vaginal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/vaginal/patient/vaginal-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/vaginal/research
|
||
|
|
https://www.cancer.gov/types/vulvar
|
||
|
|
https://www.cancer.gov/types/vulvar/hp
|
||
|
|
https://www.cancer.gov/types/vulvar/hp/vulvar-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/vulvar/patient/vulvar-treatment-pdq
|
||
|
|
https://www.cancer.gov/types/vulvar/research
|
||
|
|
https://www.cancer.gov/understanding-cervical-changes.epub
|
||
|
|
https://www.cancer.gov/understanding-cervical-changes.mobi
|
||
|
|
https://www.cancer.gov/video
|
||
|
|
https://www.cancer.gov/wcrd-instructions
|
||
|
|
https://www.cancer.gov/wcrd-video
|
||
|
|
https://www.cancer.gov/what-are-clinical-trials-video
|
||
|
|
https://www.cancer.gov/widgets/termdictionarywidgetenglish
|
||
|
|
https://www.cancer.gov/widgets/termdictionarywidgetspanish
|